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Abstract

CHARACTERIZATION OF ADHERENCE, CYTOTOXICITY AND BIOFILM
FORMATION BY GARDNERELLA VAGINALIS
By: Jennifer Louise Patterson, Ph.D.
A Dissertation submitted in partial fulfillment of the requirements for the degree of Doctor
of Philosophy at Virginia Commonwealth University.
Virginia Commonwealth University, 2010
Major Director: Kimberly Jefferson, Ph.D.
Assistant Professor, Department of Microbiology and Immunology

Worldwide, bacterial vaginosis (BV) is the most common vaginal disorder in
women of childbearing age. BV is of major clinical importance due to its ability to
significantly affect pregnancy outcome and enhance the transmission and acquisition of
HIV. BV is characterized by a dramatic shift in the vaginal microflora; in most BV cases,
the predominant bacterial species is Gardnerella vaginalis. It has been demonstrated that
G. vaginalis forms an adherent biofilm on the vaginal epithelium of women with BV.
Furthemore, evidence suggests that the high rate of recurrence associated with BV is

xv

related to incomplete eradication of the biofilm. The overall goal of this study was to
characterize G. vaginalis virulence properties, including biofilm formation, in order to
better understand the pathogenesis of BV and to improve available treatment methods.
In an effort to tease apart the uncertain etiology of this disorder, we utilized in vitro
assays to compare three virulence properties of G. vaginalis relative to other BVassociated anaerobes. Only G. vaginalis demonstrated all three virulence properties,
including robust biofilm formation. It has been shown that the biofilm phenotype allows
its constituent bacteria to be resistant to many negative environmental stimuli. Therefore,
we studied the susceptibilities of biofilm vs. planktonic cultures to H2O2 and lactic acid.
Biofilms tolerated higher concentrations of both chemicals; however, when the biofilm
was proteolytically disrupted, sensitivity to the chemicals returned to planktonic levels.
Since our data suggested a critical role for a protein in biofilm formation, a partial
genome sequence of G. vaginalis was searched for sequence homology to known biofilm
adhesins using the tBLASTn program. This revealed an open-reading frame encoding a
hypothetical protein with significant homology to the staphylococcal Bap protein.
Antibody towards a portion of the identified gene product was produced in rabbits by
inoculation of a recombinant peptide to an antigenic region of the protein. Antibody
inhibition assays against biofilm formation, adherence, initial adherence and aggregation
were conducted. Relative expression levels of the biofilm-associated protein were
analyzed under different conditions by western blot analysis. Finally, the protein was
expressed in heterologous hosts and analyzed for an increase in biofilm formation.

xvi

CHAPTER 1
Introduction

Clinical overview
The human vagina is a complex environment, composed of stratified squamous
nonkeratinized epithelium and its native bacteria. In normal, healthy women, the vagina
is populated mainly by hydrogen peroxide producing lactobacilli that inhibit the growth
of other vaginal flora by maintaining the vaginal acidity, competing with other bacterial
species for space and nutrients, and producing bacteriocins (Eschenbach 1993; Boskey,
Cone et al. 2001; Atassi, Brassart et al. 2006). The mild acidity of the healthy vagina has
been shown to correlate with a decreased risk of trichomoniasis, urinary tract infection
and infection with genital mycoplasma (Stamey and Timothy 1975; Hanna, TaylorRobinson et al. 1985). One of the hallmarks of bacterial vaginosis (BV) is a reduction in
vaginal acidity.
BV is the most prevalent vaginal disorder in women of reproductive age, affecting
10 to 20% of Caucasian women and 30 to 50% of African American women, although,
estimates of its prevalence depend on the population studied (Eschenbach 1993; Sobel
2000). BV is frequently observed in women attending sexually transmitted disease
(STD) clinics, where the percentage reaches as high as 40%; however, the disease can
occur in the absence of sexual intercourse (Sobel 2000). 16-29% of pregnant women are
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BV positive, although, it is more often detected in women attending infertility clinics
(Sobel 2000).
BV is characterized by a loss of protective lactobacilli, an increase in the vaginal
pH to >4.5, and the proliferation of a variety of anaerobic species. An increase in the
prevalence and concentration of Gardnerella vaginalis, Mycoplasma hominis, Atopobium
vaginae, Prevotella sp., and numerous other gram-positive rods, is characteristic of BV
(Sobel 2000; Fredricks, Fiedler et al. 2005; Fredricks, Fiedler et al. 2007; Witkin,
Linhares et al. 2007; Oakley, Fiedler et al. 2008). Risk factors for BV include sexual
activity and number of sexual partners, use of intrauterine devices, douching, antibiotic
treatment and infection with sexually transmitted diseases (Sobel 2000).
Symptoms of BV can include a thin, grayish-white vaginal discharge with a foul
odor and mild irritation, absence of inflammatory signs and increased vaginal pH;
however, many women with BV are asymptomatic (Sobel 2000). The massive
overgrowth of anaerobes associated with BV leads to an increased production of
proteolytic enzymes, which in turn break down vaginal peptides into amines that are
volatile and malodorous. These amines are associated with the foul odor of BV and
squamous epithelial cell exfoliation, creating the typical discharge abundant with clue
cells. Clue cells, which are seen in Figure 1, are vaginal epithelial cells that are coated
by bacteria and are pathognomonic for BV (Eschenbach, Hillier et al. 1988). BV is
primarily diagnosed by the Amsel criteria, which includes: presence of a thin, white
discharge, positive whiff test with addition of 10% potassium hydroxide, an elevated
vaginal pH, and the presence of clue cells (Amsel, Totten et al. 1983).
2

Figure 1. Photomicrograph of a clue cell. ME180 vaginal epithelial cells were
allowed to interact with a G. vaginalis overnight culture for 10 minutes. The
bacteria and cells were placed on a microscopy slide, allowed to dry, flamed, then
gram stained. Arrows indicate a rough edge of the VECs where bacteria is attached.
This image is representative of what a clue cell from a patient with BV would look
like. (magnification 40X)
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BV has been consistently associated with adverse pregnancy outcomes such as
preterm delivery, low birth weight, postpartum endometritis, as well as other gynecologic
complications such as pelvic inflammatory disease and vaginal cuff cellulitis (Gravett,
Hummel et al. 1986; Soper, Bump et al. 1990; Sobel 2000; Larsson, Bergstrom et al.
2005; Denney and Culhane 2009; Nelson, Hanlon et al. 2009). Studies by Oleen-Burkey
et al. and Hillier et al. have detected increased risks of preterm birth ranging from 2.0 to
6.9 odds ratio directly attributable to BV (Hillier, Nugent et al. 1995; Oleen-Burkey and
Hillier 1995); however, patients at high risk for preterm delivery who were treated with
oral metronidazole, all showed considerable reduction in the incidence of preterm labor
associated with BV (Morales, Schorr et al. 1994; Hauth, Goldenberg et al. 1995;
McGregor, French et al. 1995; Camargo, Simoes et al. 2005). Ten trials that evaluated
the use of metronidazole for routine operative prophylaxis before abortion and
hysterectomy demonstrated a substantial reduction in postoperative infectious
complications (Jackson, Ridley et al. 1979; Soper, Bump et al. 1990; Watts, Krohn et al.
1990; Larsson, Platz-Christensen et al. 1991). Because of the increased risk of
postoperative infectious complications associated with BV, some specialists suggest
screening for BV and treating women before reproductive tract surgeries.
Importantly, BV has been linked to increased acquisition and transmission of HIV
(Cohen, Duerr et al. 1995; Sewankambo, Gray et al. 1997; Kapiga, Sam et al. 2007). In a
paper by Kapiga et al., they demonstrate a 2-fold higher risk of HIV-1 in women with BV
than compared to women with normal flora (Kapiga, Sam et al. 2007). Levels of HIV
RNA in female genital mucosal fluid are also increased in women with BV, with women
5

with the lowest numbers of lactobacilli having 15.8 fold higher endocervical HIV-1 RNA
than women with normal lactobacilli levels (Coleman, Hitti et al. 2007). Normal, healthy
women with no vaginal disruptions have a low susceptibility to HIV infection because
they lack suitable HIV-1 host cells; however, BV may increase a women’s risk of HIV
acquisition by causing leukocytosis and recruitment of potential HIV-sensitive host cells
into the vagina (Anderson and Hill 1991). Many BV-associated bacterial pathogens
produce sialidases and other mucin-degrading enzymes that alter the epithelial layer thus
weakening the mucosal barrier and increasing the transmission of HIV from infected
male partners (Larsson, Bergstrom et al. 2005). Perhaps most importantly, there is a
decrease in the number of hydrogen-peroxide producing lactobacilli found in the vagina
of women with BV. Hydrogen peroxide is not only toxic to a number of microorganisms,
but capable of inactivating viruses such as HIV as well (Klebanoff and Coombs 1991). A
reduction in the amount of hydrogen peroxide in the vagina also leads to an increase in
vaginal pH and activation of CD4 lymphocytes, or HIV-target cells (Schmid, Markowitz
et al. 2000).
The most successful oral therapy for BV remains metronidazole, although
clindamycin is also used. The beneficial effect of metronidazole results from its activity
against anaerobic bacteria and the susceptibility of G. vaginalis to the
hydroxymetabolites of the antibiotic. The Centers for Disease Control and Prevention
(CDC) recommends 500 mg of metronidazole orally twice a day for 7 days. Topical
therapy with 2% clindamycin gel once daily for 7 days or 0.75% metronidazole gel once
daily for 5 days was shown to be as effective as oral metronidazole (Ferris, Litaker et al.
6

1995). Antibiotic therapy can fail in up to 60% of cases (Anukam, Osazuwa et al. 2006)
and even when effective, BV frequently recurs, with rates as high as 20% within one
month and 80% within 9 months (Hillier and Holmes 1990; Hay 1998; Beigi, Austin et
al. 2004).
Although BV is not considered an inflammatory disorder, several cytokines are
upregulated. The abnormal vaginal microbiota associated with BV has been shown to
increase cytokines like IL-1"/# and IL-8 (Platz-Christensen, Mattsby-Baltzer et al. 1993;
Wennerholm, Holm et al. 1998). Cervicovaginal lavage samples (CVL) from women
with BV were able to induce expression of TNF-" secretion by primary peripheral-blood
mononuclear cells and monocytic cell lines. The CVL samples from women with BV
also increased expression of Toll-like Receptor 4 (TLR-4) mRNA expression up to 60fold in cell lines; this suggests a new mechanism whereby BV can affect HIV
transmission (Zariffard, Novak et al. 2005). It has been seen that stimulation through
TLR4 is able to increase HIV expression by infected cells (Equils, Faure et al. 2001;
Bafica, Scanga et al. 2004); the paper by Zariffard et al. suggests that HIV-infected cells
present in the genital tract of women with BV may be directly stimulated through TLR4
to express increased levels of HIV (Zariffard, Novak et al. 2005).
Not only does an altered microbiota and presence of BV lead to changes in the
cytokine profile in the vagina, but it also affects the presence of vaginal hydrolytic
enzymes and certain immunoglobulins found in the vagina. A paper by Cauci et al.
showed that pregnant women with BV have higher concentrations of sialidase and
prolidase, two microbial enzymes that affect the vaginal epithelium integrity (Cauci, Hitti
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et al. 2002). In addition, pregnant women with BV have lower antibodies to the
vaginolysin toxin produced by G. vaginalis than women with normal flora (Cauci, Hitti et
al. 2002). The presence of higher than normal sialidase and lower amounts of antivaginolysin antibodies could potentially hamper the local mucosal immune response by
degrading glycoproteins such as antibodies, or by failing to adequately bind circulating
toxin (Pilatte, Bignon et al. 1993).
Although BV is characterized by low levels of lactobacilli and increased numbers
of anaerobic bacteria, the etiology of BV is poorly understood with no single causative
agent isolated. Gardnerella vaginalis, however, has been found to be present in up to
95% of cases and is found only rarely and in low numbers in healthy women (Gardner
and Dukes 1955). To date, BV is still considered a polymicrobial disorder and the
disruption of normal vaginal flora is not disputable; however, a critical question that
relates to the sequence of the disruption is whether the loss of protective lactobacilli and
an increase in vaginal pH must precede the overgrowth of anaerobic bacteria or whether
anaerobes such as G. vaginalis colonize the vagina leading to a decrease in lactobacilli
and increased pH.

Gardnerella vaginalis
G. vaginalis cells are small, pleomorphic rods, which were once classified as
Haemophilus sp. by Gardner and Dukes because of their ability to grow on chocolate
agar (Gardner and Dukes 1955; Catlin 1992). The tendency to retain the crystal violet
dye in the Gram reaction and some other corynebacterium-like features, suggested that
8

the organism might be better associated with the genus Corynebacterium, hence it was
referred to C. vaginale in later years (Zinnemann and Turner 1963). Finally, after two
large taxonomic studies were published in 1980 which analyzed DNA-DNA
hybridization and electron microscopy data, the bacteria were classified into a new genus
and called Gardnerella (Greenwood 1983; Piot and Van Dyck 1983).
G. vaginalis cells are nonmotile and do not possess flagella, catalase, endospores
or typical capsules (Catlin 1992). Pyrosequencing of a strain isolated from a woman
without signs of BV (G. vaginalis 5-1) found that the genome size was approximately
1.65 MB. Electron microscopy by Reyn et al. proved that G. vaginalis has a grampositive cell wall (Reyn, Birch-Andersen et al. 1966); however, the physiological state of
the bacteria affects their morphology and staining reactions (personal observation). The
bacterial cells have an angular or palisade arrangement of cells and volutin granules form
in G. vaginalis during growth in the presence of a fermentable compound, leading to
polar granule observation during gram staining (Edmunds 1960). G. vaginalis is betahemolytic on media containing human or rabbit blood but not on sheep blood agar; this
hemolysis is improved in anaerobic incubation (Edmunds 1960; Shaw, Forsyth et al.
1981; Greenwood 1983; Lam and Birch 1991). G. vaginalis produces a pore-forming
cytolysin, called vaginolysin, which is specific to mammalian epithelial cells and has
been hypothesized to be involved in the pathogenesis of BV (Gelber, Aguilar et al. 2008).
The most successful media for isolation of G. vaginalis possesses both differential
and selective features. The addition of human blood allows identification of betahemolytic G. vaginalis from nonhemolytic colonies, semiselective medium containing
9

colistin or nalidixic acid, to which G. vaginalis is resistant, allows for identification of
resistant vs. sensitive bacteria, and addition of 1% corn starch allows for identification of
G. vaginalis by the hydrolytic clearing of the opaque starch (Goldberg and Washington
II. 1976; Mickelsen, McCarthy et al. 1977). We have employed a combination of
selective and differential media, containing nalidixic acid (30!g/ml), starch, and the pH
indicator bromocresol purple. The plates contain starch and when fermented by G.
vaginalis, the pH indicator allows for selection of yellow colonies on a purple
background. Incubation of G. vaginalis at 37ºC for 24-48 hrs in an anaerobic box with
10% CO2 produces adequate growth of this fastidious organism.
Electron microscopy revealed a fibrillar exterior layer (Figure 2) and ruthenium
red staining indicates it has a polysaccharide component; however, this component is not
capsular (Criswell, Stenback et al. 1972; Greenwood 1983). Electron microscopy has
also revealed pili radiating from the surface of G. vaginalis (Johnson and Davies 1984;
Boustouller, Johnson et al. 1987). The authors noted that clinical isolates displayed more
heavily piliated cells and that laboratory strains quickly lost pili upon frequent subculture
(Johnson and Davies 1984; Boustouller, Johnson et al. 1987). Both the
exopolysaccharide component and pili could be involved in G. vaginalis extraordinary
ability to adhere to vaginal epithelial cells. It has been shown that G. vaginalis cells
adhere better to vaginal epithelial cells scraped from the vaginal wall than do L.
acidophilus cells (Mardh, Holst et al. 1984). Increasing acidity of the test medium also
allowed for high adherence of G. vaginalis to vaginal epithelial cells (Sobel, Schneider et
al. 1981). Pretreatment of G. vaginalis with subinhibitory concentrations of
10

Figure 2. Electron micrograph of G. vaginalis. Overnight G. vaginalis cultures
grown in sBHI with 8% human serum were pelleted and washed with PBS, then
negatively stained with phosphotungstic acid. Electron microscopy revealed a
fibrillar exterior layer indicated by the arrow. (Electronmicrograph courtesy of Dr.
Michael Harwich, VCU)
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metronidazole was able to significantly reduce the adherence of some of the strains tested
(Peeters and Piot 1985). Not only can G. vaginalis adhere to epithelial cells, it can
hemagglutinate red blood cells; although, it seems that different adhesins are responsible
for adherence to the two cell types (Scott and Smyth 1987). Electron microscopy verified
that adhesion to red blood cells occurred by means of pili, while adhesion to the epithelial
cell line, McCoy, involved the outer fibrillar layer (Scott, Curran et al. 1989).
G. vaginalis is sensitive to ampicillin, which was originally used to treat BV;
although, it is now treated with metronidazole or clindamycin, which have shown a
higher degree of efficiency. G. vaginalis is resistant to low levels of metronidazole;
however, it is highly susceptible to the hydroxyl-metabolite of metronidazole (Easmon,
Ison et al. 1982). It is highly resistant to colistin, nalidixic acid, and amphotericin and
can be resistant to tetracycline if the genome contains the TetM determinant, which is
most often associated with a conjugative transposon located in streptococcal species
(Huang, Gascoyne-Binzi et al. 1997).
Many animal models have been tested to analyze the role of G. vaginalis in BV;
however a practical model is still lacking. Intravenous inoculation of mice with viable G.
vaginalis produced no effects (Boustouller, Johnson et al. 1986). Different primate
species were studied in an attempt to develop an animal model of BV infection; pigtailed
macaques were colonized but no clue cells were found, tamarins and chimpanzees were
not colonized, and grivet monkeys were able to be colonized with G. vaginalis, but only
when a mixed culture of G. vaginalis and Mobiluncus were used to infection the monkey
(Johnson, Ison et al. 1984; Mardh, Holst et al. 1984). There has also been work to
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develop an equine model; Gardnerella strains have been detected in the genital flora of
mares, the first observation of natural infection in animals (Salmon, Walker et al. 1991).
The significance of G. vaginalis in BV is disputed. However, approximately 95%
of women suffering from BV are heavily colonized by G. vaginalis (Gardner and Dukes
1955; Holst, Svensson et al. 1984; Borchardt, Adly et al. 1989). The finding of a
negative G. vaginalis culture had a 97% predictive value of exclusion of bacterial
vaginosis (Amsel, Totten et al. 1983; Cristiano, Coffetti et al. 1989). G. vaginalis has
also been detected as the sole infecting species in other infection sites, including the
bloodstream, urogenital tract of both men and women, the kidneys, and bone tissue; this
points to the pathogenic potential of G.vaginalis (Piot, Van Dyck et al. 1984; Reimer and
Reller 1984; Reimer 1991; Amaya, Al-Dossary et al. 2002; Graham, Howes et al. 2009).
In the laboratory, G. vaginalis is sensitive to phagocytosis and killing by
neutrophils in the presence of human serum, in a process mediated by complement
activated by the alternative pathway (Easmon, Clark et al. 1985). However, it has been
shown by Swidsinski et al. that G. vaginalis is able to form an adherent biofilm on the
vaginal epithelium of women with BV (Swidsinski, Mendling et al. 2005). The
formation of this biofilm may interfere with the immune response to G. vaginalis. A
follow-up paper observed the resurgence of a dense and active bacterial biofilm on the
vaginal mucosa, consisting primarily of G. vaginalis, after treatment of BV with
metronidazole (Swidsinski, Mendling et al. 2008). They hypothesized that development
of an adherent biofilm by G. vaginalis contributes to the pathogenesis and recurrence of
BV (Swidsinski, Mendling et al. 2005). Little is known about the G. vaginalis biofilms;
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therefore, we sought to characterize the biofilm, and identify genes involved in formation
of the biofilm.

Biofilms
It has recently been recognized that planktonic cell growth does not accurately
reflect bacterial growth in nature or in infectious diseases, where most bacteria grow as
biofilms (O'Toole, Kaplan et al. 2000; Lindsay and von Holy 2006). Biofilms are
communities of microorganisms that are surrounded by an extracellular polymeric matrix
composed of polysaccharides, proteins and/or nucleic acids, which promote intercellular
adhesion and adhesion to surfaces. Examples of microorganisms that utilize primarily
polysaccharide components in their biofilm matrix include S. aureus which utilizes polyN-acetylglucosamine or PNAG (O'Gara 2007) and P. aeruginosa which utilizes alginate
(Ryder, Byrd et al. 2007). Examples of microorganisms that utilize primarily protein
components in their biofilm matrix include Acinetobacter baumannii which utilizes a
biofilm-associated protein or BAP (Loehfelm, Luke et al. 2008) and Bacillus subtilis
which utilizes a polysaccharide and the protein TasA (Chai, Chu et al. 2008). The final
type of biofilm matrix is a nucleic acid based matrix, normally composed of extracellular
DNA (eDNA). Examples of microorganisms that utilize eDNA in their biofilm matrix
include Listeria monocytogenes (Harmsen, Lappann et al. 2010) and Bacillus cereus
(Vilain, Pretorius et al. 2009). These matrix components are not mutually exclusive;
organisms able to utilize a combination of matrix components are quite common.
Salmonella sp. are able to use curli, cellulose, and the biofilm-associated protein BapA to
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form a biofilm (Jonas, Tomenius et al. 2007). Enterococcus faecalis, which produces a
biofilm-associated protein Esp, also has been found to promote autolysis of its own cells
to release eDNA which plays a role in biofilm formation by the organism (Thomas,
Thurlow et al. 2008). Not only is there considerable variation in biofilm structure
between different bacterial species, but a single species may also produce biofilms that
vary considerably in matrix composition depending on environmental conditions. An
example of this is Staphylococcus epidermidis, in which Hennig et al. described a
spontaneous switch from biofilm formation mediated by polysaccharides to biofilm
formation mediated by proteins in an icaC insertion mutant (Hennig, Nyunt Wai et al.
2007).
The biofilm mode of growth imparts on its constituent bacteria resistance to
antimicrobial agents (Passerini de Rossi, Garcia et al. 2009), disinfectants (Kim, Ryu et
al. 2007), drying (Vanderlinde, Harrison et al. 2009), ultraviolet light (Bak, Ladefoged et
al. 2009), acid exposure (Kubota, Senda et al. 2009), phagocytosis (Cerca, Jefferson et al.
2006) and sheer stress (Giao, Azevedo et al. 2008). This resistant phenotype of biofilms
is due to many factors including: restricted penetration of antibiotics/disinfectants,
production of antimicrobial destroying enzymes, altered growth rate of some cells, and
overexpression of stress response genes (del Pozo and Patel 2007).
Biofilm development requires a series of complex but distinct and well-regulated
steps. The exact molecular mechanisms differ from organism to organism, but the stages
are similar across a wide range of microorganisms. The steps of biofilm development
are: (1) microbial attachment to a surface, (2) intercellular attachment and aggregation of
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bacterial cells, (3) biofilm maturation, and (4) dispersal of bacterial cells for production
of new biofilms (Figure 3). Many environmental cues can stimulate or repress biofilm
formation. For example, changes in salt concentration affect biofilm formation by the
water pathogen Vibrio cholera, leading to an increase in bacterial mobility and increased
infection rate during dry or flood conditions (Shikuma and Yildiz 2009). Examples of
other environmental cues that can affect biofilm formation are low temperature, which
increases expression of biofilms in E. coli and Y. pestis (Perry, Bobrov et al. 2004;
White-Ziegler, Um et al. 2008), and growth in non-optimal growth conditions, which
increases biofilm formation in environmental isolates of E. coli (Castonguay, van der
Schaaf et al. 2006).
A well characterized biofilm whose development has been extensively researched,
is the formation of a biofilm on the surface of a subvenous catheter. When inserting the
catheter into the bloodstream, bacteria become attached to the tip and length of the
catheter surface. Rapidly, blood plasma proteins, platelets, fibrin and leukocytes bind to
the surface of the catheter; these host products serve as scaffolding for the developing
biofilm and receptors for newly arriving bacteria (Cappelli, Tetta et al. 2005). S. aureus
adheres to proteins like fibrinogen and fibronectin found on the catheter in the first step
of biofilm development (Arciola, Campoccia et al. 2005; O'Neill, Humphreys et al.
2009).
Once bacteria are attached to the surface of the catheter, phenotypic changes in
the bacteria alters protein expression to further produce adhesins that anchor the bacterial
cells to each other and to the catheter surface (Vandecasteele, Peetermans et al. 2003). S.
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Figure 3. Steps of biofilm development. (1) Attachment: Cells affix to
substratum using surface proteins like MSCRAMMs and surface induced gene
expression results in a protein profile significantly different from planktonic
bacteria, (2) Aggregation: Cells orient themselves using surface proteins like
Biofilm-associated proteins (BAPs), allowing for development of clusters and
motility is lost, (3) Maturation: Cell communication (potentially through
quorum sensing) leads to cell clusters reaching maximum thickness via
production of exopolysaccharide, (4) Dispersal: Production of enzymes to
disperse bacteria or in some bacteria, the protein profile begins to resume that of
planktonic bacteria allowing for the dispersal of bacteria from the biofilm.
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aureus bovine mastitis isolates produce a biofilm-associated protein called Bap that acts
as an intercellular adhesion, anchoring bacteria to each other and causing maturation of
the biofilm (Cucarella, Solano et al. 2001). As the bacterial cells multiply, they can
produce exopolysaccharides or “slime” which leads to differentiation into true biofilms:
exopolysaccharide-encased bacterial communities resistant to many negative
environmental stimuli (Costerton, Stewart et al. 1999). Furthermore, just as there are
environmental cues for events leading to biofilm development, there are cues which lead
to maturation of the biofilm. Many bacteria utilize a communication system that employs
“messengers” produced by individual bacterial cells; when these signals accumulate to a
certain density they cause the expression of specific sets of genes, including genes
involved in biofilm formation. An example of this communication system is quorum
sensing in gram negative bacteria which utilize acylhomoserine lactone signals to talk
between bacteria (Fuqua, Winans et al. 1994).
Finally, in order to colonize new surfaces the bacteria within the biofilm must
detach and disseminate. Dispersal is accomplished by shearing, where pieces of the
biofilm can break off in the flow of blood or urine and colonize new surfaces, or by
enzymatic dispersal. An example of enzymatic dispersal is seen in P. aeruginosa, which
produces an enzyme called alginate lyase that is able to digest the polysaccharide
component of its biofilm, releasing bacteria into the environment (Boyd and Chakrabarty
1994).
The medical community has gradually recognized biofilms as important aspects
of disease, especially in patients with indwelling medical devices or who are
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immunocompromised (Lindsay and von Holy 2006). The biofilm phenotype is
associated with chronic, indolent, and relapsing infections. Examples of widely studied
and well-recognized biofilms include those found in dental plaque, catheter infections,
pulmonary infections, and endocarditis. Most biofilm diseases are treated by antibiotic
therapy and removal of the infected device (i.e. catheter, heart valve, artificial joint).
Extended administration of antibiotics may be required and even prolonged therapy may
not be effective. Device removal is not cost-effective and may extend the patient’s
recovery period; therefore, more effective therapies, like biofilm-dispersing enzymes are
being developed. An important step in understanding the pathogenesis of BV would be
characterization of biofilm formation in G. vaginalis. Identification and characterization
of the gene responsible for biofilm formation in Gardnerella could lead to novel
treatment modalities and an improved understanding of this inadequately described
condition.
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Chapter 2
Materials and Methods

BV-associated strains and culture conditions. All media components were from Becton
Dickinson unless otherwise noted (BD, Franklin-Lakes, NJ). BV-associated bacterial
species used in this study, references to their association with BV, and the source of the
strains are listed in Table 1. The bacterial strains used in this study were purchased from
ATCC or isolated from confirmed cases of BV (confirmed by Amsel criteria and Nugent
score) at Brigham and Women’s Hospital, Boston, MA (Onderdonk, Lee et al. 2003), or
isolated as part of this study from Virginia Commonwealth University Women’s Health
Clinic. Strains from the VCU Women’s Health Clinic were isolated from vaginal swab
specimens from women diagnosed with BV by the Amsel criteria (Holmes, Spiegel et al.
1981). Individual colonies were isolated from Brucella Blood agar (Oxyrase, Mansfield,
OH) and cultured in supplemented Brain Heart Infusion broth (sBHI); Brain Heart Infusion
broth (Difco) containing 2% (w/v) gelatin, 0.5% yeast extract, 0.1% starch, and 0.1%
glucose. All cultures were grown under anaerobic conditions, in approximately 10% CO2
with the use of the AnaeroPack system (Mitsubishi Gas Chemical Co, Tokyo, Japan). For
some experiments, cultures were grown in sBHI supplemented with 1% glucose (sBHIG),
sBHI supplemented with 8% heat-inactivated human serum (sBHIs), or in standard BHI or
BHIG.
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Table 1. BV-associated bacterial species used in this study.

Organism

*

Strain
and
source

Reference to involvement in BV

Gardnerella
vaginalis

5-1*,
465*,
101-1!,
49145"

Menard et al. (2008), Oakley et al.
(2008), Fredricks et al. (2005),
Marrazzo et al. (2008)

Atopobium
vaginae

FA!

Menard et al. (2008), Oakley et al.
(2008), Fredricks et al. (2005),
Marrazzo et al. (2008)
Zhou et al. (2004)

Mobiluncus mulieris

BV 26-9!

Menard et al. (2008), Oakley et al.
(2008), Fredricks et al. (2005),
Marrazzo et al. (2008)

Prevotella bivia

29303",
715BVD!

Oakely et al. (2008), Fredricks et al.
(2005)

Veillonella sp.

715BVA!

Oakley et al. (2008), Lefevre et al.
(1985), Biagi et al. (2009)

Peptostreptococcus
sp.

715BVC!

Oakley et al. (2008), Marrazzo et al.
(2008)

Peptoniphilus sp.

718BVA!

Fredricks et al. (2005), Marrazzo et
al. (2008)

Fusobacterium
nucleatum

718BVC!

Oakley et al. (2008)

Brigham and Women’s Hospital.

! VCU Women’s Health Clinic.
"

American Type Culture Collection.
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16s Polymerase Chain Reaction (PCR) and identification of BV-associated anaerobes.
Genomic DNA was isolated from cultured BV-associated anaerobes from patients from the
VCU Women’s Health Clinic using the DNeasy Blood and Tissue kit (Qiagen, Valencia,
CA) and amplified by PCR using universal primers for the 16S rRNA gene found in Table
2. PCR reactions were performed in a TC-312 thermocycler (Techne, Staffordshire, UK).
PCR reaction mixtures consisted of 25 !l HiFi PCR Mix (Invitrogen, Carlsbad, CA) and 4
mM primers.
Conditions for PCR were as follows, one initial cycle at 94ºC for 2 minutes
followed by 35 cycles of: 94ºC 30 seconds to denature, 50ºC 30 seconds to hybridize, and
71ºC 30 seconds for extension. A final extension at 72ºC for 5 min after the final cycle
and the reactions were chilled to 4ºC. PCR products were sequenced at the VCU Nucleic
Acids Core Facility under the supervision of Dr. Gregory Buck and species were identified
by a 98% or greater identity to sequences in the NCBI database using BLASTn.

Non-BV related strains, culture conditions and plasmids used. E. coli was grown
aerobically in Luria-Bertani broth (LB) and on LB agar with appropriate antibiotics at the
following concentrations: ampicillin 100 !g/ml and chloramphenicol 35 !g/ml. S. aureus
cultures were grown aerobically in TSB broth at 37ºC with appropriate antibiotics at the
following concentrations: chloramphenicol 10 !g/ml and erythromycin 10 !g/ml. L.
lactis cultures were grown aerobically in GM-17 broth at 30ºC (LB, TSB and GM-17
media from Sigma-Alderich, St. Louis, MS). Plasmids used are seen in Table 3.
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Table 2. Primers used in this study.
Primer Label

Sequence

UnivFWD

5’-AGAGTTTGATCCTGGCTCAG-3’

UnivREV

5’-GGACTACCAGGGTATCTAAT-3’

AP1

5’-GTAATACGACTCACTATAGGGC-3’

AP2

5’-ACTATAGGGCACGCGTGGT-3’

GSP1

5’-TCTGACGAATTGGTTATATTCGCATC-3’

GSP2

5’-CAACAAGTTCACGACACCACTTATTG-3’

BapEpiIntein3

5’-GTGTGGTTGCTCTTCCGCAACCTACA-3’

BapEpiRev3

5’-GTGTGGCATATGGATATTGCAAATAA-3’

BapSbfFWD

5’GGTTGGCCTGCAGGCGTGATTAATTCATA
TACGAATAAATTAC-3’

BapSbfREV

5’GGTTGGcctgcaggTTAGTCGCGCTTCTTCC
TGCG-3’
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Table 3. Non-BV organisms and plasmids used in this study.

Non-BV Organisms Used

Strain

Escherichia coli

CH3-Blue chemically competent bacteria
(Bioline)
BL21-CodonPlus (DE3)-RIL Competent
bacteria (Stratagene)

Lactococcus lactis

ATCC 11454

Staphylococcus aureus

RN4220
RN4220!ica (eyrthromycin 10 !g/ml)

Plasmids Used

Antibiotic Resistance

pCR2.1®Topo

E. coli, Ampicillin 100 !g/ml

pCR3.2®Topo-bapL

E. coli, Ampicillin 100 !g/ml

pKYB1

E. coli, Kanamycin 50 !g/ml

pKYB1-bapL

E. coli, Kanamycin 50 !g/ml

pRB473

E. coli, Chloramphenicol 35 !g/ml
S. aureus, Chloramphenicol 10 !g/ml

pRB473-bapL

E. coli, Chloramphenicol 35 !g/ml
S. aureus, Chloramphenicol 10 !g/ml
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Agarose gels. Agarose gels were prepared by dissolving agarose in 1X Tris-AcetateEDTA (TAE) buffer (Fisher Scientific, Pittsburgh, PA). Ethidium bromide was added to
0.15 !g/ml prior to pouring the gel. Generally, PCR products were run on a 1.5% agarose
gels and 10X BlueJuice gel loading buffer (Invitrogen) was added to PCR products to
reach a 1X dye concentration. Gels were run at 120 volts until the dye front had migrated
roughly $ of the length of the gel and then visualized under UV light. DNA size was
measured against a % DNA ladder, which was made of 1/10 volume of HindIII digested %
DNA (New England Biolabs, Ipswich, MA), 1/5 volume of 10X Blue Juice gel loading
buffer and 7/10 volume of deionized, distilled sterile water.

Gardnerella biofilm growth assay. Gardnerella vaginalis strain ATCC 49145 (American
Type Culture Collection, Manassas, VA) and strains 5-1 and 465-5 (kindly provided by Dr.
Robin Ross, Boston, MA) were grown under anaerobic conditions, in ~10% CO2 using the
AnaeroPack system (MGC, Tokyo, Japan). 96-well tissue culture plate assays were
performed essentially as previously described to determine optimal growth conditions for
biofilm formation (Christensen, Simpson et al. 1985). G. vaginalis was grown in Corning
Cell-Bind Plates (Corning, Corning, NY) in various media without or with 1%
supplemental glucose (G) including Luria broth (LB, LBG), Tryptic Soy Broth (TSB,
TSBG), Mueller-Hinton (MH, MHG), Brain Heart Infusion (BHI, BHIG), De Man Rogosa
Sharpe (MRS, MRSG), and a chemically defined medium resembling vaginal secretions
(CDM, CDMG) (Onderdonk, Lee et al. 2003).
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Biofilm assay of BV-associated organisms. Biofilms were grown using 96 well Corning
Cell Bind Plates (Corning). Overnight cultures of G. vaginalis or BV-associated anaerobes
were diluted 1:10 with fresh sBHI and individual wells of a sterile, polystyrene 96 well
tissue culture plate were inoculated with 0.2 ml of dilute culture. The tissue culture plates
were incubated for 24-72 hrs at 37 °C, under anaerobic conditions. Growth was analyzed
using a 96-well plate spectrophotometer with a 595nm filter (BioTek 800 Plate reader,
Winooski, VT). Spent medium was removed, wells were washed once with 200 µl
phosphate buffered saline (PBS) to remove nonadherent bacteria, and the plates were air
dried for 1 hr. Biofilms were stained with 200 µl of safranin for one min, wells were
washed gently to remove the safranin, and the plates were air dried. After the biofilms
were visually analyzed and imaged using a flatbed scanner, the safranin was solubilized
with 200 µl of 33% (v/v) acetic acid per well. For quantitative results, the solubilized
safranin was analyzed at optical density of 562nm using the 96-well plate reader (BioTek).

Cell line. ME-180 cervical epithelial cells (ATCC) were cultured at 37ºC in 5% CO2 in
McCoy’s 5A medium (Quality Biologic, Gaithersburg, MD) supplemented with 10% fetal
bovine serum and 1IU ml-1 penicillin/streptomycin (MediaTech, Manassass, VA). ME-180
cervical epithelial cells were used in place of vaginal epithelial cells due to availability and
cost effectiveness.

Confocal microscopic adherence assay. ME-180 epithelial cells were seeded into 6-well
tissue culture plates (Greiner Bio One, Monroe, NC) at a density of 1.5 X 105 cells/well
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and incubated for 72 hrs or until a monolayer of cells had formed. The growth medium was
removed, the cell monolayer was washed twice with sterile PBS and stained with 2.5!l/ml
per well of Vybrant DIL membrane stain (Invitrogen) for 30 min at 37 °C, 5% CO2.
Following incubation, the monolayers were washed twice with sterile PBS to
remove excess stain. Overnight cultures of the various bacterial species were standardized
to an optical density of 600 nm (OD600nm) of 0.150 using a NanoDrop 1000 (Thermo
Scientific, Waltham, MA), and 2 ml of each culture was centrifuged to collect the cells.
Bacteria were washed twice with 1 ml of sterile PBS and stained with 5!l of BacLight
green bacterial stain in 1ml PBS (Invitrogen).The bacterial cells were incubated in the dark
for 30 min at 37 °C, washed twice with 1 ml of sterile PBS to remove excess stain. 1 X 107
stained bacteria in 0.5 ml PBS were added per well containing ME-180 cells. The plates
were centrifuged at 700 rpm (18 g) for 2 min to maximize contact between the bacteria and
cells.
Time course assays indicated that adherence of bacteria to ME-180 cells did not
increase after 15 minutes of contact (data not shown); therefore, the plates were incubated
covered for 15 min at 37°C, 5% CO2. After 15 minutes of exposure to G. vaginalis at
37°C the ME-180 cells began to exhibit cytopathogenic changes. G. vaginalis was
therefore incubated at 10°C to prevent cytotoxicity; these conditions did not affect binding
of any of the other species. Finally, the wells were washed vigorously twice with sterile
PBS to remove nonadherent bacteria and the wells were analyzed by confocal microscopy
using a muliphoton confocal scanning laser microscope (Zeiss LSM 510; Microscopy Core
Facility, Neuroscience Department, VCU, Richmond, VA).
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Adherence assays were repeated 3 times on separate days, with three fields of view
assessed. Adherence scores were based on a qualitative scoring system ranging from (-) to
(+++) where (-) denotes that no adherent bacteria were observed in any field of view on all
days tested; (+/-) indicates that less than 25% of ME180 cells had bacteria attached in any
field of view on 1 or 2 days, but it was not repeatable for all 3 experiments; (+) denotes
that less than 25% of ME180 cells had bacteria attached in all fields of view on all days
tested; (++) denotes that greater than or equal to 25% to less than 75% of ME180 cells had
bacteria attached in all fields of view on all days tested; and (+++) denotes that greater than
or equal to 75% to 100% of ME180 cells had bacteria attached in all fields of view on all
days tested.
Adherence of G. vaginalis was also tested when bacteria had been pretreated with
proteinase K. Overnight G. vaginalis cultures were centrifuged and resuspsended in PBS,
and subjected to 20 !l/ml of a 20 mg/ml stock of proteinase K (Qiagen), rocking at room
temperature for 1 hour. After an one hour incubation, the bacteria was collected and
washed three times with 1 ml of sterile PBS to remove residual proteinase K. The bacteria
were then used for confocal adherence assays as described above.

G. vaginalis bacteria vs. supernatant cytotoxicity assay. Overnight cultures of G.
vaginalis strain 5-1 were centrifuged to remove bacteria and supernatant removed and
dialyzed against 0.1X PBS overnight. ME-180 epithelial cells were seeded into a 6-well
tissue culture plate at a density of 3.0 X 104 cells per well. After 72 hours, or when a
monolayer of cells had formed, the media was removed, and approximately 1 X 106
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bacteria in PBS or dialyzed supernatant were added to individual wells. The monolayers
were analyzed for cytotoxicity by light microscopy every hour for 4 hours.
Cytopathogenicity was scored from 0 to 5 where 0 denotes no difference between
the experimental well and control; a 1 indicates that less than 25% of cells were rounded; a
2 indicates that 25-50% of cells were rounded; a 3 denotes that greater than 50% of cells
were rounded; a 4 indicates that greater than 50% of cells were rounded with partial
disruption of the monolayer; and a 5 indicates complete disruption/absence of the
monolayer. After the monolayers were analyzed for 4 hours and given a cytotoxicity score,
the bacteria were removed by pipetting off the liquid from each well and microscopic
images of each well were taken with an Olympus CK2 microscope (Olympus, Center
Valley, PA).

Trans-well cytotoxicity assay. Overnight cultures of G. vaginalis strain 5-1 were collected
and resuspended in 1X PBS. ME-180 epithelial cells were seeded into a 6-well tissue
culture plate at a density of 3.0 X 104 cells per well. To assess the contact dependence of
G. vaginalis-associated cytotoxicity, the media from the confluent 6-cell tissue culture
plate was replaced with 2ml of 1X PBS, a sterile transwell with pores of either 0.45 µM or
8 µM was inserted into a well, and 1.5 ml of the bacterial suspension was added to the top
portion of the transwell. The monolayers were monitored every hour by light microscopy
for cytopathogenic changes, such as cell rounding, loss of adhesion, and disruption of the
monolayer. Cytopathogenicity was scored using the scoring system described above and
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microscopic images of each well were taken with an Olympus CK2 microscope at
magnifications of 100X and 400X (Olympus).

BV-associated anaerobe cytotoxicity assay. ME-180 epithelial cells were seeded into a 96well tissue culture plate at a density of 3.0 X 104 cells per well. After 72 hours, or when a
monolayer of cells had formed, the media was removed, and approximately 1 X 106
bacteria in PBS were added to individual wells. The monolayers were analyzed for
cytotoxicity by light microscopy every hour for 4 hours. Cytopathogenicity was scored
using the scoring system described above and microscopic images of each well were taken
with an Olympus CK2 microscope (Olympus).

Biochemical characterization of G. vaginalis biofilm matrix. For biofilm cultures, G.
vaginalis strain ATCC 49145 was grown anaerobically in BHI in T75 tissue culture flasks
(Corning). Planktonic cultures were grown in BHI with shaking. Media was removed from
biofilms; planktonic bacteria were collected by centrifugation and were washed once with
double-distilled water. Loosely associated surface material was extracted by the vigorous
resuspension of bacteria in distilled, deionized water, for a final cell density of 109
CFU/mL, as estimated by optical density at 650 nm (OD650). Protein concentrations in the
extracts were determined with the use of Coomassie Protein Assay Reagent and the
Bradford assay (Pierce Biotechnology, Rockford, IL). Nucleic acid content was estimated
by measuring the optical density at 260 nm (OD260). Hexosamine contents were estimated
by standard phenol-sulfuric acid assay with the use of glucose dilutions as standards
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(Dubois, Gilles et al. 1951) . Three separate experiments were performed, and statistical
significance was determined with the Student t test.

Bradford assay for protein concentration. Protein concentrations were determined by
performing a Bradford assay on known concentrations of bovine gamma globulin (Pierce
Biotechnology) to generate a standard curve. This standard curve was applied to
measurements taken from dilutions of sample protein. 20 !l of protein sample was added
to 200 !l of Coomassie Protein Reagent (Pierce Biotechnology) and vortexed for 20
seconds. The absorbance at 595 nm was then measured on a NanoDrop 1000
spectrophotometer (Thermo Scientific) three times for each sample as well as each
standard. The average was then used to generate the standard curve and determine protein
concentration.

Lectin blots of G. vaginalis matrix material. For lectin blots, 100 µL of the cellular
extracts of G. vaginalis were diluted serially 5-fold in PBS and dilutions were blotted onto
nitrocellulose with a vacuum manifold and probed with peroxidase-conjugated lectins:
wheat germ agglutinin (WGA), concanavalin A, and Glycine Max (Sigma), as described
previously (Jefferson and Cerca 2006). The blots were developed with the use of the ECLPlus Western blotting detection system (GE Healthcare, Piscataway, NJ).

Confocal microscopy of G. vaginalis biofilms. Strain 49145 was grown in BHIG in 35-mm
collagen-coated glass-bottom dishes (MatTek, Ashland, MA) at 37°C anaerobically for 48
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hours. Biofilms were stained with 3 µL SYTO 9 and 3 µL Alexa Fluor 633-conjugated
WGA (Invitrogen) in 3 mL phosphate-buffered saline solution for 15 minutes with
rocking. Biofilms were washed twice with PBS solution, and confocal imaging was
performed with a multiphoton confocal scanning laser microscope (Zeiss LSM 510;
Microscopy Core Facility, Neuroscience Department, VCU, Richmond, VA). The
objective was an Acroplan 63X/0.9W (Carl Zeiss Microimaging, Inc, Thornwood, NJ).
The excitation wavelengths that were used were 488 nm and 633 nm; bandpass filters for
emitted light were 500 nm to 530 nm and 650 nm.

Biofilm degradation assays. To analyze the dissolution of established biofilms, 24 hourold biofilms were subjected to 5-fold dilutions of various compounds in fresh BHIG (or in
50 mM/L NaOAc; pH 4.2 for sodium metaperiodate). Stock solutions were 20 mg
proteinase K/mL (Qiagen), 20 mg trypsin/mL, 5U chitinase/mL, 30% H2O2, 10 M/L lactic
acid, 20% sodium dodecyl sulfate (SDS), 4 mg sodium metaperiodate/mL in 50 mM/L
sodium acetate pH 4.2, and 25 U deoxyribonuclease (DNasel)/mL (Ambion, Austin, TX).
Biofilms were incubated for 20 hours, the media was removed, and the biofilms were
washed with PBS solution, dried, and stained with safranin. Digital images of the biofilms
were taken by an HP color LaserJet 2820 printer with scanning capabilities (HewlettPackard Company, Palo Alto, CA).

Luciferase assay for bacterial viability. The BacTiter luciferase assay for adenosine
triphosphate (Promega Corp, Madison, WI) was used to determine bacterial viability. To
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correlate viability with relative light units, planktonic cultures and biofilm cultures that had
been resuspended by pipetting up and down were diluted serially 10-fold in BHI. 10 µL of
each dilution was plated on BHI agar. The plates were incubated anaerobically for 72
hours, and colony forming units (CFUs) were determined, and 200 µL of each serial
dilution was placed in Cell Bind–coated 96-well clear bottom black plates (Corning).
Cells were collected by centrifuging the plates, and the media were replaced with 50 µL
BacTiter reagent (Promega). After 10 minutes at 21°C, luminescence was analyzed with a
Tropix luminometer (GE Healthcare, Piscataway, NJ) for 1 second.

Planktonic and biofilm culture sensitivity assays. For sensitivity assays, 200 mM
hydrogen peroxide and 2 M lactic acid (Sigma) were diluted 2-fold in BHI or CDM and
added to G. vaginalis biofilm and planktonic cultures. Plates were incubated anaerobically
for 20 hours at 37°C; cells were collected by centrifugation, resuspended in 50 µL BacTiter
reagent (Promega), and transferred to black 96-well plates (BD Falcon). Viability was
assessed as described earlier for the luciferase asay. The concentration of H2O2 or lactic
acid that was required to bring about a 90% decrease in relative light units was recorded as
the MBC90 for each chemical.

Proteinase K-treated biofilm sensitivity assays. The effect of treating biofilms with 100 µg
proteinase K/mL for 24 hours on viability was determined with the BacTiter assay, as
described earlier. For proteinase K–treated biofilm sensitivity assays, the media in the
wells was replaced with BHIG that contained 100 µg of proteinase K/mL. The biofilms
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were preincubated with the protease for 1 hour; sensitivity to H2O2 and lactic acid was
determined as described earlier. For a Proteinase K time course, biofilms were stained
using Live/Dead BacLight stain, 100 µg of proteinase K/mL was added to a G. vaginalis
biofilm, and confocal images of the same field of view were collected every 20 minutes for
280 minutes. Red color indicates live bacteria, while green color indicates dead bacteria.

Degradation assay with natural proteases. To analyze the dissolution of established
biofilms by natural proteases, 24 hour-old biofilms were subjected to 5-fold dilutions of
various enzymes in fresh PBS at pH 4.5 or 7.4. Stock solutions were 10 U Bromelain, 10
U Papain, 5.78 U Ficin, and 345 U Pepsin. Biofilms were incubated for 20 hours, the
media was removed, and the biofilms were washed with PBS, dried, and stained with
safranin. Digital images of the biofilms were scanned using an HP color LaserJet 2820
printer (Hewlett Packard Company). The safranin stained biofilms were solublized with
200 µl of 33% (v/v) acetic acid per well. For quantitative results, the solubilized safranin
was analyzed at optical density of 562nm using a 96-well plate reader (BioTek). Technical
replicates and biologic replicates were performed on each strain and the absorbance
readings were averaged. These averaged absorbance readings were compared to control to
give a percent reduction in biofilm mass.

Antibiotic sensitivity assay using natural proteases. 24 hour biofilms were grown in 96well plates in BHIG anaerobically at 37°C. Planktonic cultures were grown in 50 ml
conical tubes in BHIG with gentle shaking anaerobically at 37°C. Media was removed
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from biofilm wells and replaced with either 200 !l BHIG as control, 200 !l of 1.8375
!g/ml clindamycin (3X MIC) in BHIG, 200 !l of 10 U papain in BHIG or 200 ul of 10 U
papain containing 1.8375 !g/ml of clindamycin in BHIG. These cultures were incubated
anaerobically for 16 hours at 37°C. Media was removed from another biofilm well and
pretreated with 200 !l of 10 U papain in BHIG for 2 hours anaerobically at 37°C, media
was removed and wells washed with 200 !l of sterile PBS and 200 !l of 1.8375 !g/ml
clindamycin was added to the wells and incubated for 16 hours anaerobically at 37°C.
After the 16 hour incubation, all bacteria were harvested by 3 pulses of a sonicator, 10-fold
diluted in 200 !l of BHIG and drip plated for CFU.
Identification of Biofilm-Associated Protein (BAP) in G. vaginalis. A partial sequence of
the G. vaginalis genome is available from the Gardnerella vaginalis Genome Project,
Stanford Genome Technology Center, which is funded by the Ellison Medical Foundation.
The amino acid sequence of the staphylococcal Bap protein was compared to the partial
genome of G. vaginalis using blastP software. Structural similarities between the two
proteins were analyzed by the RADAR software (EMBEL-EBI).
DNA extraction. Genomic DNA was isolated from G. vaginalis strain 5-1 using a phenolchloroform extraction. Briefly, 100 ml of culture was centrifuged at 4000 rpm (4ºC) for 15
min to pellet the bacteria. The pellet was resuspended with 10 ml of lysis buffer
containing lysozyme (10 mM Tris HCl pH 8.0, 10 mM NaCl, 10 mM EDTA, 1% Triton
X100 and 10 mg Lysozyme) and allowed to incubate at 37ºC for 1 hr. 100 !l of Proteinase
K (20 ug/ml stock) was added to the mixture and allowed to incubate at 65ºC for 1 hr
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(Qiagen). 10 ml of a 1:1 mixture of phenol:chloroform was added, mixed gently as not to
shear the DNA, and centrifuged at 12000 rpm (4ºC) for 5 min. The upper aqueous solution
was removed to a clean tube and two chloroform washes were performed. The DNA was
precipitated by addition of one tenth the volume of 3M sodium acetate and 2 volumes of
ice-cold 100% ethanol. This was allowed to rest at -20C for at least 1 hr. The DNA was
collected by centrifugation at 12000 rpm (4ºC) for 1 hr. The DNA was washed once with
70% ethanol and allowed to air dry for 15 minutes before being resuspended with an
appropriate volume of nuclease-free water.

Genome walking. The 5’ upstream region of the bapL locus of G. vaginalis was amplified
using the genome walking technique. Briefly, a Universal Genome Walker Kit (Clontech,
Palo Alto, CA) was used to construct a number of adaptor ligated G. vaginalis DNA
fragment libraries (Sung, Chantler et al. 2006). These libraries were used as a template for
PCR amplification using a gene specific primer (GSP1) and an adaptor specific primer
provided by the genome walking kit (AP1) (see Table 2 for primer list). These PCR
products were then used as a template for a second nested PCR using an internal gene
specific primer (GSP2) and an internal adaptor specific primer (AP2). Both PCRs were
performed using a DNA polymerase suitable for long distance PCR (Clontech). A single
band was excised from the gel, purified, and then sequenced using the nested adaptor
specific primer to initiate sequencing.
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Full G. vaginalis genome sequencing. Sequencing was performed in the VCU Nucleic
Acids Core Facility using Roche 454 technology (Roche, Branford, CT). One full run of
GS FLX and one half run GS FLX XLR were done for strain 5-1 (coverage of ~175 X).
Five micrograms of DNA was sequenced as per the standard Roche sequencing protocol.
Production of pKYB1-bapL for expression of peptide fragment of BapL. Forward and
reverse primers were used to amplify an antigenic region in the BapL protein, which was
chosen by in silico analysis using the EMBOSS:antigenic program (EMBOSS explorer).
The primers also introduced Sap1 and Nde1 restriction sites at the ends of the 0.5 kb PCR
product; this allowed for the production of an intein-chitin binding domain (CBD) tagged
fusion peptide (Zhang, Gonzalez et al. 2001). The forward primer used was BapEpiIntein3
and the reverse primer used was BapEpiRev3 (Table 2). The 0.5 kb PCR product was
then digested with Sap1 and Nde1 using specific buffers and BSA per the manufacturer’s
instructions (New England Biolabs). After digestion, the PCR product was gel purified
using the QIAquick Gel Extraction Kit (Qiagen) as described by the manufacturer. The
digested 0.5 kb PCR product was ligated into the linearized E. coli vector pKYB1 (kan50)
using Ready-to-Go T4 DNA Ligase tubes (Amersham Biosciences, Piscataway, NJ) with
an hour incubation at 16ºC.

CH3 chemically competent E.coli transformation. 2 !l of purified plasmid DNA was
added to 50 !l of CH3 blue chemically competent E. coli cells (Bioline, Taunton, MA).
This mixture was incubated on ice for 10 minutes. The tubes were then transferred to a
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water bath at 42ºC for 30 seconds and immediately after the incubation, 250 !l of SOC
media (2% (wt/vol) tryptone, 0.5% (wt/vol) yeast extract, 85.5 mM NaCl, 2.5 mM KCl, 10
mM MgCl2, 20mM glucose) was added to the tube and incubated for one hour at 37ºC with
shaking. Following this recovery period, the cells were plated on LB plates with
appropriate antibiotic selection.

Plasmid DNA purification and screening. Plasmid mini-preps were prepared from
individual E. coli transformants that were grown overnight in 5 ml of LB broth with
appropriate antibiotic, using a QIAprep Spin Miniprep Kit (Qiagen), as described by the
manufacturer. Plasmids were screened for correct insert by digestion with Nde1 and Kpn1
(Bioline). Plasmids with correct insert sizes were sequenced to confirm insertion of the
accurate antigenic region of BapL before being used to transform BL21CodonPlus®(DE3)-RIL E. coli cells (Stratagene, La Jolla, CA).

Induction of recombinant BapL peptide. The pKYB1-based construct expressing the
antigenic peptide from BapL was introduced into BL21 CodonPlus®(DE3)-RIL E.coli
cells by transformation (Stratagene). Strains harboring this plasmid were grown in 6 liters
of LB supplemented with kanamycin 50 !g/ml to an OD600 of 0.8 and then IPTG (Fisher)
was added to 1mM to induce expression of the recombinant peptide.

Purification of recombinant peptide. After induction, cells were grown for 6.5 hours and
harvested by centrifugation at 6,000 rpm at 4ºC for 15 minutes. Cell pellets were
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resuspended in Impact buffer (20 mM Tris, 0.4 M NaCl, 0.1% Triton X100 and
Complete™ protease inhibitor cocktail (Roche Applied Science, Mannheim, Germany)).
Bacteria were lysed sequentially with a Thermo IEC French pressure cell press (Thermo
Scientific) with 750 p.s.i. 3 times per 25 ml of resuspended bacteria, followed by
sonication with a 60 Sonic Dismembrator at 15 watts (RMS) for 20 seconds 6 times on ice
with 20 seconds rest between each repetition (Fisher). Cell lysates were centrifuged at
20,000 rpm at 4ºC for 30 minutes and supernatants were collected, filtered through a 0.45
!M filter, and run through a chitin column. The lysate was loaded onto a column made of
chitin beads (New England Biolabs); the flow-thru was collected and passed back over the
column to ensure protein binding to the column. The column was washed with 5 column
volumes of cold, sterile Impact buffer, followed by 2 washes with 15 ml of Impact buffer
and 1:1000 dilution of Triton X100. Finally, the column was washed with 15 ml of Impact
buffer containing 750 !l DTT, about 1 inch of liquid was left in the column and the
column was sealed with parafilm and left overnight at 4ºC. After the overnight incubation,
the BapL peptide was eluted with the addition of 45 ml of Impact buffer. The BapL
peptide was concentrated, analyzed by SDS-PAGE using 4-12% Tris-glycine gels
(Invitrogen) and protein concentrations were estimated by the Bradford method (Bradford
1976). Approximately 10 mg of purified recombinant peptide was submitted to Invitrogen
for production of polyclonal rabbit antiserum by their standard protocols.

Polyacrylamide Gel Electrophoresis. Protein samples were analyzed using the NuPAGE
protein system (Invitrogen) and were separated on pre-cast NuPAGE Novex Bis-Tris 441

12% gradient gels (Invitrogen). 4X NuPAGE LDS loading buffer was added to samples to
achieve a 1X concentration and these samples were then boiled for 10 minutes prior to gel
loading. Gels were run in 1X MES SDS Running Buffer (Invitrogen), rinsed in deionized
water three times for 5 minutes each and then stained in Imperial Protein Stain (Thermo
Scientific) for 1-2 hours, followed by destaining in water overnight.

Western blot analysis of BapL expression. Samples for western blot analysis were
prepared as follows. Biofilm samples were grown for 48 hours in BHI or BHIG with
media change after 24 hours. Planktonic samples were grown for 24 hours in BHI with
gentle shaking. One BHIG biofilm was treated for 1 hr with 6 !l/ml of proteinase K (20
!g/ml stock, Qiagen) to disrupt the biofilm and bacteria collected by centrifugation of the
media. Protein amount was standardized by pellet weight after centrifugation to collect the
bacteria. Proteins were extracted from the samples by resuspending with 1 ml of lysis
buffer containing lysozyme and incubating for 45 minutes at room temperature with
rocking. Samples were centrifuged to collect the cell debris, supernatants collected,
NuPAGE loading buffer added and samples boiled for 10 minutes. Proteins were
separated on NuPAGE Bis-Tris 4-12% gels as described. Following electrophoresis, the
polyacrylamide gel was rinsed in deionized water. PVDF membrane was wetted in 100%
methanol then incubated in transfer buffer. Sponges were wetted in transfer buffer and
used to surround the gel and membrane to ensure the system remained saturated with
transfer buffer at all times. The transfer was performed at 35 volts for 1 hour and 20
minutes and later the membrane was incubated overnight in 1X PBS, 5% skim milk and
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5% BSA (Difco, Franklin Lakes, NJ) at 4ºC. The membrane was then incubated for 2
hours at room temperature with shaking in a 1:1000 dilution of anti-BapL antibody in 1X
PBS, 0.15% skim milk and 0.15% BSA. The membrane was then washed 4 times for 10
minutes each in 1X PBS, 0.05% Tween-20 (Fisher Scientific) followed by an incubation in
a 1:10,000 dilution of goat anti-rabbit-HRP conjugate secondary antibody (Invitrogen) in
1X PBS, 0.15% skim milk and 0.15% BSA for 1 hour at room temperature. The
membrane was washed four times for 10 minutes each in 1X PBS, 0.05% Tween-20. The
blot was incubated in ECL™ Plus chemiluminesce developing reagent (GE Healthcare).
The blot was then wrapped in saran wrap, exposed to X-ray film, and developed in an XO-Mat.

Reverse-transcriptase PCR. The mRNA levels of G. vaginalis grown as a biofilm in BHI
and BHIG and as a planktonic culture were analyzed for expression of bapL. Overnight
cultures of G. vaginalis strain 5-1 were diluted 1:25 in fresh BHI or BHIG in T75 flasks.
The flasks were grown anaerobically for 48 hours with fresh media change after 24 hours.
Biofilms were washed with deionized, distilled H20 to remove non-adherent cells and
bacteria were collected by addition of 1ml ddH20 and scraping of cells from the surface.
Planktonic cultures of G. vaginalis strain 5-1 were grown in 250 ml flasks of BHI
anaerobically for 48 hours with gentle stirring to keep bacteria in the planktonic state. All
cultures were centrifuged to pellet the cells and RNA from both planktonic and biofilm
cultures were extracted using a Fastpro RNA kit (MP Biomedicals, Solon. OH). Isolated
RNA was DNase treated to ensure the absence of genomic DNA contamination. RNA was
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converted to cDNA using bapL and G. vaginalis 16S reverse primers along with
Accuscript reverse transcriptase (Stratagene, La Jolla, CA). Syber green PCR reagent
containing MgCl2, dNTPs and Taq polymerase was combined with cDNA and either bapL
or 16S specific primers (Quantace, Norwood, MA). Amplification was carried out using a
thermocycle profile that included: stage 1, 95ºC for 3 minutes; stage 2 consisting of 40
cycles of 95ºC for 15 seconds, 61.5ºC for 15 seconds, 72ºC for 15 seconds; and stage 3
consisting of 81 cycles of 55ºC for 15 seconds.
The absolute Ct values from 3 qPCR assays were averaged to determine the cycle
threshold value from each sample. Expression of bapL was normalized to 16S rRNA as
determined by cycle threshold values using the following equation: E=2^(16S Ct – bapL
Ct).

Immuno-fluorescence microscopy. Cultures of G. vaginalis and L. lactis were grown
overnight as previously stated, and diluted to an equal OD600 to ensure equal numbers of
bacteria. 1 ml of each diluted culture was centrifuged to pellet the bacteria and washed
two times by resuspending with 1 ml of sterile 1X PBS. After washing, the pellets were
resuspended with 1 ml of sterile 1X PBS, sonicated with 1 second pulses eight times to
ensure the bacteria were not clumped, then a 1:10 dilution of BapL specific polyclonal
rabbit serum was added to each tube and incubated at 37ºC for 30 minutes. After the
incubation, both bacteria were washed three times with sterile 1X PBS and then a 1:100
dilution of Alexa-488 labeled goat-anti rabbit antibody was added to the tubes and
incubated at room temperature in the dark for 30 min. The bacteria were washed an
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additional three times, resuspended with 1 ml of PBS, sonicated with 1 second pulses eight
times, and a small volume was placed on a microscope slide and observed with an
Olympus BX51 fluorescence microscope using a FITC filterset. Both differential
interference contrast (DIC) and fluorescence images were taken to localize the
fluorescence staining to individual bacteria.

Purification of anti –bapL IgG antibodies. BapL-specific IgG antibodies were purified
from harvested rabbit serum by a ProPur Protein G Antibody Purification kit (NUNC™
Thermo Fisher Scienctific, Rochester, NY). Briefly, 12 ml of filtered, harvested rabbit
serum containing polyclonal antibodies against BapL were diluted 1:1 with binding buffer
A, or 0.1 M sodium phosphate, 0.15 NaCl, pH 7.4. The sample was then pipetted onto an
equilibrated Protein G spin column and centrifuged at 150 g for 30 minutes. The spin
column was washed twice with 10 ml of binding buffer A to remove unbound
contaminants. Bound IgG was eluted with 10ml elution buffer B2, or 0.2M Glycine/HCl
pH 2.5 directly into a fresh centrifuge tube containing 1.3 ml neutralization buffer C, or 1
M Tris/HCl ph 9.0, to bring the pH of the sample to approximately 7.5. The tube was
swirled to ensure thorough mixing of the final eluate with neutralization buffer C. The
elution step was repeated, the samples pooled, and the antibody preparation was de-salted
and concentrated using a 10 kDa MWCO ultrafiltration spinner that was supplied.
Aliquots of 50 !l of purified BapL antibody were stored at -20ºC until further use.
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Antibody inhibition assay of biofilm formation. Overnight cultures of G. vaginalis were
diluted 1:100 in fresh BHIG and incubated for 30 minutes at room temperature on a rotator
with either 400 !g of anti-BapL antibody or 400 !g of preimmune antibody. 200 !l of
each culture was added to a 96-well plate and incubated anaerobically at 37ºC for 24 hours.
The wells were washed twice with sterile PBS to remove nonadherent bacteria and stained
with safranin to assess biofilm formation. Photographic images of the biofilm were taken
by an HP color LaserJet 2820 printer with scanning capabilities (Hewlett-Packard
Company).

Antibody inhibition assay of initial adherence. Overnight cultures of G. vaginalis were
diluted 1:50 in fresh BHIG and incubated for 30 minutes at room temperature on a rotator
with either 400 !g of anti-BapL antibody or 400 !g of preimmune antibody. 200 !l of
each culture was added to a 96-well plate and incubated anaerobically at 37ºC for 2 hours.
The wells were washed twice with sterile PBS to remove nonadherent bacteria and stained
with safranin to assess biofilm formation. Photographic images of the biofilm were taken
by an HP color LaserJet 2820 printer with scanning capabilities (Hewlett-Packard
Company).

Antibody inhibition assay of aggregation. Overnight cultures of G. vaginalis were
standardized to ensure equal numbers of bacteria and either treated with PBS as a control,
400 !g of anti-BapL antibody or 400 !g of preimmune antibody. The OD600 of the
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cultures was measured every 15 minutes for 120 minutes at room temperature and the
measurements were plotted and slopes analyzed.

Antibody inhibition assay of adherence to epithelial cells. Overnight cultures of G.
vaginalis were incubated for 30 minutes at room temperature on a rotator with either 400
!g of anti-BapL antibody or 400 !g of preimmune antibody, standardized via OD600
measurements to ensure equal numbers of bacteria then added to 80% confluent
monolayers of ME180 cervical epithelial cells. The plates were centrifuged at 600 rpm for
2 minutes to maximize interaction between the bacteria and epithelial cells and incubated
at 37ºC for 15 minutes in 5% CO2. After the incubation, the wells were washed twice with
PBS to remove nonadherent bacteria then bacteria were harvested by addition of 5%
saponin for 5 minutes. The wells were diluted 10-fold in PBS and 10 !l of each dilution
was plated on BPS agar plates and incubated for 48 hours. Colony-forming units were
counted and percentage of adherence measured using the equation:
% adherence = (Experimental CFU/ Control CFU) x 100

Extracellular matrix (ECM) protein adherence assay. Overnight cultures of G. vaginalis
were diluted 1:10 in PBS and incubated for 30 minutes at room temperature on a rotator
with either 400 !g of anti-BapL antibody or 400 !g of preimmune antibody. Immulon
plates (Thermo Fisher Scientific) were pre-coated with the ECM proteins fibrinogen,
fibronectin, hyaluronic acid, elastin, and collagen IV by diluting the ECM proteins in 100
mM carbonate buffer to a final concentration of 20 !g/ml and adding 200 !l of each per
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well and allowing the plate to incubate for 16 hours at 4ºC. 200 !l of each bacterial culture
was added to the Immulon plate that had been previously immobilized with ECM proteins.
The plates were centrifuged at 600 rpm for 2 minutes to maximize the interaction between
the bacteria and ECM proteins then incubated at 37ºC for 10 minutes. After the 10 minute
incubation, the wells were washed twice with 200 !l of sterile PBS to remove nonadherent
bacteria, plates dried and the wells were stained with 200 !l of safranin. Photographic
images of the biofilm were taken by an HP color LaserJet 2820 printer with scanning
capabilities (Hewlett-Packard Company).

Mucin adherence assay. Overnight cultures of G. vaginalis were diluted 1:10 in PBS and
incubated for 30 minutes at room temperature on a rotator with either 400 !g of anti-BapL
antibody or 400 !g of preimmune antibody. Immulon plates (Thermo Fisher Scientific)
were pre-coated with porcine mucin (stock 5%) in 100 mM carbonate buffer to a final
concentration of 20 !g/ml and 200 !l of the diluted mucin was added to each well and
incubated for 16 hours at 4ºC. 200 !l of each bacterial culture was added to the Immulon
plate that had been previously immobilized with porcine mucin. The plate was centrifuged
at 600 rpm for 2 minutes to maximize the interaction between the bacteria and porcine
mucin then incubated at 37ºC for 10 minutes. After the 10 minute incubation, the wells
were washed twice with 200 !l of sterile PBS to remove nonadherent bacteria, plates dried
and the wells were stained with 200 !l of safranin. Photographic images of the biofilm
were taken by an HP color LaserJet 2820 printer with scanning capabilities (HewlettPackard Company).
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Mucin Dot Blot. A 5% and 1% porcine mucin solution in 1X PBS was dotted onto strips
of nitrocellulose membrane. The membranes were allowed to dry at room temperature for
1 hour then incubated for 1 hour at room temperature in 1X PBS with 5% skim milk and
5% BSA. G. vaginalis surface proteins were extracted by pelleting an overnight culture of
G. vaginalis, rinsing the cell pellet in PBS, then sonciating the pellet for 30 seconds three
times on ice. Supernatant was collected and protein amount analyzed by OD280
measurements. 400 !g of G. vaginalis proteins were allowed to interact with the blocked
membranes for 1 hour in 1X PBS, 0.05% Tween-20 (Fisher Scientific). After incubation
with the G. vaginalis protein, the membrane was then washed 4 times for 10 minutes each
in 1X PBS, 0.05% Tween-20, followed by an incubation with 10 !g/ml of purified antiBapL antibody in 1XPBS, 0.05% Tween-20, 0.15% skim milk and 0.15% BSA for 1 hour.
After the primary antibody, the membrane was washed as described above, and incubated
with a 1:10,000 dilution of goat anti-rabbit-HRP conjugate secondary antibody
(Invitrogen) in 1X PBS, 0.15% skim milk and 0.15% BSA for 45 minutes at room
temperature. The membrane was then washed four times for 10 minutes each in 1X PBS,
0.05% Tween-20. The blot was incubated in ECL™ Plus chemiluminesce developing
reagent (GE Healthcare). The blot was then wrapped in saran wrap, exposed to X-ray film,
and developed in an X-O-Mat.

Opsonophagocytosis assay. White blood cells (WBC) were prepared from fresh human
blood collected from a healthy adult volunteer. 25 ml was mixed with an equal volume of
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dextran-heparin buffer and incubated at 37°C for 1 hr. The upper layer containing the
leukocytes was collected, the cells were pelleted by centrifugation, and hypotonic lysis of
the remaining erythrocytes was accomplished by resuspsion of the cell pellet in ddH20.
WBC were then washed three times and resuspended in RPMI buffer (Gibco). A
hemocytometer was used to give a final WBC count of 1.5 X 106 WBC per 100 !l. The G.
vaginalis bacterial strains to be evaluated for phagocyte-dependent killing activity of the
anti-BapL antibody were grown anaerobically overnight in BHIG on 0.1 mm glass beads
to stimulate biofilm formation. Biofilms on the glass beads were dispersed by sonication
on ice for 10 seconds. The complement source was 50 !l of baby rabbit serum diluted in
RPMI buffer.
The opsonophagocytic assay was performed with 100 !l of leukocytes, 50 !l of
either dispersed bacteria or biofilm beads, 50 !l of complement solution, and 50 !l of 1:20
diluted anti-BapL antibody or preimmune antibody. The reaction mixture was incubated
on a rotor rack at room temperature for 90 min. The tubes were sonicated for 10 sec and
10-fold diluted in RPMI buffer and plated on BPS agar plates. The percentage of killing
was calculated by determining the ratio of CFU surviving in tubes with bacteria,
leukocytes, complement and antibody to CFU surviving in control tubes. The percent
killing was compared between biofilm samples and dispersed biofilm samples.

Sandwich western of ME180 proteins probed with G. vaginalis proteins. Monolayers of
ME180 cervical epithelial cells were grown in T75 flasks until 100% confluent. Cells
were harvested by trypsin digestion, centrifuged at 1000 rpm for 12 minutes to remove the
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trypsin then resuspended in 1 ml of sterile PBS. Proteins were extracted by the addition of
200 !l of NuPAGE loading buffer and incubation for 10 minutes at room temperature
while rocking. ME180 cervcial epithelial cell proteins were separated on NuPAGE BisTris 4-12% gels as described earlier. Following electrophoresis, the polyacrylamide gel
was rinsed in deionized water. PVDF membrane was wetted in 100% methanol then
incubated in 1X transfer buffer (20X NuPAGE transfer buffer and 10% methanol).
Sponges were wetted in transfer buffer and used to surround the gel and membrane to
ensure the system remained saturated with transfer buffer at all times. The transfer was
performed at 35 volts for 1 hour and 20 minutes following which the membrane was
incubated for 1 hour in 1X PBS, 5% skim milk and 5% BSA (Difco, Franklin Lakes, NJ)
at 4ºC. The membrane was then incubated for 1 hour with 200 !g of G. vaginalis surface
proteins. G. vaginalis surface proteins were extracted by pelleting an overnight culture of
G. vaginalis, rinsing the cell pellet in PBS, then sonciating the pellet for 30 seconds three
times on ice. Supernatant was collected and protein amount analyzed by OD280
measurements. After incubation with the G. vaginalis protein, the membrane was then
washed 4 times for 10 minutes each in 1X PBS, 0.05% Tween-20 (Fisher Scientific)
followed by an incubation with 10 !g/ml of purified anti-BapL antibody in 1XPBS, 0.05%
Tween-20, 0.15% skim milk and 0.15% BSA for 1 hour. After the primary antibody, the
membrane was washed as described above, and incubated with a 1:10,000 dilution of goat
anti-rabbit-HRP conjugate secondary antibody (Invitrogen) in 1X PBS, 0.15% skim milk
and 0.15% BSA for 45 minutes at room temperature. The membrane was then washed
four times for 10 minutes each in 1X PBS, 0.05% Tween-20. The blot was incubated in
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ECL™ Plus chemiluminesce developing reagent (GE Healthcare). The blot was then
wrapped in saran wrap, exposed to X-ray film, and developed in an X-O-Mat.

Immunoprecipitation of ME180 proteins that interact with BapL. The buffer of purified
anti-BapL antibody was exchanged and desalted using Econo-Pac 10DG columns from the
Affi-Gel® Hz Immunoaffinity Kit (BioRad, Hercules, CA). The desalted purified antiBapL antibody was then coupled to Affi-Gel Hz Hydrazide Gel using the Affi-Gel® Hz
Immunoaffinity Kit (BioRad). Briefly, that purified anti-BapL antibody was oxidized by
adding one-tenth the volume of sodium periodate to the purified IgG sample. This mixture
was rotated end-over-end for 1 hour at room temperature. The oxidized antibody was then
desalted again as described previously. The oxidized, desalted anti-BapL antibody was
incubated end-over-end for 16 hours at room temperature with washed Affi-Gel Hz
Hydrazide Gel. After the coupling reaction was complete, the gel was washed with PBS
0.5 M NaCl, pH 7.4. 10 mg of G. vaginalis protein and 10 mg of ME180 cervical
epithelial cell protein was allowed to interact for 30 minutes at room temperature while
rotating. This mixture was added to the washed Affi-Gel Hz Hydrazide Gel and allowed to
rotate for 2 hours at 4ºC. The Affi-Gel Hz Hydrazide Gel was then placed into a column,
washed 2 times with PBS 0.5 M NaCl pH 7.4 and 2 times with PBS 50 mM NaCl pH 7.4.
Bound protein was eluted by addition of 10 ml of 0.2M Glycine/HCl pH 2.5 into a tube
containing 1.3 ml 1M Tris/HCl pH 9.0 to neutralize the protein solution. The protein was
concentrated using a 3 kDa MWCO filtration spinner. The protein was separated by SDS-
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PAGE and the gel was stained overnight with Imperial Protein stain (Thermo Scientific),
following by destaining in water.

Ethyl methanesulfonate (EMS) mutagenesis. A kill curve using liquid EMS (Sigma,
molecular weight 124.16) amounts of 10 !l, 50 !l, and 250 !l for 5 minutes, 15 minutes,
30 minutes and 1 hr showed that 50 !l of EMS for 30 minutes produced approximately
90% killing of G. vaginalis bacteria. 3 mls of an overnight culture of G. vaginalis was
centrifuged to collect the cells. The bacteria were washed once with sterile PBS and
resuspended in 500 !l of sterile PBS. 50 !l of stock EMS compound was added to the
bacteria and allowed to rock at 37°C for 30 minutes. After the 30 minute incubation, the
bacteria were rinsed four times with sterile BHIG. The final resuspension was in 1 ml of
BHIG; this was allowed to incubate for 24 hours anaerobically at 37°C. An additional 5
ml of sterile BHIG was added to the mutagenized bacteria after the 24 hour incubation; this
was allowed to incubate for an additional 24 hours before being used for FACS analysis.
EMS is highly toxic and appropriate precautions were used including a lab coat and eye
protection. EMS usage was in a chemical safety hood and all equipment that came into
contact with EMS was rinsed in 1M NaOH for at least 24 hours before being disposed of
appropriately.

Fluorescence-activated cell sorting (FACS) staining and analysis. A 48 hour EMS
mutagenized culture of G. vaginalis was centrifuged to collect the cells. The pellet was
washed two times with sterile PBS and sonicated for 8 one second pulses to ensure the
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bacteria were not clumped. The bacteria were stained with a 1:10 dilution of anti-BapL
antibody for 30 minutes at 37°C. After this incubation, the bacteria were collected by
centrifugation and washed two times with sterile PBS. The bacteria were then stained with
a 1:100 dilution of Alexa-488 labeled goat anti-rabbit secondary antibody in the dark at
room temperature for 30 minutes. After this incubation, the bacteria were collected by
centrifugation and washed two times with sterile PBS, before being sonicated for 3 one
second pulses. These stained bacteria were then analyzed by FACS, gating on
fluorescence intensity. Individual bacterial cells with low fluorescence intensity,
signifying a potential bapL mutant, were collected in wells of a 96-well plate. After the
FACS run, the 96-well plate harboring low fluorescent bacteria was incubated
anaerobically at 37°C for 48 hours. Wells with growth after the 48 hour incubation were
collected and added to snap-cap tubes containing 5 ml of BHIG. These tubes were allowed
to incubate anaerobically at 37°C for 24 hours before the culture was analyzed for biofilm
formation using the 96-well assay described previously.

Long-Distance PCR of the bapL gene. Long-distance PCR reactions were performed in a
TC-312 Techne thermocycler (Techne). Primers used were BapSbfFWD and BapSbfREV
which incorporated Sbf1 restriction sites onto each end of the PCR product (Table 2).
PCR reaction mixtures consisted of 2.5 mM dNTPs, 5X Phire Buffer, 100 pM forward and
reverse primers, F-120S Phire Hot start polymerase (Finnzymes, Espoo, Finland), water
and genomic DNA.
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Conditions for PCR were as follows, one initial cycle at 94ºC for 2 minutes
followed by 10 cycles of: 94ºC 30 seconds to denature, 52ºC 30 seconds to hybridize, and
70ºC 10 minutes for extension. Immediately following, there was a second step with 30
cycles of: 94ºC 30 seconds to denature, 56ºC 30 seconds to hybridize, and 72ºC 10
minutes for extension. A final extension at 72ºC for 15 minutes after the final cycle and
the reactions were chilled to 4ºC. A two cycle protocol was used; cycle one utilized a
lower annealing temperature to increased the number of bapL gene products that could be
used for amplification, while cycle two utilized a higher annealing temperature that
produced highly specific amplification of the bapL gene.

Production of pRB473-bapL for heterologous expression. The 9.1 kb bapL PCR product
was gel purified using the QIAquick Gel Extraction Kit (Qiagen) as described by the
manufacturer. The resulting PCR product was subcloned into the plasmid pCR2.1®-Topo
(Invitrogen) to construct the recombinant plasmid pCR2.1-Topo-bapL. This plasmid was
used to transform CH3 blue chemically competent E.coli cells (Bioline) and plated on LB
ampicillin 100!g/ml plates. The recombinant plasmid was purified from pooled colonies
of E. coli and subjected to Sfb1 restriction digest using its specific buffer and BSA per the
manufacturer’s instructions (New England Biolabs) to drop out the bapL PCR product.
The digested bapL PCR product was ligated into the Pst1-linearized E. coli/S. aureus
shuttle vector pRB473 (amp100/cm10) using Ready-to-Go T4 DNA Ligase tubes
(Amersham Biosciences) with an hour incubation at 16ºC. 2 !l of purified plasmid DNA
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was added to 50 !l of CH3 blue chemically competent E. coli cells and transformed as
described above.
Plasmid mini-preps were prepared from individual E. coli transformants that were
grown overnight in 5 ml of LB broth with ampicillin concentration of 100 !g/ml, using a
QIAprep Spin Miniprep Kit (Qiagen), as described by the manufacturer. Plasmids were
screened for correct insert by digestion with Pst1 (New England Biolabs). Plasmids with
correct insert sizes were used to transform S. aureus RN4220.

Production of electrocompetent S. aureus RN4220. Electrocompetent S. aureus cells were
prepared from cultures grown in TSB at 37ºC with shaking. Cultures were grown to
exponential phase (OD600= 0.5-0.8) and then incubated on ice for 10 minutes. The cultures
were collected by centrifugation for 15 minutes at 4,000 rpm at 4ºC. Care was taken to
ensure all subsequent steps were performed on ice. The pellet was then washed three times
with one tenth the volume of ice-cold sterile water. The pellet was then washed one time
with one fifth the volume of cold sterile 10% glycerol. The pellet was then resuspended in
one tenth the volume of ice-cold sterile 10% glycerol and incubated at room temperature
for 15 minutes. The culture was collected by centrifugation for 5 minutes at 4,000 rpm at
4ºC, resuspended in 500 !l of ice-cold 10% glycerol, and aliquots (100 !l) were then
stored at -80ºC until further use.

Transformation of electrocompetent S. aureus. Plasmid DNA isolated as described above
was used to transform S. aureus RN220. Plasmid DNA (5 !l) was added to 75 !l of
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electrocompetent S. aureus and incubated on ice for 10 minutes. The mixture was then
transferred to an electroporation cuvette with a gap length of 0.1 cm and pulsed one time
using the MicroPulser (BioRad) pre-set S. aureus setting Sta (1.8 kV, 2.5 msec, 25 !F).
Following electroporation, 250 !l of LB broth was added immediately to the cuvette and
this mixture was then transferred to an eppendorff tube. The antibiotic to be used for
selection was added at a subinhibitory concentration (chloramphenicol = 0.1 !g/ml) and
the cells were incubated for 1 hour with shaking at 37ºC. Aliquots (75 !l and 225 !l) were
then spread on TSA supplemented with appropriate antibiotic selection and incubated at
30ºC for 48 hours.

S. aureus biofilm assay. Biofilms were grown using 96 well Corning Cell Bind Plates
(Corning). Overnight cultures of S. aureus RN4220 with empty vector or pRB473-bapL or
S. aureus RN4220!ica with empty vector or pRB473-bapL were diluted 1:10 in fresh
media and individual wells of a sterile, polystyrene 96 well tissue culture plate were
inoculated with 0.2 ml of dilute culture. The tissue culture plates were incubated for 24-72
hrs at 37 °C, under aerobic conditions. Growth was analyzed using a 96-well plate
spectrophotometer with a 595nm filter (BioTek 800 Plate reader, Winooski, VT). Spent
medium was removed, wells were washed with 200 µl once with phosphate buffered saline
(PBS) to remove nonadherent bacteria, and the plates were air dried for 1 hr. Biofilms were
stained with 200 µl of safranin for one min, wells were washed gently to remove the
safranin, and the plates were imaged using a HP color LaserJet 2820 printer with scanning
capabilities (Hewlett-Packard Company).
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Poly-N-acetyl glucosamine (PNAG) blot. Standardized amounts of overnight bacterial
cultures were centrifuged to pellet the cells and resuspended in 250 !l of 0.5 M EDTA.
The samples were boiled for 5 minutes then centrifuged to pellet cell debris. The
supernatant was transferred to a new tube, 20 !l of proteinase K was added then the sample
was heated at 65ºC for 1 hour. After the 1 hour incubation, the samples were boiled for 5
minutes to inactivate the proteinase K. The samples were sonicated for 3-5 seconds and
dilutions made in 1X PBS. A piece of nitrocellulose blotting membrane (BioTrace NT,
Pall Corporation) was cut to fit inside the blot apparatus (7.5 cm wide by 11.5 cm long).
The cover paper was removed from the nitrocellulose and the membrane was soaked in 50
ml of 5% methanol for 1-2 minutes. The nitrocellulose membrane was rinsed in 50 ml of
1X PBS; the nitrocellulose membrane was placed within the blotting apparatus and care
was used to ensure that the instrument gasket had produced a tight seal. 200 !l of stock or
diluted PNAG samples were loaded into individual wells in the blotting apparatus and the
machine was allowed to run for 10 minutes or until all sample have been soaked up by the
membrane. The membrane was removed carefully and allowed to dry overnight between
pieces of kimwipe.
The dried nitrocellulose membrane was soaked in 25 ml of 5% bovine serum
albumin (BSA) solution for 1 hour at room temperature on a rocker. The membrane was
probed with 15 ml of primary antibody solution containing 3 !l of goat anti-PNAG
antibody (1:5000 dilution), 1 ml 5% BSA solution, and 14 ml of 1X PBS for 3 hours at
room temperature on a rocker. The membrane was washed 3X with 15 ml of 1X PBS for 4
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minutes each. After the wash steps, the membrane was probed with l5 ml of secondary
antibody solution containing 1.5 !l of rabbit anti-goat-HRP labeled antibody (1:10,000
dilution) and 15 ml of 1X PBS for 1 hour at room temperature on a rocker. The membrane
was again washed 3X with 15 ml of 1X PBS for 4 minutes each. The blot was incubated
in ECL™ Plus chemiluminesce developing reagent (GE Healthcare). The blot was then
wrapped in saran wrap, exposed to X-ray film, and developed in an X-O-Mat.

Phage Transduction. The generalized transducing phage 80& was used to create the allelic
exchange mutation of ica in S. aureus RN4220. A freezer stock of Sa113 !ica was
inoculated onto TSA supplemented with erythromycin, and grown overnight at 37ºC. A
single colony was subcultured onto a new plate and allowed to grow overnight at 37ºC.
All of the culture was removed from the plate and resupended in 0.5 ml of TSB in a small
tube. 200 !l of this culture was added to 0.4% soft agar in a new tube, along with 5 !l of
2M CaCl2 and either 75 !l of phage 80& or no phage. This mixture was plated on TSA
plates and monitored for lysis.
Following lysis, the soft agar was collected, centrifuged, and the supernatant was
filter sterilized through a 0.45 !m filter. Aliquots of this lysate, either 75 or 150 !l, were
then mixed with 150 !l of recipient bacteria, or S. aureus RN4220, and 5 !l of 2M CaCl2.
The mixture was incubated with shaking at 37ºC for exactly 20 minutes, 5 ml of 20mM
sodium citrate was added, the culture was centrifuged to pellet the bacteria, the pellet
washed twice with 20 mM sodium citrate, then incubated for 1 hour and 45 minutes in 500
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!l of 20 mM sodium citrate. Finally, the mixture was plated on TSA supplemented with
erythromycin and sodium citrate and these plates were incubated for 48 hours at 37ºC.
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CHAPTER 3
Analysis of Virulence Potential of Gardnerella vaginalis

Introduction
Gardnerella vaginalis is present in up to 95% of cases of BV (Catlin 1992;
Marrazzo, Thomas et al. 2008); however, with the advancement of molecular tools, it has
been shown that the number and diversity of anaerobes associated with BV is high
(Oakley, Fiedler et al. 2008). One study found that pure cultures of G. vaginalis do not
always cause BV and the organism can occur, albeit in low numbers, in healthy women
(Gardner and Dukes 1955; Fredricks, Fiedler et al. 2007). Together, these findings cast
doubt on the role of G. vaginalis in the pathogenesis of BV. Recently, the term functional
equivalent pathogen/pathogroup (FEP) has been proposed for polymicrobial infections in
which no one species alone is capable of causing disease, but rather the synergistic effects
of the consortium give rise to the pathophysiology (Dowd, Wolcott et al. 2008).
Inarguably, the vagina is colonized by numerous anaerobic bacteria during BV, but
whether the symptoms and the syndrome are a consequence of the multi-species
consortium or whether there is a key species in each case that precipitates the disorder has
been a matter of debate for decades. A follow-up study to the report that G. vaginalis in
pure culture did not reliably cause BV found that fresh cultures initiated the infection more
frequently (Criswell, Ladwig et al. 1969). This study may suggest that under conditions
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that foster expression of virulence determinants, G. vaginalis may have greater pathogenic
potential. Furthermore, recent studies indicate that G. vaginalis is equipped with a number
of virulence properties and consequently, the idea that it is the etiologic agent of BV is
being revisited (Swidsinski, Mendling et al. 2005; Gelber, Aguilar et al. 2008).
One such virulence determinant is the ability of G. vaginalis to form a biofilm.
Swidsinski et al. showed that G. vaginalis was able to form an thick, tenacious biofilm on
the vaginal epithelium of women with BV (Swidsinski, Mendling et al. 2005). This
biofilm incorporated other bacterial groups into its layers, suggesting that the biofilm may
enable other anaerobes to colonize the vagina. Not only could formation of a biofilm
allow other anaerobes to colonize the vagina, but the biofilm phenotype allows its
constituent bacteria to be resistant to many negative environmental stimuli. This biofilm
phenotype may explain the high rates of relapse seen with BV.
G. vaginalis also produces the toxin vaginolysin, which is a member of the
cholesterol-dependent family of pore-forming toxins that lyse human red blood cells and
vaginal epithelial cells (Gelber, Aguilar et al. 2008). Vaginolysin has been hypothesized to
be involved in the pathogenesis of BV. G. vaginalis can also adhere well to vaginal
epithelial cells and attaches equally well to exfoliated vaginal epithelial cells and to tissue
culture cells (Sobel, Schneider et al. 1981; Scott and Smyth 1987). Finally, not only does
G. vaginalis have numerous virulence factors that could contribute to the pathogenesis of
BV, it has also been implicated as the sole etiologic agent of infections outside of the
reproductive tract. There have been reports of G. vaginalis as the causative agent of
vertebral osteomyelitis and discitis, retinal vasculitis, acute hip arthritis, and bacteremia
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(Lagace-Wiens, Ng et al. 2008; Graham, Howes et al. 2009; Neri, Salvolini et al. 2009;
Sivadon-Tardy, Roux et al. 2009).
Many of the bacterial species associated with BV have evolved to exist only in
humans and consequently a reliable animal model for BV does not exist. This has stymied
efforts to tease out the pathogenesis of BV, hence studies of the etiology of BV are
lacking. Reports of the frequency with which different species are isolated exist but point
only to association and not cause. For example, Atopobium vaginae is frequently isolated
from BV and one study indicates its potential to induce an inflammatory response, but
there has not been a demonstration that it is equipped with specific virulence factors
(Libby, Pascal et al. 2008). In an effort to begin to unravel this etiologic mystery, we
designed a simple model to test adherence to vaginal epithelial cells and used established
models to analyze biofilm forming capacity and cytotoxicity of G. vaginalis and a number
of additional BV isolates including A. vaginae, Prevotella bivia, Mobiluncus mulieris, a
Veillonella sp., a Peptostreptococcus sp., a Peptoniphilus sp., and Fusobacterium
nucleatum (Verstraelen, Verhelst et al. 2004; Nikolaitchouk, Andersch et al. 2008; Oakley,
Fiedler et al. 2008).

Results
Adherence of BV-associated anaerobes to cervical epithelial cells
We analyzed the ability of G. vaginalis strains 5-1, 465, and 101-1 to bind to ME180 cervical epithelial cells. Overnight cultures were standardized to ensure equal
numbers of bacteria. The bacteria were stained with a green fluorophore, and allowed to
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interact with the monolayer of red fluorescent-labeled ME-180 cervical epithelial cells for
15 minutes before washing to remove nonadherent bacteria. Figure 4 shows
representative confocal microscopic images of the G. vaginalis adherence assay. All G.
vaginalis strains tested exhibited considerable adherence. We next analyzed the ability of
BV isolates: A. vaginae, M. mulieris, P. bivia, Veillonella, Peptostreptococcus,
Peptoniphilus, and F. nucleatum (Table 1) to bind to ME-180 cervical epithelial cells.
Figure 5 shows representative confocal microscopic images of red ME-180 cells and green
BV-associated bacteria; G. vaginalis is shown as a positive control. Both G. vaginalis and
Peptoniphilus exhibited considerable adherence. Peptoniphilus adhered more
homogenously to the ME-180 cells whereas G. vaginalis, which is very aggregative,
adhered as large clusters. As shown in Figure 5, F. nucleatum and A. vaginae exhibited
some adherence to the epithelial cells, although to a significantly lesser degree than G.
vaginalis or Peptoniphilus. M. mulieris, P. bivia strain 715BVD, P. bivia strain 29303
(data not shown), Veillonella, and Peptostreptococcus were unable to adhere to the cervical
epithelial cells under these conditions. Table 4 lists the adherence scores for each species
after the 15 minute incubation with the monolayer; the scores correlate with the confocal
microscopy images. Each experiment was repeated three times with similar results
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Figure 4. Adherence of G. vaginalis to cervical epithelial cells. Bacteria were
grown in sBHIG anaerobically at 37 °C for 24 hrs. Bacteria (green) were
standardized to ensure equal numbers, added to vaginal epithelial cells (red) and
incubated for 15 minutes before washing to remove nonadherent bacteria.
Qualitative estimates of adherence were ascertained by confocal microscopy.
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Control-ME180 only

Control-GV only

GV adherence

Figure 5. Adherence of G. vaginalis and BV-associated anaerobes to cervical
epithelial cells. Bacteria were grown in sBHIG anaerobically at 37ºC for 24 hours.
Bacteria (green) were standardized to ensure equal numbers, added to cervical
epithelial cells (red) and incubated for 15 minutes before washing to remove
nonadherent bacteria. Qualitative estimates of adherence were ascertained by
confocal microscopy. P. bivia strain 29303 is not shown but did not exhibit
adherence.
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Table 4. Adherence and Cytotoxicity scores for the BV-associated
anaerobes.
Strain

Cytotoxicity score*

Adherence score!

PBS control

0

-

G. vaginalis 5-1

5

+++

G. vaginalis 101-1

5

+++

G. vaginalis 465

5

+++

A. vaginae FA

0

++

M. mulieris BV26-9

0

±

P. bivia 29303

0

±

P. bivia 715BVD

0

±

Veillonella sp. 715BVA

0

-

Peptostreptococcus sp.
715BVC

0

-

Peptoniphilus sp.

0

+++

F. nucleatum 718BVC

0

+

Adherence and cytotoxicity scores of the bacterial strains. Adherence
scores ranged from (-), indicating no bacteria atdhered to the ME180 cells, to
(+++), indicating many bacteria adhered to the ME180 cells. Cytotoxicity
scores ranged from 0, indicating no change, to 5, indicating complete lysis of
the ME180 monolayer. Experiments were repeated three times and produced
similar results each time.
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Cytotoxicity of G. vaginalis
G. vaginalis strains 5-1, 465, and 101-1 were tested for their ability to cause cell
rounding and lysis of ME-180 cervical epithelial cells. Equal numbers of each bacterial
species were added to a confluent monolayer of ME-180 cervical epithelial cells.
Cytotoxicity scores (Table 4) and microscopic images (Figure 6) of the monolayer were
recorded after 4 hours. All G. vaginalis strains tested were a 5 on the cytotoxicity scale,
causing complete lysis of the monolayer within 4 hours. Supernatant from a G. vaginalis
culture was also tested for cytotoxicity; however, supernatant had no cytopathic effect on
the cervical epithelial cells.

Trans-well assay to elucidate contact dependence of G. vaginalis cytotoxicity
Other cholesterol-dependent cytolysins depend upon adherence to exert their
activity (Madden, Ruiz et al. 2001). To investigate whether G. vaginalis requires direct
contact with cervical epithelial cells to exert its cytotoxic effects, we performed
cytotoxicity assays as described above; however, the bacteria were separated from the
cervical epithelial cell monolayers with trans-well filters with a pore size of either a 0.45
!m or 8.0 !m. The trans-well filter with a pore size of 0.45 !m prevents direct contact of
the bacteria and monolayer but does allow proteins produced by G. vaginalis to interact
with the monolayer; whereas, the trans-well filter with a pore size of 8.0 !m allows direct
contact of the bacteria with the monolayer. Cytotoxicity was observed when the 8.0 !m
transwell was used but not when the 0.45 !m transwell separated the bacteria from the
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Figure 6. Cytotoxic changes of cervical epithelial cell monolayers challenged
with G. vaginalis strains. Bacteria were grown in sBHIG anaerobically at 37ºC for
24 hours, standardized to ensure equal numbers, added to cervical epithelial cells
and incubated for 4 hours. Light microscopy images were taken after the 4 hour
incubation. (magnification 100x)
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epithelial cells (Figure 7) suggesting that direct contact between the bacteria and
monolayer is required for cytotoxicity.

Cytotoxicity of the BV-associated anaerobes
The BV-associated anaerobes were tested for their ability to cause cell rounding
and lysis of ME-180 cervical epithelial cells. Equal numbers of each bacterial species
were added to a confluent monolayer of ME-180 cervical epithelial cells. Cytotoxicity
scores (Table 4) and microscopic images (Figure 8) of the monolayer were recorded after
4 hours. As shown in Figure 8, only the G. vaginalis strains induced rounding and cell
death of the ME-180 cells. All of the G. vaginalis strains were given a score of 5 on the
cytotoxicity scale, indicating complete lysis of the monolayer within 4 hours. All other
anaerobes tested lacked detectable cytotoxic activity and remained a zero on the
cytotoxicity scale. Each experiment was repeated three times with similar results.

Biofilm formation by BV-associated anaerobes
Biofilm assays were performed to analyze the biofilm-forming potential of G.
vaginalis and other BV-associated anaerobes. When cultured overnight on tissue-culturetreated polystyrene, G. vaginalis stains 5-1, 465 and 101-1 produced a thick, tenacious
biofilm (Figure 9A). F. nucleatum was able to produce a moderate, fluffy biofilm that
was partially dislodged by washing. The ease with which F. nucleatum biofilms were
dislodged by washing is reflected by the large standard deviation in Figure 9B. The other
anaerobes tested: A. vaginae, M. mulieris, P. bivia, Veillonella, Peptostreptococcus, and
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Figure 7. Cytotoxicity caused by G. vaginalis strains is contact-dependent.
Bacteria were grown in sBHIG anaerobically at 37ºC for 24 hours. Equal numbers
of bacteria were loaded into trans-well filters containing either 0.45 !m or 8 !m
pores. The cells were monitored microscopically every hour for a 4 hour incubation
and light microscopy images were taken after the 4 hour incubation. (magnification
100x)
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Control – No
Bacteria
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+ Gardnerella

PBS control

8.0 !m + Gardnerella

Permissible

8.0 !m control

0.4 !m + Gardnerella

Non Permissible
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Figure 8. Cytotoxic changes of cervical epithelial cell monolayers challenged
with various BV-associated anaerobes. Bacteria were grown in sBHIG
anaerobically at 37ºC for 24 hours, standardized to ensure equal numbers, added
cervical epithelial cells and incubated for 4 hours. Light microscopy images were
taken after the 4 hour incubation. P. bivia strain BVD is not shown but was similar
to P. bivia strain 29303, which did not exhibit cytotoxicity. (magnification 1000x)
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(Magnification x 1000)
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Figure 9. Biofilm formation of G. vaginalis strains and various BV-associated
anaerobes. (A) Bacteria were grown in sBHIG anaerobically at 37ºC for 24 hours.
Nonadherent cells were removed from the wells and the adherent bacteria were
stained with safranin. OD595 readings were determined to ensure similar growth of
each species. Experiments were repeated 3 times with similar results and a
representative image is shown. (B) Quantitiative assessment of the biofilmforming capacities were made by dissolving the safranin stain in 33% acetic acid
and measuring OD562. 8 technical replicates and 3 biologic replicates (N=24) were
performed on each stain and the absorbance readings were averaged. Error bars
represent standard deviations. P. bivia strain BVD is not shown but was similar to
P. bivia strain 29303, which did not exhibit biofilm formation.
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Peptoniphilus, demonstrated significantly lower biofilm formation relative to G. vaginalis
(student’s t-test, p<0.0001).

Discussion
Despite the fact that G. vaginalis can be isolated in greater than 95% of BV cases, a
study with healthy human volunteers indicating that pure cultures of the bacteria did not
always cause BV, cast perpetual doubt on its pathogenic potential (Gardner and Dukes
1955; Criswell, Ladwig et al. 1969). However, the link between vaginolysin and BV along
with studies showing G. vaginalis as the predominant species in the biofilm that forms on
the vaginal epithelium during BV suggests that the role of this species as a pathogen
should be readdressed.
As animal models for BV are lacking, we designed a series of in vitro experiments
to compare the relative virulence capacities of G. vaginalis and other BV-associated
anaerobes. Adherence is a key first step in pathogenesis, as a potential pathogen must first
adhere to host tissues in order to avoid clearance by host defense mechanisms such as the
mucociliary escalator, urine flow, and the flow of vaginal secretions. Furthermore,
adherence is the first step in the formation of a biofilm and the capacity to form a biofilm
on polystyrene is irrelevant to pathogenesis unless the bacteria can first adhere to the
vaginal epithelium. We therefore analyzed the ability of BV-associated anaerobes to
adhere to cervical epithelial cells in tissue culture. Only, G. vaginalis and Peptoniphilus
adhered avidly to ME-180 cervical epithelial cells. G. vaginalis tended to form clumps of
bacteria that adhered to epithelial cells, while Peptoniphilus was more evenly distributed
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around the borders of the epithelial cells. Our data confirms previous studies showing that
G. vaginalis adheres to McCoy cells and human red blood cells (Scott, Curran et al. 1989).
Peptoniphilus has been only recently named and is associated with persistent cases of BV,
with 36% of persistent cases of BV having the organism (Marrazzo, Thomas et al. 2008).
This is the first study demonstrating its robust adherence to cervical epithelial cells, which
is an interesting and potentially important observation. Perhaps Peptoniphilus associates
with G. vaginalis during cases of BV and leads to the pathogenesis seen with the disorder;
this hypothesis warrants more research into the role Peptoniphilus plays in the
pathogenesis of BV. A. vaginae and F. nucleatum exhibited only moderate adherence, and
adherent M. mulieris, P. bivia and Peptostreptococcus were not detected. The process of
dental biofilm formation is initiated by bacterial species with affinity for the tooth pellicle
such as the streptococci and actinomycetes. These species are referred to as initial
colonizers. Other bacterial species adhere to the initial colonizers and this leads to the
development of a complex biofilm community composed of a large variety of species,
many of which are unable to adhere to teeth on their own. Specifically, F. nucleatum
expresses receptors that adhere to a large variety of other bacterial species and acts as a
bridge between early and late colonizers (Kolenbrander, Andersen et al. 2002; Periasamy
and Kolenbrander 2009). Because G. vaginalis is able to adhere to and form a biofilm on
cervical epithelia, it is plausible that it is an initial colonizer that paves the way for
additional species with low innate pathogenic potential to become established in the
vagina.
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The production of a cytolysin by G. vaginalis was first reported in 1990, but has
only recently been named vaginolysin and characterized as a pore-forming cytotoxin which
utilizes the complement regulatory molecule CD59 to activate the epithelial p38 mitagen
activated protein kinase pathway in human epithelial cells, leading to cell death (Rottini,
Dobrina et al. 1990; Gelber, Aguilar et al. 2008). IgA antibodies against vaginolysin have
been linked to the mucosal immune response during BV, further supporting the role of
vaginolysin in BV pathogenesis (Cauci, Driussi et al. 2002). We analyzed the relative
cytotoxic activity levels of the BV-associated anaerobes and found that only G. vaginalis
was able to induce rounding and lysis of ME180 cervical epithelial cells. The other BVassociated species did not elicit detectable cytopathologic changes, even when the bacteria
were incubated with the ME180 cells overnight (data not shown). It is important to note
that the cytotoxic effect of G. vaginalis was contact dependent; this phenotype has been
described in Streptococcus pyogenes which utilizes an injection pathway for streptolysin O
called cytolysin-mediated translocation (Madden, Ruiz et al. 2001). The streptolysin O
forms a pore in the eukaryotic cell through which an effector is translocated and the
cytolysin and effector act synergistically to trigger cytoxicity (Madden, Ruiz et al. 2001).
Future studies should analyze whether vaginolysin is transported by cytolysin-mediated
translocation and if it helps move effector molecules into cervical epithelial cells.
Next, we analyzed biofilm formation. Biofilm formation is an important virulence
factor because it confers heightened antibiotic tolerance and resistance to host immune
defenses. Due to the fact that biofilm bacteria are not effectively cleared by the immune
system or completely killed by antibiotics, biofilm-related infections tend to be chronic
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and/or relapsing. BV tends to be a smoldering infection with a high rate of relapse or
recurrence. Indeed, direct evidence from the microscopic analysis of vaginal biopsies of
women with BV revealed the presence of a bacterial biofilm on the vaginal epithelium
(Swidsinski, Mendling et al. 2005). A follow-up study revealed that metronidazole therapy
failed to clear the biofilm and suggested that this was related to relapse (Swidsinski,
Mendling et al. 2008). These studies revealed biofilm formation as an important virulence
determinant in BV. In our in vitro assay, G. vaginalis formed a moderate or strong
biofilm, depending on the strain and F. nucleatum formed a moderate biofilm that was
easily dislodged. None of the other BV-associated anaerobes were able to from a
significant biofilm.
Our study did not include all of the bacterial species found to be associated with
cases of BV. BV is a polymicrobial disorder and the diversity of species associated with
the disorder continues to increase as detection methods such as 16S rRNA gene
pyrosequencing improve. Because of the large number of candidates and because many
bacteria found to be associated with BV are unculturable, we focused instead on a
relatively small number of commonly isolated species. The in vitro model of adherence
used in this study is limited by the fact that cell monolayers of ME180s are not polarized as
are cervical epithelial cells in vivo. The assay for biofilm formation is limited by the fact
that the growth medium does not contain the same factors found in vivo and some in vivo
cues may turn on expression of biofilm-related genes. These limitations aside however, in
vitro models can be very informative and are key to furthering our understanding of BV as
the lack of a tractable animal model for BV has thwarted efforts to understand the etiology
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of this common and important women’s health concern. While it is plausible that our in
vitro study did not test for virulence properties that play an important role in BV
pathogenesis or that the conditions used did not allow for full expression of virulence
factors, our results are suggestive of a higher innate virulence potential of G. vaginalis
relative to other BV-associated species. While a number of the BV-associated anaerobes
had one of the three virulence properties tested, only G. vaginalis displayed robust
cytotoxicity, strong adherence to vaginal epithelial cells and a propensity to form a dense
biofilm, suggesting a key role for G. vaginalis in BV pathogenesis. Additional virulence
factors produced by G. vaginalis include sialidase and prolidase, two hydrolytic enzymes
that may have a role in degrading several key mucosal protective factors, such as mucins,
as well as contributing to exfoliation and detachment of vaginal epithelial cells (Cauci,
Culhane et al. 2008). In sum, there is strong evidence that G. vaginalis does possess innate
pathogenic potential. Other BV-associated anaerobes may also have as yet un-described
virulence factors, or may be more pathogenic in the presence of other species. It is also
likely that the primary etiologic agent of BV, if there is one, varies on a case-by-case basis.
However, this study suggests that due to its collection of virulence factors, it is likely that
G. vaginalis has a pathogenic capacity and could be the key agent in certain cases of BV.
Although we have shown that G. vaginalis is able to form a thick, tenacious
biofilm, not much is known about how G. vaginalis actually forms this biofilm. Many
bacteria are able to produce biofilms and this biofilm mode of growth imparts tolerance to
many negative environmental stimuli; therefore, in order to produce therapies that have
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higher efficacy and lower rates of relapse, it is imperative to characterize the biofilm
produced by G. vaginalis.
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CHAPTER 4
Characterization of the Gardnerella vaginalis biofilm matrix

Introduction
Recent evidence suggests that, in many infections, bacteria assume a biofilm rather
than a planktonic mode of growth. Biofilms are adherent communities of microorganisms
that are held together by a polymeric matrix that is composed of polysaccharides, proteins,
and/or nucleic acids. The distinct gene expression pattern and the physical structure of
biofilms increase bacterial resistance to many negative stimuli. Bacterial biofilm
infections are particularly problematic because the biofilm phenotype allows for increased
tolerance to antibiotics, inhibition of normal immune responses, and an increase in
difficulty of eradicating the infection. Biofilm cells are capable of persisting in the
presence of antimicrobials at concentrations that are 1,000-fold higher than those necessary
to eradicate planktonic bacteria (Hamilton 2002; Cerca, Martins et al. 2005). Biofilm
infections can become chronic and recalcitrant; treatment often results in long periods of
hospitalization, morbidity, severe functional impairment and increased mortality
(Chaignon, Sadovskaya et al. 2007). Because of this, biofilm research has focused on
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analyzing the architecture, antibiotic resistance profile and gene expression in biofilms in
order to improve current antibiotic therapy and discovery of novel targets for therapy.
Although BV does not have a high rate of morbidity and mortality, it is associated
with a high rate of relapse or recurrence. This is due to the fact that in most cases of BV, a
thick, adherent biofilm, with G. vaginalis being the predominant species, forms on the
vaginal epithelium (Swidsinski, Mendling et al. 2005). In addition, previous studies show
that G. vaginalis biofilms can tolerate higher concentrations of certain antibiotics (Muli
and Struthers 1998; Swidsinski, Mendling et al. 2008). We hypothesize that the biofilm
phenotype confers a survival advantage on BV-associated anaerobes within the vagina and
is an important component of the pathogenesis of BV.
In order to combat the high rate of recurrence seen with BV, new therapeutic
modalities need to be developed. Some researchers speculate that introduction of probiotic
strains of lactobacilli, or ones in which copious amounts of lactic acid and hydrogen
peroxide are produced, could kill the biofilm bacteria and repopulate the vagina. We
hypothesize that elaboration of a biofilm could enable G. vaginalis to survive, even in the
presence of lactobacilli-derived H2O2 and lactic acid, and therefore probiotic therapy will
prove ineffective. To test this we compared sensitivities of biofilm vs. planktonic cultures
to H2O2 and lactic acid.
The most promising new therapies for BV are ones in which the biofilm matrix is
targeted, leaving more susceptible planktonic bacteria in the place of biofim. It has been
shown that some bacteria, like Actinobacillus actinomycetemcomitans, produce a biofilm
dispersing enzyme that allows bacteria to be released from the biofilm matrix to populate
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other locations (Kaplan, Ragunath et al. 2003). The enzyme is called Dispersin B (DspB)
and it has been shown to disperse biofilms composed of # (1,6)-linked Nacetylglucosamine. Other enzymes with biofilm dispersing potential are
deoxyribonucelase 1 (DNase1) which has been shown to degrade P. aeruginosa biofilms
(Barken, Pamp et al. 2008), streptokinase (Varidase) which has been shown to degrade S.
aureus biofilms (Nemoto, Hirota et al. 2000) and proteases from the Antarctic krill shrimp
referred to as Krillase which have been shown to degrade oral biofilms (Berg, Kalfas et al.
2001).
Other agents that are not designed to specifically target biofilms also have biofilmdispersing properties. For examples, sodium metaperiodate hydrolyzes carbon:carbon
bonds and degrades certain polysaccharides, and can therefore disperse biofilms with
susceptible polysaccharide matrices. Proteases like trypsin and proteinase K can degrade
bacterial biofilms that require a proteinaceous component for intercellular adhesion
(Chaignon, Sadovskaya et al. 2007; Badel, Laroche et al. 2008; Fredheim, Klingenberg et
al. 2009).
The plant cysteine-proteinases bromelain, papain and ficin offer a wide spectrum of
therapeutic efficacies; they demonstrate in vitro and in vivo, antiedemateous, antiinflammatory, antithrombotic and fibrinolytic activities and may prove more specific and
less harmful to human tissue (Maurer 2001; Tysnes, Maurer et al. 2001). Bromelain is a
crude extract from the stems and immature fruits of pineapples, constituting an unusually
complex mixture of different thiol-endopeptidases, phosphatases, glucosidases,
peroxidases, cellulases, and glycoproteins (Taussig and Batkin 1988; Maurer 2001).
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Papain is found in the latex of the papaya fruit and along with bromelain, has been used
therapeutically in wound debridement (Kravitz, McGuire et al. 2008; Ramundo and Gray
2008). Ficin is derived from fig latex and has been shown to have a negative effect on the
cuticle of nematodes and therefore has antihelmintic activity (de Amorin, Borba et al.
1999; Stepek, Buttle et al. 2005). Finally, Pepsin is an enzyme whose precursor is released
by the chief cells in the stomach and upon contact with the hydrochloric acid is
autocatalytically cleaved to activate itself. Pepsin degrades food proteins into peptides and
functions best in acidic environments (Fruton 2002).
The architecture and matrix material of G. vaginalis biofilms has not yet been
characterized. Therefore, in this study, we employed biochemical assays to determine the
amounts of protein, carbohydrate and nucleic acid found in the biofilm matrix. We
employed lectin blots to identify any polysaccharide component and used confocal
microscopy to characterize the biofilm architecture. Finally, we treated the biofilms with a
variety of compounds to determine which class of compounds was able to disperse the
bacteria.

Results
Biofilm formation by G. vaginalis in vitro
To determine optimal conditions for in vitro biofilm formation, G. vaginalis was
cultured anaerobically in 96-well plates in Luria Bertani broth (LB), Tryptic Soy broth
(TSB), Brain Heart Infusion broth (BHI), Mueller Hinton broth (MH), Man, Rogosa and
Sharpe broth (MRS), or a chemically defined medium resembling vaginal secretions
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(CDM) (Geshnizgani and Onderdonk 1992). Because glucose increases biofilm formation
in other bacterial species (Hall-Stoodley and Stoodley 2002), G. vaginalis was also
cultured in the presence of 1% glucose (LBG, TSBG, BHIG, MHG, MRSG and CDMG).
Biofilms were stained with safranin, which binds to DNA, polysaccharides and other
biologic materials and imparts a red color to biofilms. As shown in Figure 10, biofilm
formation was poor in LB, TSB, TSBG, MRS and MRSG. Optimal biofilm formation was
observed in BHI with1% glucose.

Biochemical characterization of G. vaginalis biofilms
The crude biochemical composition of the extracellular matrix of G. vaginalis
biofilms was characterized by extracting loosely-associated material from biofilm and
planktonic bacteria. Protein concentrations in the extracts were determined with the use of
Coomassie Protein Assay Reagent and the Bradford assay, nucleic acid content was
estimated by measuring the optical density at 260 nm, and carbohydrate content was
estimated by the standard phenol-sulfuric acid assay with the use of glucose dilutions as
standards. Biofilm extracts contained more than 4 times as much total carbohydrate per
106 bacterial cells compared to planktonic bacteria (Table 5) but protein and nucleic acid
concentrations were not significantly different (p>0.05 and p>0.5, respectively) suggesting
that neither proteins nor nucleic acids are a major component of the extracellular biofilm
matrix.
To further characterize the carbohydrate component of the biofilm matrix, matrix
extracts were blotted onto nitrocellulose membranes and probed with various lectins,
90

Figure 10. Biofilm formation by G. vaginalis in vitro in different media. G.
vaginalis strain ATCC 49145 was grown in various media with or without added
glucose anaerobically at 37ºC for 24 hours. Non-adherent cells were removed from
the wells and the adherent bacteria were stained with safranin. Strains 465 and 5-1
produced similar results.
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Table 5. Biochemical analysis of extracts from planktonic and biofilm
bacteria.
mg protein#

mg nucleic acid*#

mg carbohydrate#

Planktonic

0.44 ± 0.06

0.13 ± 0.01

0.28 ±0.09

Biofilm

0.21 ± 0.14

0.14 ± 0.02

1.23 ± 0.5!

#

mg of protein, nucleic acid and carbohydrate are all per 109 CFU of
bacteria
* Nucleic acid concentration in mg nucleic acid/109 CFU were calculated
using the equation OD260Xdilution factorX0.05
! p<0.05 by Student’s t-test
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which are sugar-binding proteins that are highly specific for their sugar moieties, which
were conjugated to horseradish peroxidase (HRP). Glycine Max, which binds to Nacetylgalactosamine bound weakly to extracts from biofilms grown in CDM but not to
planktonic extracts or extracts from biofilms grown in BHI (Figure 11B). Concanavalin
A, which binds to "-mannose and "-glucose, did not bind to extracts from biofilms or
planktonic bacteria (Figure 11C). Wheat germ agglutinin, which binds to Nacetylglucosamine, reacted with all extracts, but biofilm bacteria grown in BHI contained
approximately 25-fold more of the material that reacted with the lectin in comparison to
planktonic bacteria grown in BHI (Figure 11A) suggesting that N-acetlyglucosamine is a
major component of the biofilm matrix.

Structural analysis of G. vaginalis biofilms
Confocal microscopy was used to further analyze the N-acetylglucosaminecontaining polysaccharide component of G. vaginalis biofilms cultured in BHIG. Biofilm
bacteria were stained with the green nucleic acid stain SYTO® 9 and Alexa Fluor® 633conjugate of Wheat germ agglutinin, which binds to polysaccharides within the biofilm
matrix. Figure 12 shows that the biofilm was ~44 !m thick and exhibited a characteristic
heterogeneous biofilm structure with peaks and “valleys” and microcolonies separated by
channels. WGA adhered to material around the bacteria (red), but did not co-localize with
the nucleic acid stain (green) suggesting that, as expected, the carbohydrate was
extracellular and possibly only loosely associated with the cell surface.
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Figure 11. Lectin blots of biofilm extracts react with Wheat germ agglutinin
(WGA) but not with Concanavalin A (ConA) or Glycine max (Gly). Serial 5fold dilutions of extracts from biofilms grown in BHI, BHIG, or CDM and
planktonic cultures grown in BHI or CDM were blotted onto nitrocellulose and
probed with peroxidase-conjugated lectins. Panel A was probed with WGA-HRP,
panel B was probed with Gly-HRP and panel C was probed with ConA-HRP.
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Figure 12. Confocal microscopy of G. vaginalis biofilm structure. Biofilms
were stained with SYTO® 9 and a fluorescent Alexa Fluor® 633-conjugate of
WGA and analyzed by confocal scanning laser microscopy. The large panel is a
“bird’s-eye view of the biofilm. The right panel is a side view of an x-axis section
and the lower panel is a side-view of the y-axis section. Green color indicates
nucleic acid while red staining indicates presence of polysaccharide. The biofilm
shown was formed by strain 465; biofilms formed by other strains yielded similar
results.
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Sensitivity of G. vaginalis biofilms versus planktonic cultures
To determine if biofilm bacteria were more resistant than planktonic bacteria to
H2O2 and lactic acid, we exposed biofilm and planktonic cultures to these agents and
determined their viability by luciferase assay. The luciferase reagent is added directly to
the bacterial cells; it supports bacterial cell lysis and generation of a luminescent signal.
The luminescent signal is proportional to the amount of ATP present, which is directly
proportional to the number of viable cells in culture. When reproducing these results with
G. vaginalis, Figure 13A demonstrates that the relative light units (RLU) emitted from the
luciferase assay directly related to the number of colony forming units of G. vaginalis
present. Figure 13B and 13C show the MBC90’s (minimum concentration required to
reduce viability by at least 90%) for H2O2 and lactic acid. Biofilms were more resistant
and tolerated 4-fold higher concentrations of H2O2 and 8-fold higher concentrations of
lactic acid than planktonic cultures.
To better replicate the conditions that G. vaginalis would encounter in the vagina,
we grew biofilms and planktonic cultures in CDM and tested the sensitivity of the cultures
to H2O2 and lactic acid. As shown in Figure 13, biofilms grown in CDM were resistant to
4-fold higher concentrations of H2O2 and 4-fold higher concentrations of lactic acid.

Dissolution of G. vaginalis biofilms
We hypothesized that degradation of the exopolysaccharide component within the
biofilm matrix would lead to dissolution of the biofilms and would restore sensitivity to
different agents. To test this, biofilms were treated with sodium metaperiodate, which
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Figure 13. Sensitivity assays demonstrate that biofilms exhibit increased
tolerance to H2O2 and lactic acid. (A) Illustrates the direct correlation between
the number of colony forming units (x-axis) and relative light units (y-axis)
measured in the viability assay. (B) Shows the MBC90 of H2O2, or the
concentration required to decrease viability of biofilms and planktonic cultures
grown in BHI or CDM by at least 90% is shown. (C) Shows the concentration of
lactic acid required to decrease viability of biofilm and planktonic cultures grown in
BHI or CDM by at least 90% is shown. Bars in Panels B and C represent the
averages of three separate experiments and error bars represent the standard
deviations.
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hydrolyzes polysaccharide, and chitinase, which degrades beta-1,4-linked polymers of Nacetylglucosamine. As shown in Figure 14, chitinase reduced the biofilm thickness only
very slightly, even at the highest concentration tested and sodium metaperidoate had no
effect.
We then tested other catabolic enzymes and compounds on mature biofilms to
determine their biofilm-dispersing activities (Figure 15). Concentrations of proteinase K
and trypsin as low as 32 !g/ml and 6.4 !g/ml (respectively) effectively disrupted the
biofilms produced by all three strains. H2O2, lactic acid, SDS, and DNaseI, which have
been shown to disrupt some Pseudomonas aeruginosa biofilms, did not have an effect
(Whitchurch, Tolker-Nielsen et al. 2002).

Effect of Proteinase K on biofilm structure
Confocal microscopy was used to further analyze the structural changes associated
with proteinase K treatment of G. vaginalis biofilms. For the proteinase K time course,
stained biofilms were treated with 100 !g proteinase K/mL and confocal images of the
same field of view were collected every 20 minutes for 280 minutes. Figure 16 shows the
proteinase K time course; at time zero microscopy revealed a thick, characteristically
heterogeneous G. vaginalis biofilm with peaks and “valleys” and microcolonies separated
by channels. By 40 minutes, the structure of the G. vaginalis biofilm was lost, with no
microcolonies or channels remaining. By the end of the time course, no distinguishable
biofilm remained. This shows that proteinase K is effectively cleaving a component of the
biofilm that is very important in structure and architecture. Because proteinase K cleaves
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Figure 14. Treatment of G. vaginalis biofilms with chitinase and sodium
metaperiodate. G. vaginalis strain 465 was grown as a biofilm and treated for 20
hours at 37ºC with chitinase and sodium metaperiodate. The reagents were serially
diluted 5-fold horizontally across the plate. The biofilm wells were washed and
stained with safranin to shown biofilm dissolution as a decrease in red color.
Biofilms formed by strains 5-1 and ATCC 49145 yielded similar results.
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Figure 15. Treatment of G. vaginalis biofilms with proteases. G. vaginalis
strain 465 was grown as a biofilm and treated for 20 hours at 37ºC with proteinase
K, trypsin, H2O2, lactic acid, SDS or DNaseI. The reagents were serially diluted 5fold horizontally across the plate. The biofilm wells were washed and stained with
safranin to shown biofilm dissolution as a decrease in red color. Biofilms formed
by strains 5-1 and ATCC 49145 yielded similar results.
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Figure 16. Effect of proteinase K treatment on biofilm structure over time.
Biofilms were stained with Live/Dead BacLight staining and analyzed by confocal
scanning laser microscopy. The large panels are a “bird’s-eye view of the biofilm.
The right panels are a side view of an x-axis section and the lower panels are a sideview of the y-axis section. Images were taken every 20 minutes for a total of 280
minutes. Red color indicates viable bacteria while green color indicates dead
bacteria. The biofilm shown was formed by strain 465; biofilms formed by other
strains yielded similar results.
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proteins, this points to a proteinaceous adhesin playing an important role in G. vaginalis
biofilm structure and architecture.

Effect of biofilm dissolution on sensitivity
To determine whether proteolytic dissolution of biofilms would restore the MBC90
to levels associated with planktonic bacteria, we pre-treated biofilms with proteinase K to
degrade the biofilm structure before adding H2O2 and lactic acid. Proteinse K alone did
not affect bacterial viability (data not shown); however, treatment of biofilms with the
protease significantly increased the sensitivities to H2O2 and lactic acid back to planktonic
levels (Figure 17).

Effect of natural proteases on G. vaginalis biofilm
To determine the ability of natural proteases to degrade the G. vaginalis biofilm, 24
hour biofilms were grown anaerobically, then subjected to 5-fold dilutions of ficin,
bromelain, papain and pepsin in either PBS pH 7.4, which would represent how the
enzyme could be potentially stored, and PBS pH 4.5, which would represent the average
pH of the vagina during BV. Stock concentrations used were 10 U of bromelain and
papain, 5.78 U of ficin and 345 U of pepsin. Figure 18A shows representative images of
the degradation seen with each protease; both pH conditions gave similar results. The best
degradation was seen with the enzyme ficin. Ficin was highly effective at degrading G.
vaginalis biofilms at both pH 7.4 and pH 4.5. At the highest concentration of enzyme
tested, 5.78 Units, ficin exhibited 93 and 92% biofilm reduction at pH 7.4 and 4.5,
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Figure 17. Sensitivity of proteinase-K-treated biofilms to H2O2 and lactic acid.
The concentrations of H2O2 (A) and lactic acid (B) required to decrease viability of
planktonic cultures, biofilms and proteinase-K-treated biofilms by at least 90% are
shown. Proteinase-K treated biofilm cultures exhibited sensitivities similar to that
of planktonic cultures. Bars represent the averages of three separate experiments
and error bars represent the standard deviations.
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respectively (Figure 18B). Bromelain was also an effective biofilm degrading agent
regardless of pH, it was able to cause a 76% reduction in biofilm mass (Figure 18B).
Similar efficient degradation was seen with papain; at the highest concentration of enzyme
tested, papain exhibited 89 and 85% biofilm reduction at pH 7.4 and 4.5, respectively
(Figure 18B). The enzyme pepsin was not effective at degrading G. vaginalis biofilms
(Figure 18A and 18B). Table 6 shows the amount of enzyme required to reduce G.
vaginalis biofilm density by at least 75% at pH 7.4 and 4.5; this enzyme concentration
could have therapeutic potential when used in conjunction with antibiotics. The percent
biofilm reduction for each enzyme concentration tested is seen in Appendix A.

Effect of natural protease papain on antibiotic sensitivity of G. vaginalis
To determine the ability of the enzyme papain to increase the sensitivity of G.
vaginalis to the antibiotic clindamycin, 24 hour biofilm and planktonic cultures were
grown anaerobically at 37°C. Biofilms were either treated with BHIG as a control, with 10
U of papain as a control, or with 3 times the MIC of clindamycin (1.84 !g/ml) in BHIG,
then incubated for 16 hours before bacteria were harvested, diluted and plated for CFU.
Biofilms were either dispersed with 10 U of papain for 2 hours prior to treatment with
clindamycin and nonadherent bacteria were removed by washing, or clindmycin was added
directly to papain and allowed to incubate for 16 hours before bacteria were harvested,
diluted and plated for CFU. Planktonic cultures were either treated with BHIG or
clindamycin as a control for 16 hours before bacteria were harvested, diluted and plated for
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Figure 18. Treatment of G. vaginalis biofilms with natural proteases. G.
vaginalis strain 5-1 was grown as a biofilm and treated for 20 hours at 37ºC with
ficin, bromelain, papain and pepsin. The reagents were serially diluted 5-fold
horizontally across the plate. The biofilm wells were washed and stained with
safranin to shown biofilm dissolution as a decrease in red color. (A) Images of
stained biofilms. (B) Quantitative measures of biofilm degradation. Stained G.
vaginalis biofilms were resolublized in 33% acetic acid and optical density of the
solution was measured at 562 nm. The percentage of biofilm reduction was
calculated using the equation described in the text. Biofilms fomed by strains 5-1
and ATCC 49145 yielded similar results.
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A.

Ficin
5.78 U
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5-fold dilutions

10 U

5-fold dilutions

Papain

5-fold dilutions

10 U

Pepsin
345 U

5-fold dilutions
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Table 6. Amount of enzyme required to reduce biofilm density by at least
75% at pH 4.5 and pH 7.4. (N/A indicates that pepsin was unable to
reduce biofilm density by at least 75%, even at the highest enzyme
concentration tested, 345U)

Proteases

pH 4.5

pH 7.4

Bromelain

10 U

0.4 U

Papain

0.4 U

0.4 U

0.2312 U

1.156 U

N/A

N/A

Ficin
Pepsin
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CFU. Figure 19 shows the CFU counts of bacteria treated under various conditions.
Clindamycin was able to reduce the CFU count of biofilm bacteria by approximately 70%;
however, no recoverable bacteria were seen when planktonic bacteria were treated with the
same amount of antibiotic. This showcases the need to find a compound that can help
reduce the resistance of biofilm bacteria to antibiotics. When the biofilm was first
dispersed by papin and nonadherent cells removed by washing, this was able to reduce the
CFU count of biofilm bacteria by approximately 98%. When clindamycin was added
directly to papain and allowed to interact with the biofilm, it reduced the CFU count of
biofilm bacteria by approximately 95%. Papain itself was able to reduce the CFU count of
biofilm bacteria; therefore, more research is needed into whether papain acts in
conjunction with the antibiotic, or if the enzyme is all that is needed to reduce the
recoverable CFUs. This data suggests that papain treatment in combination with an
antibiotic could be an effective new therapy for BV.

Discussion
The etiology and pathogenesis of BV have remained enigmatic ever since initial
reports of the condition in 1954 (Gardner and Dukes 1954). Confounding issues include
the polymicrobial nature of BV and the role of host factors, both genetic and behavioral.
The recent demonstration that BV is associated with the formation of a biofilm in which
the predominant species is G. vaginalis (Swidsinski, Mendling et al. 2005) is an important
advance towards understanding its pathogenesis. We therefore sought to develop a simple
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Figure 19. Treatment of G. vaginalis biofilm with papain increased the
sensitivity to antibiotic challenge. 24 hour biofilm and planktonic cultures were
grown anaerobically in BHIG at 37°C. Biofilms were treated with either BHIG as a
control (Control), 10 U of papain in BHIG as a control, 1.8375 !g/ml of
clindamycin in BHIG (Clindamycin), papain and clindamycin in BHIG (Prot +
Clinda), or biofilms were dispersed with 10 U of papain for 2 hours prior to
treatment with clindamycin (Wash, Clinda). Planktonic cultures were treated with
BHIG as a control or clindamycin (Planktonic Clinda). The cultures were
incubated for 16 hours anaerobically at 37°C and bacteria were harvested, 10-fold
diluted and plated for CFU.
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model for studying G. vaginalis biofilms in vitro. We found that when cultured
anaerobically in BHI + 1% glucose, the bacteria formed a thick, tenacious biofilm on
polystyrene.
Growth of G. vaginalis is normally suppressed by healthy lactobacilli. This
inhibition is attributed to the production of lactic acid and H2O2. We hypothesized that the
formation of a biofilm would increase the resistance of the bacteria to H2O2 and lactic acid
leading to colonization even in the presence of lactobacilli. Bacterial sensitivity is
normally assessed by analyzing the minimum inhibitory concentration (MIC) required to
inhibit the growth of suspension of bacteria at low cell density. This type of assay cannot
be used to measure biofilm sensitivities because the bacteria within biofilms are at a high
cell density. We therefore measured bacterial viability of biofilms and high cell density
planktonic cultures using a luciferase reagent that quantitatively measures ATP. Using this
method, MBC90’s, or the concentrations required to reduce viability by at least 90%, for
planktonic bacteria were ~0.2 mM H2O2 and ' 125-250 mM lactic acid. The
concentrations of lactic acid required to kill G. vaginalis were considerably higher than the
amounts reported to be secreted by lactobacilli (~30-60 mM) (McLean and McGroarty
1996), but since our assay measured bactericidal rather than bacteriostatic activity, it is
possible that the concentration of lactic acid required to suppress growth is lower. Biofilm
cultures were more resistant and tolerated 4-5 fold higher concentrations of H2O2 and 4-6
fold higher concentrations of lactic acid than planktonic cells. The finding that
concentrations of H2O2 (0.8-1.3 mM) and lactic acid (1,000 mM) required to produce a
90% decrease in viability in biofilm bacteria were substantially greater than the MBC90’s
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for planktonic bacteria, could imply that G. vaginalis forms a biofilm in the vaginal
environment in order to resist the detrimental effects of lactic acid- and H2O2-producing
lactobacilli.
We hypothesized that enzymatic dissolution of biofilms would restore the
sensitivity to H2O2 and lactic acid to planktonic-like levels. In order to find a compound to
dissolve the biofilms, we preliminarily characterized the composition of the biofilm matrix.
Biochemical analysis suggested that the extracellular matrix of the biofilms was
predominantly composed of carbohydrate rather than protein and/or nucleic acid. Most
previously characterized biofilms contain an exopolysaccharide intercellular adhesion so it
is likely that the carbohydrate component we detected is a polysaccharide (Heilmann,
Schweitzer et al. 1996; Kaplan, Ragunath et al. 2004; Wang, Preston et al. 2004;
Overhage, Schemionek et al. 2005). Wheat germ agglutinin, a lectin from Triticum
vulgaris bound to the matrix material, suggesting that the matrix contains Nacetylglucosamine. We therefore tested chitinase, an enzyme that cleaves the #-1-4
linkage between N-acetylglucosamine residues in chitin, for the ability to dissolve G.
vaginalis biofilms. At the highest concentration tested, chitinase reduced the biofilm
thickness only slightly. The extracellular polysaccharide adhesion involved in biofilm
formation by a variety of unrelated bacterial species including Staphylococcus aureus and
S. epidermidis, E. coli and Actinobacillus actinomycetemcomitans is a #-1-6-linked
polymer of N-acetylglucosamine referred to as PGA or PNAG (McKenney, Hubner et al.
1998; Kaplan, Velliyagounder et al. 2004; Wang, Preston et al. 2004). The #-1-6-linkage
of PNAG is resistant to chitinase and it is possible that the polysaccharide matrix of G.
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vaginalis biofilms has a similar structure and is therefore not degraded by chitinase. We
also tested sodium metaperiodate, which cleaves polysaccharides by oxidation and
chemical cleavage of carbon-carbon bonds for biofilm dissolving activity. Surprisingly,
sodium metaperiodate did not affect the G. vaginalis biofilms. It is possible that a
component of the biofilms affected sodium metaperiodate activity or that other nonpolysaccharide based adhesions are involved. Even though our biochemical analyses did
not suggest a significant nucleic acid component to the biofilms, we tested DNaseI against
G. vaginalis biofilms. It is known that P. aeruginosa biofilm matrix contains a significant
amount of nucleic acid and that these biofilms are dispersed by DNaseI treatment
(Whitchurch, Tolker-Nielsen et al. 2002). However, no degradation of G. vaginalis
biofilms by DNaseI was observed. Treatment of the biofilms with the proteases proteinase
K and trypsin did, however, effectively remove the biofilm from the polystyrene wells.
Biofilm extracts did not contain significantly more protein than planktonic bacteria
suggesting that the extracellular matrix is not largely proteinaceous. It is possible
however, that surface proteins are required to anchor the polysaccharide matrix to the
bacteria or to somehow link the polysaccharides together. Cleavage of the protein anchors
could, in this theoretical model, release the bacteria from the polysaccharide matrix and
hence from the biofilm.
Dissolution of biofilms with proteinase K increased the sensitivities to both H2O2
and lactic acid. The finding that biofilm dispersal increases sensitivity suggests that an
enzyme that specifically targets the biofilm structure could be therapeutically useful. The
use of probiotic therapy for BV, whereby healthy lactobacilli are re-introduced into the
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vagina, has been proposed, and this study suggests that G. vaginalis would be more
sensitive to probiotic therapy if it were planktonic (Reid 2001). In addition to increasing
the sensitivity of the bacteria to H2O2 and lactic acid, biofilm dissolution could increase the
rate of explusion of the bacteria from the vagina by the natural flow of mucous. Biofilm
dispersal may also increase the susceptibility of the bacteria to the immune defenses.
Proteinase K is a nonspecific protease that would likely damage the vaginal epithelium and
would not be considered for clinical use.
We next tested the ability of four natural proteases to degrade the G. vaginalis
biofilm. The four fruit proteases, ficin, bromelain and papain, were effective biofilm
degraders. Papain produced a 75% reduction in biofilm mass at the lowest enzyme
concentration used, 0.4 U, at both pH 7.4 and 4.5. Although ficin produced an overall
higher percentage of biofilm reduction, with 93 and 93% biofilm reduction at pH 7.4 and
4.5, respectively, papain was used in the follow-up protease/antibiotic sensitivity assay due
to its low cost and abundance in the laboratory. Pepsin was a poor biofilm degrader;
however, this is not surprising due to its limited activity in non-acidic environments.
Sensitivity assays using papain show that while 1.84 !g/ml of clindamycin led to a
70% reduction in biofilm CFU, biofilms that had been pretreated with papain for 2 hours,
then washed to remove nonadherent bacteria, had a 98% reduction in CFU counts. Also,
when papain and clindamycin were added to biofilms and incubated overnight, CFUs were
reduced by 95%. This suggests that treatment of patients with BV with both papain and an
antibiotic, may increase the bacterial sensitivity to the antibiotic. Although biofilm
bacteria are more tolerant to antibiotics, as seen by the viability of 30% of the biofilm
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bacteria, biofilms that have been dispersed by proteases such as papain, led to an almost
100% eradication of biofilm bacteria; the few remaining planktonic bacteria may be more
easily killed by the immune system. More research is needed into the in vivo effects of the
fruit proteases on the vaginal epithelium; the identification of an animal model would
increase the knowledge of whether fruit proteases would be a valuable, harmless addition
to antibiotic therarpy
This data suggests that a proteinaceous adhesin has an important role in biofilm
formation in G. vaginalis. Therapies aimed at disrupting this adhesin could prove
extremely important in reducing the number of relapsing BV cases seen after antibiotic
treatment. The idea that bacteria can produce a biofilm matrix whose most important
component is a protein is not new; however, the idea of targeting this protein in order to
produce more effective anti-biofilm therapies is a recent one. Lending precedence to the
idea that BV may one day have an anti-biofilm therapy is the recently developed dispersal
enzyme, Dispersin B, which is in the research phase at Walter Reed Army Institute of
Research to analyze its efficacy in inhibiting or disrupting single- and mixed-species
bacterial biofilms associated with combat trauma wound infections. Although we have
shown that G. vaginalis biofilms are able to be degraded by proteases suggesting a role for
a proteinaceous adhesin, it is imperative to identify and characterize the gene(s) involved
in biofilm formation.
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CHAPTER 5
Identification and Characterization of a Gardnerella vaginalis BiofilmAssociated Protein

Introduction
Biofilms are communities of microorganisms that are surrounded by an
extracellular polymeric matrix composed of polysaccharides, proteins and/or nucleic acids,
which promote intercellular adhesion and attachment to a surface. The biofilm mode of
growth imparts on its constituent bacteria tolerance to antimicrobial agents, dessication, pH
changes, ultraviolet light, acid exposure, phagocytosis and sheer stress (Lindsay and von
Holy 2006; del Pozo and Patel 2007).
In most bacterial biofilms that have been characterized, the major intercellular
adhesin holding the community together is an exopolysaccharide. In the staphylococcal
species, the biofilm matrix is composed of an extracellular polysaccharide homopolymer
of #-1,6-linked N-acetylglucosamine (PNAG); this polymer is essential for biofilm
formation and causes hemagglutination and bacterial aggregation (Heilmann, Schweitzer et
al. 1996; Mack, Riedewald et al. 1999; Vuong, Voyich et al. 2004). Many other bacteria
can produce PNAG, including Acinetobacter baumanni and E. coli (Cerca and Jefferson
2008; Choi, Slamti et al. 2009). Although many bacteria produce a polysaccharide based
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biofilm matrix, others are able to produce biofilms cemented by proteins (Cucarella,
Solano et al. 2001; Latasa, Roux et al. 2005; Branda, Chu et al. 2006; Loehfelm, Luke et
al. 2008). Henning et al. described a spontaneous switch from biofilm formation mediated
by polysaccharides to biofilm formation mediated by proteins in a Staphylococcus
epidermidis icaC insertion mutant (Hennig, Nyunt Wai et al. 2007). In S. epidermidis,
several surface proteins involved in biofilm formation have been described, including
SSP1, SSP2 and the AtlE autolysin (Veenstra, Cremers et al. 1996; Heilmann, Hussain et
al. 1997). Other reports show that Staphylococcus sp. produce a protein adhesin named
Bap, for biofilm-associated protein, which is involved in primary attachment and biofilm
maturation (Cucarella, Solano et al. 2001). Bap is a large, cell surface-associated protein
containing a series of repeats that is found in isolates of several coagulase negative
staphylococcal species, as well as S. aureus mastitis isolates (Cucarella, Solano et al.
2001). This protein falls within a family of surface proteins involved in biofilm formation,
called biofilm-associated proteins, which are found on the bacterial surface, have a high
molecular weight, and contain a core domain of tandem repeats (Lasa and Penades 2006).
Other proteins found within this family include the newly identified Bap protein of
Acinetobacter baumannii, the Esp protein of E. faecalis and the BapA protein of
Salmonella sp. (Latasa, Roux et al. 2005; Tendolkar, Baghdayan et al. 2005; Loehfelm,
Luke et al. 2008).
We have demonstrated that compounds that degrade polysaccharide-based
biofilms, such as sodium metaperiodate, have little effect on Gardnerella biofilms, while
proteases are able to effectively degrade the biofilms (Patterson, Girerd et al. 2007). This
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suggests that a proteinaceous adhesin, like Bap, may mediate biofilm formation in G.
vaginalis. In this study, a partial genome sequence of G. vaginalis was analyzed for
homology to the staphylococcal Bap protein. This search identified a large hypothetical
protein, with a core of internal repeating units, which we call BapL for Bap-like. An
antibody was produced against a small antigenic peptide of this protein and was used for
inhibition of function assays. It has also been shown that certain biofilm-associated
proteins, like the enterococcal SgrA protein, can act as initial adhesins, binding to
extracellular matrix proteins (Hendrickx, van Luit-Asbroek et al. 2009); therefore, the
BapL protein was analyzed for its ability to bind to ECM proteins by blockage with the
anti-bapL antibody. Also, biofilm associated proteins has been found to have homology
to mucus-binding protein; therefore, the BapL protein was also analyzed for its ability to
bind to mucin.
It has been shown that G. vaginalis adheres robustly to ME180 cervical epithelial
cells (Patterson, Stull-Lane et al. 2010). To help elucidate whether the BapL protein
interacts with a component on the surface of ME180 epithelial cells, immunoprecipitation
assays were performed. Random mutagenesis was performed using the mutagen ethyl
methanesulfonate (EMS) to produce a bapL deficient mutant, and finally, the BapL protein
was expressed in the heterologous host S. aureus RN4220.

Results
Identification of a biofilm-associated protein
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In order to identify new factors involved in biofilm formation, we searched a partial
genome sequence of G. vaginalis, provided by the Gardnerella vaginalis Genome Project,
Stanford Genome Technology Center (funded by the Ellison Medical Foundation) for
sequence homology to the S. aureus Bap protein using the tBLASTn program provided by
NCBI. Our analysis revealed one incomplete open-reading frame encoding a hypothetical
protein with significant similarity to Bap. The identified gene encodes a protein of large
size, with 9 Rib (resistance to proteases) domains, and 35% homology to the
staphylococcal Bap protein, therefore, we have designated the gene BapL for Bap-like.
Rib domains are found in group B streptococci and confer protective immunity to the
bacteria (Stalhammar-Carlemalm, Stenberg et al. 1993). The BapL protein also has
homology to other known biofilm-associated proteins (Table 7). Using Softberry’s
FGENESB and BPROM programs, it was determined that the identified gene was missing
the beginning of the open reading frame and promoter; therefore, we initiated genome
walking experiments to identify the remainder of the gene. The additional sequencing data
found by genome walking was confirmed by pyrosequencing, which was performed at the
VCU Nucleic Acids Core Laboratory using Roche 454 technology. One full run of GS
FLX and one half fun GS FLX XLR were done for G. vaginalis strain 5-1 (coverage of
~175X). The fully sequenced open reading frame is 9,144 base pairs and encodes a protein
with a predicted molecular mass of 325 kDa. Analysis of the amino acid sequence reveals
a repetitive structure consistent with the Bap family of proteins, as well as a cell wallanchoring motif consistent with surface expression in Gram-positive organisms (Figure
20).
128

Table 7. Homologies between the Bap protein of S. aureus and the
BapL protein of G. vaginalis to other known biofilm-associated
proteins.

Organism

Protein

Similarity to
Bap

E. faecium

Esp

38%

39%

S. epidermidis

Aap

71%

34%

Salmonella sp.

BapA

29%

34%

Bap

33%

34%

A. baumanii
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Similarity to
BapL

Figure 20. Structural schematic of the BapL protein from G. vaginalis
compared to the Bap protein from S. aureus. Both proteins are large, cell wall
anchored surface proteins with tandem repeating units. BapL is 325 kDa, contains
9 Rib (resistance to proteases) domains which are associated with protective
immunity, and 35% homology to the staphylococcal Bap protein.
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The BapL protein is highly expressed under biofilm conditions
In order to determine which conditions induce BapL expression, surface associated
proteins were extracted from planktonic and biofilm cultures grown in BHI, as well as
from biofilm cultures grown in BHIG. Bacterial pellets were standardized by weight then
proteins extracted. The proteins were separated by SDS-PAGE, transferred to a PVDF
membrane, and probed with purified polyclonal IgG rabbit antibodies raised against a
small, antigenic peptide of BapL. As shown in Figure 21, a band of approximately 325
kDa is seen in the biofilm samples, while it is absent in the planktonic sample. This
suggests that BapL is more highly expressed under conditions that promote biofilm
formation. A biofilm grown in BHIG was treated with proteinase K to disrupt its biofilm
structure and subjected to the same treatment to remove cell surface associated proteins.
The absence of a BapL specific band in Figure 21 indicates that the BapL protein was
removed by this proteinase K treatment. The finding that proteinase K treatment disrupts
biofilms and removes BapL from the surface suggests that BapL could possibly be
involved in the biofilm structure.

The bapL gene is highly expressed under biofilm conditions
We next analyzed the expression of the bapL gene under different conditions.
Overnight cultures of G. vaginalis strain 5-1 were diluted in fresh BHI or BHIG in T75
flasks and incubated anaerobically for 48 hours with fresh media change after 24 hours.
Planktonic cultures of G. vaginalis were grown in 250 ml flasks of BHI anaerobically for
48 hours with gentle stirring to keep the bacteria in the planktonic state. Bacteria were
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Figure 21. Western blot analysis of G. vaginalis proteins grown under different
conditions. G. vaginalis cultures were grown overnight as biofilms in BHI or
BHIG and as planktonic cultures in sBHIs and BHIG. Proteins were then extracted
by sonication and loaded into each well. Proteins were separated by SDS-PAGE,
transferred to PVDF membrane and probed with anti-bapL antibodies. Molecular
mass standards are indicated in kilodaltons.
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harvested and mRNA extracted. Isolated mRNA was converted to cDNA using bapL and
16S reverse primers and analyzed by real time reverse transcriptase PCR. Expression of
the bapL gene was normalized to 16s rRNA. Figure 22 shows that expression of the bapL
gene is highest in biofilms grown in BHI, whereas, expression is lowest in planktonic
cultures. Biofilms grown in BHI had two times more expression of bapL than biofilms
grown in BHIG. Planktonic expression of bapL was very low, with only a 0.0025 fold
increase in bapL expression compared to expression of the 16S rRNA genes. This data
shows that the bapL gene is significantly upregulated under biofilm conditions.

Anti-BapL antibody is specific and binds to the surface of G. vaginalis
Confocal microscopy was used to determine whether the anti-BapL antibody was
specific and if the BapL protein was surface associated. Cultures of G. vaginalis and
Lactococcus lactis, used as a negative control, were collected and washed with PBS then
stained sequentially with purified anti-BapL antibody and labeled goat anti-rabbit
secondary antibody. Figure 23 shows that the anti-BapL antibody bound specifically only
to Gardnerella bacteria, as demonstrated by the high fluorescence seen with addition of the
anti-BapL antibody, while unrelated species, like Lactococcus lactis, showed no
fluorescence with the addition of the anti-BapL antibody. Binding of the antibody to the
surface of G. vaginalis confirms that the BapL protein is surface associated.

Anti-BapL antibody does not inhibit biofilm formation of G. vaginalis
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Figure 22. The bapL gene is highly expressed in biofilm cultures. Overnight
cultures of G. vaginalis were diluted in fresh BHI or BHIG in T75 flasks.
Planktonic cultures were grown in 250 ml flasks of BHI. Each culture was grown
anaerobically for 48 hours, either with media changer after 24 hours (biofilm only)
or with gentle stirring (planktonic only). Cultures were harvested by centrifugation
to pellet cells and RNA from all cultures was extracted using a Fastpro RNA kit.
Isolated RNA was DNase treated to ensure the absence of genomic DNA
contamination and converted to cDNA using bapL and 16S reverse primers. The
bapL gene expression was then analyzed by reverse transcriptase PCR. The
absolute Ct values from 3 qPCR assays were averaged to determine the cycle
threshold value from each sample. Expression of bapL was normalized to 16s
rRNA as determined by cycle threshold values using the following equation:
E=2^(16s Ct – bapL Ct).
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Expression of bapL under planktonic and biofilm conditions

Figure 23. Confocal microscopy confirms surface expression of BapL. Cultures
of overnight G. vaginalis and Lactococcus lactis, which was used as a negative
control, were pelleted and washed with PBS, then stained sequentially with the antiBapL Ab and Alexa 488 labeled goat ant-rabbit antibody and analyzed by confocal
microscopy.
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To determine if the BapL protein plays a role in biofilm formation by G. vaginalis,
antibody inhibition assays were performed. Overnight cultures of G. vaginalis were
diluted 1:100 in fresh BHIG and incubated for 30 minutes at room temperature on a rotator
with either 400 !g of anti-BapL antibody or 400 !g of preimmune antibody. 200 !l of
each culture was added to a 96-well plate and incubated anaerobically at 37ºC for 24 hours.
The wells were washed with PBS to remove nonadherent bacteria and stained with
safranin, which imparts a red color to biofilms. Figure 24 shows that bacteria treated with
anti-BapL antibody and preimmune antibody formed biofilms that were no different from
wildtype bacteria. This shows that the addition of anti-BapL antibody was unable to
inhibit biofilm of G. vaginalis.

Anti-BapL antibody does not inhibit initial adherence of G. vaginalis
Because it has been shown that the staphylococcal Bap protein has roles in both
primary attachment and biofilm maturation, we next analyzed whether the BapL protein
was playing a role in initial adherence to a surface (Cucarella, Solano et al. 2001).
Overnight cultures of G. vaginalis were diluted 1:50 in fresh BHIG and incubated for 30
minutes at room temperature on a rotator with either 400 !g of anti-BapL antibody or
preimmune antibody. 200 !l of each culture was added to a 96-well plate, centrifuged to
maximize interaction with the surface of the 96-well plate, and incubated anaerobically at
37ºC for 2 hours. After the 2 hour incubation, the wells were washed with PBS to remove
nonadherent bacteria and stained with safranin. Figure 25 shows that bacteria treated with
anti-BapL antibody and preimmune antibody produced no significant difference in initial
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Figure 24. Biofilm formation by G. vaginalis is not inhibited by addition of
anti-BapL antibody. An overnight culture of G. vaginalis was treated with either
anti-BapL antibody or preimmune antibody for 30 minutes at room temperature on
a rotator. The culture was then plated and incubated anaerobically at 37ºC for 24
hours. Nonadherent cells were removed by washing with PBS and adherent
bacteria were stained with safranin, which imparts a red color to biofilms.
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Figure 25. Initial adherence of G. vaginalis is not affected by the anti-BapL
antibody. An overnight culture of G. vaginalis was treated with either anti-BapL
antibody or preimmune antibody for 30 minutes at room temperature on a rotator.
The culture was then plated and incubated anaerobically at 37ºC for 2 hours.
Nonadherent cells were removed by washing with PBS and adherent bacteria was
stained with safranin, which imparts a red color to biofilms
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adherence than wildtype bacteria. This shows that the addition of anti-BapL antibody was
unable to inhibit initial adherence of G. vaginalis.

Anti-BapL antibody does not affect aggregation of G. vaginalis bacteria
Aggregation is an important ability of many bacteria and sometimes utilizes the
same intercellular adhesins involved in biofilm formation (Schroeder, Jularic et al. 2009;
Thompson, Abraham et al. 2010). To analyze whether BapL was playing a role in
aggregation, we again employed antibody inhibition. Overnight cultures of G. vaginalis
were standardized to ensure equal amounts of bacteria and either treated with PBS as a
control, anti-BapL antibody or preimmune antibody. The OD600 of the cultures was
measured every 15 minutes for 120 minutes, and the measurements were plotted and
slopes analyzed. Slope values similar to the slope seen with wildtype bacteria would
indicate the anti-BapL antibody had no effect on bacterial aggregation. Figure 26 shows
that the slope of the lines for wildtype bacterial aggregation, aggregation of bacteria treated
with anti-BapL antibody and bacteria treated with preimmune antibody were similar,
ranging from -0.0130 to -0.0134. This data suggests that the anti-BapL antibody does not
affect aggregation.

Anti-BapL antibody does not affect G. vaginalis adherence to cervical epithelial cells
Because the anti-BapL antibody did not affect biofilm formation or initial
adherence, we next tested whether the antibody could inhibit adherence of G. vaginalis to
cervical epithelial cells. Overnight cultures of G. vaginalis were incubated for 30 minutes
145

Figure 26. Aggregation of G. vaginalis is not affected by the anti-BapL
antibody. An overnight G. vaginalis culture was standardized to ensure equal
numbers of bacteria and either treated with PBS as a control, anti-BapL antibody or
preimmune antibody. OD600 readings were taken ever 15 minutes for 120 minutes.
The measurements were graphed, a line plotted and the slopes compared. The
slopes were similar, ranging from -0.0130 to -0.0134, indicating that addition of the
antibodies did not affect aggregation.
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at room temperature on a rotator with either 400 !g of anti-BapL antibody or 400 !g of
preimmune antibody, standardized to ensure equal numbers of bacteria then added to
confluent monolayers of ME180 cervical epithelial cells. The plates were centrifuged to
maximize interaction between the bacteria and epithelial cells and incubated at 37ºC for 15
minutes in 5% CO2. After the incubation, the wells were washed to remove nonadherent
bacteria and harvested with addition of 5% saponin. The bacteria were then diluted 10fold, plated on BPS plates and incubated for 48 hours, before plates were analyzed and
colonies counted. Figure 27A shows the percent adherence for wildtype G. vaginalis, G.
vaginalis treated with 1:20 BapL antibody and G. vaginalis treated with 1:20 preimmune
antibody. Addition of anti-BapL antibody did not significantly affect adherence of the
bacteria to cervical epithelial cells. Although the percent adherence of G. vaginalis treated
with preimmune antibody was relatively lower than either the wildtype bacteria or bacteria
treated with anti-BapL antibody, this could have been due to clumping of the bacteria
during plating. Adherence was also analyzed by confocal microscopy (Figure 27B) and it
was seen that adherence did not differ significantly between wildtype G. vaginalis and
Gardnerella treated with anti-BapL antibody or preimmune antibody. However, when G.
vaginalis was pretreated with proteinase K prior to the adherence assay, the bacteria were
unable to adhere to the cervical epithelial cells (Figure 28). This suggests that G.
vaginalis may utilize a cell wall-anchored protein, potentially the BapL protein, for
adherence to cervical epithelial cells

Anti-BapL antibody does not affect G. vaginalis interaction with ECM proteins
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Figure 27. Adherence of G. vaginalis to cervical epithelial cells is not affected
by addition of anti-BapL antibody. Adherence of wildtype G. vaginalis, bacteria
treated with anti-BapL antibodies and bacteria treated with preimmune antibodies
was compared. (A) Percent adherence calculated from CFUs and (B) Confocal
images of adherence.
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Figure 28. Adherence of proteinase K treated G. vaginalis to cervical epithelial
cells. Bacteria were grown in sBHIG anaerobically at 37 °C for 24 hrs. G.
vaginalis was first treated with 20 !g/ml of proteinase K for an hour, pelleted and
washed to remove residual enzyme. Bacteria (green) were standardized to ensure
equal numbers, added to vaginal epithelial cells (red) and incubated for 15 minutes
before washing to remove nonadherent bacteria. Qualitative estimates of adherence
were ascertained by confocal microscopy
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A surface adhesin, SgrA, involved in biofilm formation in hospital-acquired
Enterococcus faecium strains, has recently been shown to play a role in binding to
extracellular matrix molecules nidogen 1, nidogen 2 and fibrinogen (Hendrickx, van LuitAsbroek et al. 2009). Perhaps the G. vaginalis BapL protein is acting as a microbial
surface component recognizing adhesive matrix molecules (MSCRAMM), allowing the
bacteria to interact with extracellular matrix molecular like fibrinogen or fibronectin. To
test this, overnight cultures of G. vaginalis were diluted 1:10 in PBS and incubated for 30
minutes at room temperature on a rotator with either 400 !g of anti-BapL antibody or 400
!g of preimmune antibody. 200 !l of each culture was added to a 96-well plate that had
been previously incubated and immobilized with the ECM proteins fibronectin, fibrinogen,
hyuluronic acid, elastin, and collegan IV. The plates were centrifuged to maximize
interaction between the bacteria and ECM proteins then incubated at 37ºC for 10 minutes.
After the 10 minute incubation, the wells were washed to remove nonadherent bacteria
then stained with safranin to ascertain the interaction between bacteria and ECM proteins.
Figure 29 is an image of the scanned 96-well plate with G. vaginalis allowed to interact
with the ECM proteins. No difference is seen between wildtype G. vaginalis and G.
vaginalis treated with the anti-BapL antibody or preimmune antibody. This data suggests
that the anti-BapL antibody is unable to inhibit interaction of G. vaginalis with ECM
proteins.

Adherence of G. vaginalis to mucus is not affected by the anti-BapL antibody
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Figure 29. Adherence of G. vaginalis to ECM proteins is not affected by the
anti-BapL antibody. Overnight cultures of G. vaginalis were diluted 1:10 in
PBS and incubated for 30 minutes at room temperature on a rotator with either
400 !g of anti-BapL antibody or preimmune antibody. 200 !l of each culture
was added to a 96 well plate that had been precoated with ECM proteins. The
plates were centrifuged, incubated, wells washed and stained with safranin .
Red color indicates attached bacterial cells.
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Homology searches show that the BapL protein has homology to the Lactobacillus
fermentum protein Mlp, which in turn is similar to the mucus binding protein, Mub, from
Lactobacillus reuteri (Roos and Jonsson 2002; Turner, Hafner et al. 2003). The Mub
protein is a 358 kDa protein with 14 approximately 200 amino acid repeats and features
typical of other cell surface proteins of Gram positive bacteria (Roos and Jonsson 2002).
We next analyzed whether the BapL protein was playing a role in mucus binding activity
of G. vaginalis. Overnight cultures of G. vaginalis were diluted 1:10 in PBS and incubated
for 30 minutes at room temperature on a rotator with either 400 !g of anti-BapL antibody
or 400 !g of preimmune antibody. 200 !l of each culture was added to a 96-well plate that
had been previously incubated and immobilized with mucin. The plate was centrifuged to
maximize interaction between the bacteria and mucin then incubated at 37ºC for 10
minutes. After the 10 minute incubation, the wells were washed to remove nonadherent
bacteria then stained with safranin to ascertain the interaction between bacteria and mucin.
Figure 30A demonstrates that there was no difference in mucus binding ability between
wildtype G. vaginalis and G. vaginalis treated with anti-BapL antibody or preimmune
antibody, suggesting that the anti-BapL antibody is unable to inhibit interaction of G.
vaginalis with mucus. A mucin dot blot utilizing 5% and 1% dilutions of mucin on a
nitrocellulose membrane, probed with purified surface proteins from G. vaginalis
demonstrates that the BapL protein is not binding to porcine mucin (Figure 30B).
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Figure 30. Adherence of G. vaginalis to mucus is not affected by the anti-BapL
antibody. (A) Overnight cultures of G. vaginalis were diluted 1:10 in PBS and
incubated for 30 minutes at room temperature on a rotator with either 400 !g of
anti-BapL antibody or preimmune antibody. 200 !l of each culture was added to a
96 well plate that had been precoated with mucin. The plate was centrifuged,
incubated, wells washed and stained with safranin. Red color indicates attached
bacterial cells. (B) Mucin dot blot of adherence of G. vaginalis proteins.
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Opsonophagocytosis assays demonstrate that the anti-BapL antibody acts as an
effective opsonin.
We compared phagocyte killing by the anti-BapL antibody and preimmune
antibody for biofilm and dispersed biofim cultures of G. vaginalis. It is known that biofilm
bacteria exhibit increased resistance to phagocytosis; therefore, we hypothesized that the
percent killing seen with biofilm bacteria compared to dispersed biofilm bacteria would be
low. Figure 31 shows that 100% of biofilm bacteria survived when leukocytes,
preimmune antibody, and complement were added; however, 26.3% of biofilm bacteria
were killed when preimmune antibody was replaced with the anti-BapL antibody. In
contrast, dispersed biofilm bacteria were rapidly killed by leukocytes when the anti-BapL
antibody was added (97% killing). This data suggests that dispersed biofilm G. vaginalis
bacteria are more sensitive to opsonophagocytosis and the anti-BapL antibody is acting as
an effective opsonin.

Far Western analysis failed to demonstrate an interaction between BapL and ME180
cervical epithelial protein
Since we demonstrated that G. vaginalis adheres robustly to ME180 cervical
epithelial cells, we analyzed whether the BapL protein was interacting with a structure on
the surface of the cervical epithelial cells. Proteins were extracted from confluent
monolayers of ME180 cervical epithelial cells and separated by SDS-PAGE. The gels
were then transferred to PVDF membrane and incubated with surface proteins that had
been purified from G. vaginalis by sonication. The membranes were then washed, probed
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Figure 31. Opsonophagocytic activity of anti-BapL antibody and preimmune
antibody against biofilm and dispersed biofilm cultures of G. vaginalis. G.
vaginalis biofilms were grown on glass beads. Glass beads were sonicated for 10
sec to produce dispersed biofilm cultures. Cultures were subjected to
opsonophagocytic assays utilizing leukocytes, baby bunny complement and either
anti-BapL antibody or preimmune antibody. The assays were incubated for 90 mins
then dilution plated for CFU counts. Percent killing was determined as described in
the text.
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with anti-BapL antibody followed by HRP-labeled goat anti-rabbit antibody, and analyzed
by film. Figure 32A shows three membranes, one which was probed with G. vaginalis
proteins and anti-BapL antibody, the second was probed with G. vaginalis proteins and
preimmune antibody and the third was an antibody control membrane only probed by the
anti-BapL antibody. A 23 kDa band is seen on the membrane probed with G. vaginalis
proteins with the anti-BapL antibody; however, the exact same band is seen in the antibody
control membrane which was not probed with G. vaginalis proteins. This suggests that the
anti-BapL antibody is binding nonspecifically to a ME180 cervical epithelial cell protein.
To confirm these results, we continued with an immunoprecipitation assay utilizing
the anti-BapL antibody coupled to a protein G column to pull-down BapL-ME180 protein
complexes. Anti-BapL antibody was coupled to protein G beads and allowed to incubate
with 10 mg of G. vaginalis surface proteins and 10 mg of ME180 cervical epithelial cell
proteins. After a two hour incubation, the mixture was placed in a column and washed 4X
with PBS. The bound proteins were eluted by addition of 0.2M Glycine/HCl pH 2.5 and
neutralized with 1M Tris/HCl pH 9.0. The proteins were separated by SDS-PAGE and the
gel stained with Imperial protein reagent to visualize proteins. Figure 32B shows the
immunoprecipitated proteins; only the 23 kDa cervical epithelial cell protein and a few
contaminating proteins are seen on the gel, the 325 kDa BapL protein is missing. This
suggests that the 23 kDa protein is actually interacting nonspecifically with the anti-BapL
antibody and is not interacting with the BapL protein.
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Figure 32. Immunoprecipitation assays demonstrate that the anti-BapL
antibody, not BapL, interacts with a ME180 cervical epithelial protein. Me180
cervical epithelial proteins were harvested and separated by SDS-PAGE. The gel
was transferred to PVDF membrane and incubated with surface proteins from G.
vaginalis. The membrane was probed with either anti-BapL antibody or
preimmune Ab. (A) PVDF membrane incubated with G. vaginalis proteins probed
with anti-BapL antibody, membrane incubated with G. vaginalis proteins probed
with preimmune antibody or membrane incubated with no protein and probed with
anti-BapL antibody as a control. (B) Anti-BapL antibody was coupled to a protein
G column and 10 mg of G. vaginalis surface proteins and 10 mg of ME180 cervical
epithelial cell protein were ran onto column, bound proteins were eluted by 0.2M
Glycine/HCl pH 2.5. Eluted proteins were separated by SDS-PAGE and the gel
was stained overnight with Imperial protein stain. Arrow indicates the
approximatedly 23 kDa protein that interacts nonspecifically with the anti-BapL
antibody.
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EMS mutagenesis did not produce a bapL mutant of G. vaginalis
Since no genetic system is available in G. vaginalis, we utilized random
mutagenesis in order to produce a bapL mutant. Ethyl methanesulfonate or EMS is a
mutagenic, teratogenic and possibly carcinogenic organic compound that produces random
mutations in genetic material by nucleotide substitution. EMS reacts with guanine in
DNA, forming 0-6-ethylguanine, which impairs the ability of DNA polymerase to
accurately incorporate a cytosine opposite of guanine. An EMS kill curve was performed
and 50 !l of EMS for 30 minutes was found to kill 90% of G. vaginalis. This amount of
EMS and 30 minutes was used to mutate G. vaginalis. The mutagenized G. vaginalis
culture was allowed to recover for 48 hours in BHIG before being stained with anti-BapL
antibody and an Alexa-488 labeled goat anti-rabbit secondary antibody. These stained
bacteria were then sorted by fluorescence activated cell sorting (FACS) and low
fluorescent intensity bacteria were collected. The bacteria with low fluorescence intensity
could potentially have a defect in the bapL gene, producing fewer BapL proteins on the
surface of the bacteria and thereby causing a lower amount of fluorescence intensity due to
a lower amount of anti-BapL antibody binding. Bacteria with the lowest fluorescence
intensity were collected in individual wells of a 96-well plate and allowed to incubate
anaerobically for 48 hours at 37°C.
Approximately 20 potential G. vaginalis mutants were found after the 48 hour
incubation. Because we hypothesized that BapL may be playing a role in biofilm
formation, we utilized biofilm assays to determine if any of the 20 potential mutants had a
defect in biofilm formation. Unfortunately, no defect in biofilm formation was seen in any
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of the potential mutants tested. Western blot analysis of surface proteins from each of the
potential mutants was also inconclusive, in that no mutant was definitively BapL negative.
These experiments should be repeated, since thousands of potential mutants would need to
be screened in order to cover the whole G. vaginalis genome.

Heterologous expression of BapL in S. aureus caused an increase in biofilm formation
but this was found to be due to an increase in PNAG production
Finally, the bapL gene was cloned into the E. coli/S. aureus shuttle vector pRB473
for heterologous expression in the poor-biofilm producing strain of S. aureus RN4220.
The bapL gene was PCR amplified using the primers BapSbfFWD and BapSbfReV, which
had been designed from previous sequence analysis to introduce Sbf1 restriction sites on
either end of the gene. The PCR product was subcloned into the plasmid pCR2.1®Topo to
construct the recombinant plasmid pCR2.1-Topo-bapL. This plasmid was used to
transform CH3 blue chemically competent E. coli cells, resultant colonies were pooled and
plasmid purified, and plasmid was digested with Sfb1 to drop out the bapL PCR product.
This digested bapL PCR product was then ligated into Pst1-linearized E. coli/S. aureus
shuttle vector pRB473, producing plasmid pRB473-bapL, and used to transform CH3 blue
chemically competent E. coli. Plasmid was purified from individual E. coli transformants
and screened for correct insert by digestion with Pst1. Plasmid with correct insert size was
used to transform S. aureus strain RN4220, producing strain RN4220-bapL.
Strain RN4220-bapL and RN4220 with empty pRB473 were analyzed for their
ability to form a biofilm. Figure 33 shows the biofilms produced by strain RN4220-bapL
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Figure 33. Heterologous expression of BapL in S. aureus RN4220 caused an
increase in biofilm formation. The bapL gene was PCR amplified and cloned into
the E. coli/S. aureus shuttle vector pRB473. Plasmid pRB473-bapL and empty
vector were transformed into S. aureus RN4220, which is a poor-biofilm producing
strain, by electroporation. Cultures were grown in LB + 1% glucose, BHI + 1%
glucose and TSB + 1% glucose and analyzed for biofilm formation by washing and
staining with safranin.
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and empty vector under different media conditions. S. aureus RN4220-bapL was able to
produce a thicker biofilm than RN4220 with empty vector under the media conditions
tested, producing a 2.8 fold increase in biofilm in LB + 1% glucose, a 2.2 fold increase in
biofilm in BHI + 1% glucose and a 7.3 fold increase in TSB + 1% glucose.
S. aureus has a very efficient stress response system; therefore, expression of
foreign proteins can upregulate production of PNAG. To ensure that the introduction of
the bapL gene had not led to upregulation of PNAG production, a dot blot assay for PNAG
was employed. Standardized amounts of overnight cultures of RN4220-bapL and empty
vector were centrifuged to pellet the cells and resuspended in 0.5 M EDTA. The samples
were boiled, supernatants diluted, and blotted onto nitrocellulose membrane. The
membranes were then dried, blocked with BSA, and probed with anti-PNAG antibody
followed by ant-goat HRP-labeled secondary antibody. Figure 34 shows the PNAG dot
blot of two colonies of RN4220-bapL and RN4220 with empty vector; bacteria harboring
the plasmid pRB473-bapL had a significant increase in production of PNAG compared to
bacteria with empty vector. This suggests that the increase in biofilm formation seen in
bacteria with pRB473-bapL is due to an increase in PNAG production and is not directly
related to production of the BapL protein.
To circumvent this problem of increased production of PNAG, the pRB473-bapL
plasmid was transduced into S. aureus strain RN4220!ica, which is deficient in the genes
required to produce PNAG. Biofilm formation was then assessed without the interference
of increased production of PNAG. Figure 35 shows the biofilms produced by
RN4220!ica with pRB473-bapL and empty vector in different media conditions. No
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Figure 34. Dot blot analysis of PNAG production by wildtype S. aureus
RN4220 and S. aureus RN4220-bapL and empty vector. Overnight cultures of
RN4220, RN4220-bapL and RN4220 empty vector were centrifuged to pellet the
cells and resuspended in 0.5 M EDTA. The samples were boiled to extract PNAG,
diluted and blotted onto a nitrocellulose membrane. The membranes were probed
with anti-PNAG antibody and HRP-labeled secondary antibody before being
analyzed by x-ray film.
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Figure 35. Heterologous expression of BapL in a PNAG negative strain did not
cause an increase in biofilm formation. The bapL gene was PCR amplified and
cloned into the E. coli/S. aureus shuttle vector pRB473. Plasmid pRB473-bapL and
empty vector were transduced into S. aureus RN4220!ica, which is deficient in the
genes required to produce PNAG. Cultures were grown in TSB + 1% glucose, 12.5
mM calcium, 12.5 mM EGTA and 3.25% NaCl and BHI + 1% glucose, 12.5 mM
calcium, 12.5 mM EGTA and 3.25% Nacl and analyzed for biofilm formation by
washing and staining with safranin.
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significant difference is seen between the biofilms produced by the bacteria with pRB473bapL or empty vector in any of the eight media conditions tested. This could be suggestive
of a few things: the BapL protein may not be surface exposed or functional in the
heterologous host, the protein may not be translated in the host, the BapL protein may not
be important in biofilm formation or it may need to act in concert with other proteins, like
pilin, to produce biofilm.
In order to elucidate the function of the BapL protein, heterologous expression was
attempted in a number of different organisms, including Bifidobacterium longum, which is
the closest known relative of G. vaginalis, Lactococcus lactis and Bacillus subtilis.
Unfortunately, technical limitations related to the very large size of BapL prevented
expression in the other host strains.

Discussion
Recently, Swidsinski et al. found that G. vaginalis is able to form an adherent
biofilm on the vaginal epithelium of women with BV and that this biofilm may contribute
to the pathogenesis and recurrence of BV (Swidsinski, Mendling et al. 2005). Supporting
the argument that the biofilm phenotype of Gardnerella leads to the recurrence seen with
BV are the follow-up papers by Swidsinski et al. and Patterson et al. that observed a
resurgence of a dense an active bacterial biofilm consisting primarily of G. vaginalis after
cessation of treatment and biofilms of G. vaginalis were resistant to high amounts of lactic
acid and hydrogen peroxide (Patterson, Girerd et al. 2007; Swidsinski, Mendling et al.
2008). It has also been shown that G. vaginalis produces a number of virulence properties,
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including the ability to form a biofilm, produce cytotoxic changes to mammalian cells and
adhere to vaginal epithelial cells, that many of the other BV-associated organisms do not
possess; this lends precedence to the theory that G. vaginalis may be the most important
organism in the pathogenesis of BV. We choose to study biofilm formation by G.
vaginalis in order to better understand the bacteria’s role in BV and improve available
treatment methods.
We identified a protein in G. vaginalis that has significant homology to the BAP
(biofilm-associated protein) family of proteins. The first member of the BAP family to be
described was found in Staphylococcus aureus and many have since been described in a
number of other pathogenic bacteria, including Salmonella sp., Enterococcus sp, and most
recently Acinetobacter baumannii (Cucarella, Solano et al. 2001; Toledo-Arana, Valle et
al. 2001; Latasa, Roux et al. 2005; Latasa, Solano et al. 2006; Loehfelm, Luke et al. 2008).
All BAP proteins are high molecular weight, surface proteins with a core of internal
repeats involved in biofilm formation (Latasa, Solano et al. 2006). The staphylococcal
Bap protein is involved in primary attachment of the bacteria to a surface, biofilm
maturation, and production of a persistant infection (Cucarella, Solano et al. 2001; Latasa,
Solano et al. 2006).
The newly identified G. vaginalis protein, which we call BapL for Bap-like, is a
high molecular weight protein, with a predicted molecular mass of 325 kDa. It is a highly
repetitive protein, with multiple copies of repeat domains. We hypothesize that the
extensive repeat region seen in the G. vaginalis BapL protein could serve to promote
interactions between the protein and abiotic surfaces or with other BapL proteins on
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neighboring bacteria, thus leading to biofilm formation and maturation. The BapL protein
is exposed on the surface of G. vaginalis, as seen by confocal microscopy and western blot
analysis. This is consistent with the sequencing data, which shows that the BapL protein
has a carboxy-terminal segment containing an LPxTG motif, which is typical of cell wallanchored surface proteins in gram-positive bacteria (Navarre and Schneewind 1994). The
bapL gene is also highly expressed in biofilm cultures, as analyzed by reverse-transcriptase
PCR.
An antibody was generated in rabbits against a small, antigenic peptide of the BapL
protein. This antibody was utilized in antibody inhibition assays against biofilm
formation, initial adherence, adherence to cervical epithelial cells, and adherence to ECM
proteins and mucin. However, the anti-BapL antibody was unable to inhibit any of these
properties of G. vaginalis. This does not conclusively demonstrate that BapL is not
involved in any of these properties. The antibody was designed against a small, antigenic
peptide of the BapL protein and it therefore may bind in such a way that it does not inhibit
the active site of the protein thereby making the antibody inefficient in inhibiting the role
of BapL or perhaps there is redundancy within the BapL protein and other sites on the
protein can be used to elicit a function. Another reason why the anti-BapL antibody may
not block biofilm formation is that there may be other proteins, carbohydrates or nucleic
acids involved in biofilm formation that the anti-BapL antibody is unable to block.
Next, we analyzed whether the BapL protein was interacting with a receptor on the
surface of ME180 cervical epithelial cells to cause adherence. ME180 cervical epithelial
cell proteins were separated and transferred to a PVDF membrane and incubated with G.
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vaginalis surface proteins. Upon film exposure, a 23 kDa protein was visible on the
membrane incubated with G. vaginalis proteins and probed with anti-BapL antibody.
Unfortunately, the control membrane, which was not incubated with protein but was
probed with anti-BapL antibody, also showed that 23 kDa protein. This suggests that the
anti-BapL antibody interacts nonspecifically with a ME180 cervical epithelial cell protein.
However, this does not rule out the fact that BapL could be interacting with a ME180
cervical epithelial cell protein; perhaps the BapL protein has become nonfunctional during
the purification process and is unable to bind to is receptor or the receptor did not retain
fuction after electrophoresis and electroblotting.
To further elucidate whether the BapL protein was interacting with a receptor on
the surface of ME180 cervical epithelial cells, immunoprecipitation assays were
conducted. Anti-BapL antibody was coupled to protein G beads and used to pull down
BapL:ME180 protein complexes. The protein was eluted from the column, separated by
SDS-PAGE and stained overnight to visualize proteins. Outside of a few contaminanting
proteins, the only relevant protein on the gel was the 23 kDa protein that interacts
nonspecifically with the anti-BapL antibody; no BapL protein was seen on the gel. This
suggests that the BapL protein may not be the protein that allows for adherence of G.
vaginalis to ME180 cervical epithelial cells.
When EMS was used to mutagenize the G. vaginalis genome, no bapL mutants
were found. However, this could be due to the limited numbers of mutants that have been
screened or analysis of a phenotype that is not associated with inactivation of the bapL
gene. Although there are many possible pitfalls associated with producing a mutant using
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EMS, it is the most efficient mechanism of obtaining mutant bacteria when a genetic
system is lacking.
Finally, the BapL protein was expressed in a heterologous host and the host was
analyzed for biofilm formation. Introduction of a plasmid carrying the bapL gene caused
an increase in PNAG production in the S. aureus heterologous host RN4220. When the
plasmid was moved into the PNAG deficient strain, S. aureus RN4220!ica, no difference
was seen between biofilm formation in the bacteria harboring bapL versus empty vector.
This could mean that BapL plays no role in biofilm formation or that the protein is not
being expressed functionally in the heterologous host. Equally likely other components
like carbohydrates or nucleic acid might be necessary to produce biofilm, and if not
supplied by the heterologous host, no increase in biofilm formation would be seen with the
addition of just the BapL protein. It has been shown in Salmonella sp. that curli, cellulose
and the cell surface protein BapA play a role in biofilm formation; deletion of BapA
caused a loss of the capacity to form a biofilm, however, overproduction of curli could
compensate for the biofilm deficiency in the bapA mutant strain (Latasa, Roux et al. 2005;
Jonas, Tomenius et al. 2007). It is known that G. vaginalis produces pili; perhaps pili play
a role in biofilm formation along with the BapL protein (Johnson and Davies 1984;
Boustouller, Johnson et al. 1987). Without a more advanced genetic system, like plasmids
or a transformation protocol for G. vaginalis, the exact role of BapL may not be known for
some time.
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CHAPTER 6
Conclusions and Clinical Relevance

This work was designed to elucidate the virulence properties of G. vaginalis in an
effort to better understand the pathogenesis of BV and improve current therapies. BV is of
particular clinical relevance due to its propensity to increase transmission and acquisition
of the HIV retrovirus and cause numerous pregnancy complications. These studies have
addressed basic questions relating to the virulence potential of G. vaginalis and its ability
to form a biofilm. Although it was known that G. vaginalis was able to form a biofilm on
the vaginal epithelium of women with BV, nothing was known about the components of
the biofilm matrix or what gene(s) could be involved in formation of the biofilm.
To help elucidate the role of G. vaginalis in BV, the virulence potential of G.
vaginalis and other BV-associated anaerobes were compared. It was shown that G.
vaginalis is able to form a thick, adherent biofilm, cause cytotoxicity and adhere robustly
to vaginal epithelial cells (Patterson, Stull-Lane et al. 2010). The other BV-associated
anaerobes tested had one of the virulence properties, but none had the ability to produce all
three virulence properties. Surprisingly, only Peptoniphilus sp. bacteria were able to
adhere to vaginal epithelial cells in a manner similar to G. vaginalis; although,
Peptoniphilus adhered more homogenously to the vaginal cells whereas G. vaginalis
179

adhered as large clusters. This is the first record of the ability of Peptoniphilus to adhere
to vaginal epithelial cells and this data warrants more research into the role Peptoniphilus
plays in BV.
G. vaginalis has also been found to produce a pore-forming toxin called
vaginolysin (Gelber, Aguilar et al. 2008). Our research has shown that vaginolysin
requires direct contact with epithelial cells to exert its activity. There is precedence in the
literature for cholesterol-dependent cytolysins, like vaginolysin, to be injected directly into
host cells. It has been found that the Gram-positive pathogen Streptococcus pyogenes
utilizes a type III secretion-like system called cytolysin-mediated translocation for
injection of effector proteins into the host cell (Madden, Ruiz et al. 2001). Perhaps G.
vaginalis is capable of cytolysin-mediated translocation; our data support a model in which
vaginolysin is translocated into the host cell membrane via direct contact between bacteria
and host cell. We hypothesize that once vaginolysin has produced a pore in the host cell
membrane, effector proteins could be passed into the host cell through the vaginolysin pore
and vaginolysin and the effector proteins could act synergistically to trigger cytotoxicity.
One of the most important virulence properties that G. vaginalis possesses is its
ability to form a thick, tenacious biofilm. Biochemical characterization of the G. vaginalis
biofilm matrix demonstrates an increase in carbohydrate content compared to planktonic
cultures. Lectin blots, which utilize sugar-binding proteins that are highly specific for their
sugar moieties, show that wheat germ agglutinin, which binds to N-acetylglucosamine,
binds to biofilm extracts. This suggests that N-acetylglucoasmine is a major component of
the biofilm matrix.

However, when compounds that are able to degrade N180

acetylglucoasmine, like sodium metaperidoate, were used in degradation assays, the
compound was unable to degrade G. vaginalis biofilms. This suggests that although the
polysaccharide is a major constituent of the biofilm matrix, it is not the most important
component of the biofilm in regards to structure and architecture. Other degradation assays
utilizing the proteases, proteinase K and trypsin, show that the G. vaginalis biofilm is able
to be degraded by proteolytic enzymes, suggesting that a proteinaceous adhesin is involved
in biofilm formation in G. vaginalis. This is very important data in BV research because
up until this point, nothing was known about the G. vaginalis biofilm. This data points to a
new avenue of therapeutic research; an enzyme that specifically targets the biofilm matrix
of G. vaginalis may prove a valuable addition to current antibiotic therapy.
Sensitivity assays demonstrated that G. vaginalis biofilms were more resistant to
lactobacilli derived compounds and tolerated 4-fold higher concentrations of hydrogen
peroxide and 8-fold higher concentrations of lactic acid than planktonic cultures.
However, when the biofilm was degraded with proteinase K, this increased the
susceptibility of the bacteria to hydrogen peroxide and lactic acid to planktonic levels.
This alludes to the fact that BV may be better treated if the G. vaginalis bacteria are in the
planktonic mode of growth rather than the biofilm mode of growth. A good adjuvant to
antibiotic therapy would be an enzyme that could reduce biofilm mass down to its
planktonic component before addition of the antibiotic.
Natural proteases were also analyzed for their ability to degrade G. vaginalis
biofilms. The three fruit proteases, bromelain, papain and ficin, proved to be effective
biofilm degraders. We hypothesize that natural proteases, like the fruit proteases tested,
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could have the ability to degrade the G. vaginalis biofilm without overly affecting the
vaginal epithelial cells. When papain was used to disperse the biofilm, it increased killing
by clindamycin to 95%; without first dispersing the biofilm, only 70% of the bacteria were
killed by an MIC 3 times the amount needed to kill planktonic bacteria. Perhaps, papain
will eventually be used in combination with antibiotic therapy to reduce the relapse seen
with BV. Future experiments should analyze the effect of the natural proteases on vaginal
biopsies from women with or without BV.
Since it has been seen that many bacteria which produce a protein-based biofilm
matrix utilize a family of proteins called biofilm-associated proteins or BAP, we searched
a partial genome sequence of G. vaginalis for sequence homology to the most well
characterized BAP, the staphylococcal Bap protein. Our analysis revealed an open-reading
frame encoding a hypothetical protein which was of large size and contained a core of
tandem repeating units. The protein had 35% homology to the staphylococcal Bap protein
and although this does not seem like high sequence homology, the presence of other
similar characteristics, like the large size and repeating units, make it highly likely that the
hypothetical protein falls within the family of BAP proteins. The bapL gene is also highly
expressed under biofilm conditions. Due to the protein’s similarity to the staphylococcal
protein and its expression in biofilm cultures, we have called the protein BapL for Baplike.
Because the BapL protein is so large, 325 kDa, it was unrealistic to try and purify
the whole protein from E. coli and use this to immunize rabbits for production of the antiBapL antibody. Therefore, antibody was developed against a small, antigenic peptide of
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the BapL protein. This antibody was used in western blot analysis of the expression of the
BapL protein under different conditions; it was found that BapL is more highly expressed
under the biofilm mode of growth than under planktonic conditions. The antibody was
also used for confocal microscopy which confirmed surface expression of the BapL protein
and antibiotic specificity at the species level.
Antibody inhibition assays were performed to identify the function of the BapL
protein. However, the antibody failed to inhibit biofilm formation, initial adherence,
aggregation, adherence to cervical epithelial cells, and adherence of the bacteria to ECM
proteins and mucin. Since only a small, antigenic section of the BapL protein was used to
produce antibodies, it could have produced an antibody that was able to interaction with
the BapL protein, as seen in the western blot and confocal microscopy data, but failed to
interact in such a way that it blocked the active site of the protein, thereby, allowing for
continued function when the antibody was bound. However, the data could also suggest
that the BapL protein is not involved in the functions tested or the protein is required but
needs other components to fulfill its function. This could be analyzed by producing mutant
bacteria lacking the BapL protein and other components, like carbohydrates or pilin, and
testing their ability to produce a biofilm, adhere, etc. Since no genetic system is available
for G. vaginalis, employment of random mutagenesis with a DNA mutatgen like EMS
could potentially produce a bapL mutant. Although we did not find a bapL mutant using
EMS mutagenesis, this could be due to the limited number of potential mutants that were
screened.
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Since we had seen that G. vaginalis adheres robustly to ME180 cervical epithelial
cells, we hypothesized that the BapL protein may be playing a role in this adherence. To
test this, a sandwich western blot approach was taken. ME180 cervical epithelial cells
were separated by SDS-PAGE, transferred to PVDF membrane and probed with purified
surface proteins from G. vaginalis. If the BapL protein was able to interact with a protein
on the surface of the ME180 cervical epithelial cells, it should be able to bind to that band
on the PVDF membrane. When probed with the anti-BapL antibody, the ME180
protein:BapL complex should be visible on x-ray film. A 23 kDa protein was seen when
the ME180 protein PVDF membrane was probed with purified surface proteins from G.
vaginalis; however, the same band was seen in an antibody control membrane. This
suggests that the anti-BapL antibody is interacting with a ME180 protein. This data does
not rule out the hypothesis that the BapL protein is interacting with a receptor on the
surface of the ME180 cervical epithelial cells. Perhaps during purification of the surface
proteins of G. vaginalis, the BapL protein becomes inactivated or denatured; this would
inhibit binding of the protein to its ME180 protein receptor on the PVDF membrane.
Next, immunoprecipitation assays were employed to pull down any ME180
proteins that interacted with the BapL protein. The anti-BapL antibody was coupled to
protein G beads and allowed to interact with G. vaginalis surface proteins and ME180
cervical epithelial cell proteins. After an incubation, the bound protein was eluted and
separated by SDS-PAGE. The 23 kDa protein which interacted with the anti-BapL
antibody was seen on the gel; however, other than a few contaminating proteins, the BapL
protein is not seen on the gel. This suggests that the BapL protein is not interacting with a
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ME180 cervical epithelial cell surface protein. Perhaps other yet unknown G. vaginalis
surface proteins or carbohydrates interact with the ME180 cervical epithelial cells to allow
for adherence. These results could be confirmed by production of a bapL mutant strain of
G. vaginalis and testing for its ability to adhere to cell lines.
Finally, the BapL protein was expressed in the heterologous host S. aureus
RN4220, which is a poor biofilm-producing bacterial strain. S. aureus RN4220-bapL was
able to produce a thicker biofilm than RN4220 with empty vector; however, when we
tested production of the biofilm polysaccharide PNAG, it was shown that RN4220-bapL
had a significant increase in production of PNAG. Because S. aureus has a very efficient
stress response system, it sometimes upregulates production of PNAG when large amounts
of foreign DNA, such as the plasmid pRB473-bapL, are introduced. To circumvent this
problem, the plasmid pRB473-bapL was transduced into the S. aureus strain RN4220!ica;
however, in this strain, no increase in biofilm formation was seen. We hypothesized that
perhaps the BapL protein was interacting with PNAG, allowing the carbohydrate to
become anchored to the bacterial surface causing the increase in biofilm formation.
However, a PNAG blot comparing secreted and cell surface associated PNAG from S.
aureus RN4220!ica with empty vector or RN4220!ica-bapL demonstrated no difference
between PNAG on the cell surface of bacteria with the bapL vector or empty vector control
(data not shown). Other heterologous hosts, like Bifidobacterium longum and B. subtilis,
were assessed for their ability to express BapL; however, no bacteria tested have been able
to express a cell surface associated BapL protein. Because B. longum is closely related to
G. vaginalis, a B. longum plasmid, pDOJHR, was assessed for its ability to replicate in G.
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vaginalis; however, an efficient transformation protocol for G. vaginalis has not been
identified, causing problems with detecting whether pDOJHR would be an appropriate
vector for G. vaginalis.
Until a genetic system is developed to allow for mutational analysis of G. vaginalis,
the only way to ascertain what role the BapL protein is playing in biofilm formation is to
potentially develop an antibody to the whole protein or larger portions of the protein and
employ antibody inhibition assays with a number of antibodies which span the whole
protein. Also, it would be important to know which part of the protein harbors its active
site; this could be accomplished by expressing truncated versions of the protein in a
heterologous host and looking for a particular function, like adherence or biofilm
formation. However, since we were unable to show a particular function of the BapL
protein, this experiment would be a shot in the dark, utilizing a potential function that may
not actually be expressed.
The scientific community is highly interested in the enzymatic degradation of
bacterial biofilms, as biofilm formation is a cause of many medical, industrial and
environmental problems (Chaignon, Sadovskaya et al. 2007). An agent that could
disintegrate the biofilm, releasing planktonic bacterian into the environment, would allow
antibiotics to eliminate the infection with improved efficiency (Chaignon, Sadovskaya et
al. 2007). There is great need for an animal model of BV, since possible inflammatory
effects of enzymatic treatment must first be studied before using the treatment in situ.
In conclusion, we have learned that G. vaginalis is more virulent than other BVassociated anaerobes tested. Its ability to produce a biofilm could play an important role in
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the pathogenesis of BV, since biofilm bacteria are more resistant to chemicals like lactic
acid and hydrogen peroxide. A proteinaceous adhesin is involved in biofilm formation by
G. vaginalis. This is a significant result in that it allows researchers to focus their efforts
on developing an enzyme that could be used in conjunction with antibiotic therapy, to
degrade the biofilm and allow the constituent bacteria to be more susceptible to antibiotic
challenge. This pretreatment with a protease before addition of antibiotic may reduce the
amount of relapse seen with BV.

187

Literature Cited

188

Literature Cited

Amaya, R. A., F. Al-Dossary, et al. (2002). "Gardnerella vaginalis bacteremia in a
premature neonate." J Perinatol 22(7): 585-587.
Amsel, R., P. A. Totten, et al. (1983). "Nonspecific vaginitis. Diagnostic criteria and
microbial and epidemiologic associations." Am J Med 74(1): 14-22.
Anderson, D. J. and J. A. Hill (1991). Vaginitis and Vaginosis. New York, Wiley-Liss.
Anukam, K., E. Osazuwa, et al. (2006). "Augmentation of antimicrobial metronidazole
therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1
and Lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled
trial." Microbes Infect 8(6): 1450-1454.
Arciola, C. R., D. Campoccia, et al. (2005). "Prevalence of cna, fnbA and fnbB adhesin
genes among Staphylococcus aureus isolates from orthopedic infections associated
to different types of implant." FEMS Microbiol Lett 246(1): 81-86.
Atassi, F., D. Brassart, et al. (2006). "Lactobacillus strains isolated from the vaginal
microbiota of healthy women inhibit Prevotella bivia and Gardnerella vaginalis in
coculture and cell culture." FEMS Immunol Med Microbiol 48(3): 424-432.
Badel, S., C. Laroche, et al. (2008). "New method showing the influence of matrix
components in Leuconostoc mesenteroides biofilm formation." Appl Biochem
Biotechnol 151(2-3): 364-370.
Bafica, A., C. A. Scanga, et al. (2004). "The induction of Toll-like receptor tolerance
enhances rather than suppresses HIV-1 gene expression in transgenic mice." J
Leukoc Biol 75(3): 460-466.
Bak, J., S. D. Ladefoged, et al. (2009). "Dose requirements for UVC disinfection of
catheter biofilms." Biofouling 25(4): 289-296.
Barken, K. B., S. J. Pamp, et al. (2008). "Roles of type IV pili, flagellum-mediated motility
and extracellular DNA in the formation of mature multicellular structures in
Pseudomonas aeruginosa biofilms." Environ Microbiol 10(9): 2331-2343.
Beigi, R. H., M. N. Austin, et al. (2004). "Antimicrobial resistance associated with the
treatment of bacterial vaginosis." Am J Obstet Gynecol 191(4): 1124-1129.
Berg, C. H., S. Kalfas, et al. (2001). "Proteolytic degradation of oral biofilms in vitro and
in vivo: potential of proteases originating from Euphausia superba for plaque
control." Eur J Oral Sci 109(5): 316-324.
Borchardt, K. A., B. S. Adly, et al. (1989). "Importance of Gardnerella vaginalis as an
aetiological agent in bacterial vaginosis." Genitourin Med 65(4): 285.

189

Boskey, E. R., R. A. Cone, et al. (2001). "Origins of vaginal acidity: high D/L lactate ratio
is consistent with bacteria being the primary source." Hum Reprod 16(9): 18091813.
Boustouller, Y. L., A. P. Johnson, et al. (1987). "Pili on Gardnerella vaginalis studied by
electronmicroscopy." J Med Microbiol 23(4): 327-329.
Boustouller, Y. L., A. P. Johnson, et al. (1986). "Detection of a species-specific antigen of
Gardnerella vaginalis by Western blot analysis." J Gen Microbiol 132(7): 19691973.
Boyd, A. and A. M. Chakrabarty (1994). "Role of alginate lyase in cell detachment of
Pseudomonas aeruginosa." Appl Environ Microbiol 60(7): 2355-2359.
Bradford, M. M. (1976). "A rapid and sensitive method for the quantitation of microgram
quantities of protein utilizing the principle of protein-dye binding." Anal Biochem
72: 248-254.
Branda, S. S., F. Chu, et al. (2006). "A major protein component of the Bacillus subtilis
biofilm matrix." Mol Microbiol 59(4): 1229-1238.
Camargo, R. P., J. A. Simoes, et al. (2005). "Impact of treatment for bacterial vaginosis on
prematurity among Brazilian pregnant women: a retrospective cohort study." Sao
Paulo Med J 123(3): 108-112.
Cappelli, G., C. Tetta, et al. (2005). "Is biofilm a cause of silent chronic inflammation in
haemodialysis patients? A fascinating working hypothesis." Nephrol Dial
Transplant 20(2): 266-270.
Castonguay, M. H., S. van der Schaaf, et al. (2006). "Biofilm formation by Escherichia coli
is stimulated by synergistic interactions and co-adhesion mechanisms with
adherence-proficient bacteria." Res Microbiol 157(5): 471-478.
Catlin, B. W. (1992). "Gardnerella vaginalis: characteristics, clinical considerations, and
controversies." Clin Microbiol Rev 5(3): 213-237.
Cauci, S., J. F. Culhane, et al. (2008). "Among pregnant women with bacterial vaginosis,
the hydrolytic enzymes sialidase and prolidase are positively associated with
interleukin-1beta." Am J Obstet Gynecol 198(1): 132 e131-137.
Cauci, S., S. Driussi, et al. (2002). "Correlation of local interleukin-1beta levels with
specific IgA response against Gardnerella vaginalis cytolysin in women with
bacterial vaginosis." Am J Reprod Immunol 47(5): 257-264.
Cauci, S., J. Hitti, et al. (2002). "Vaginal hydrolytic enzymes, immunoglobulin A against
Gardnerella vaginalis toxin, and risk of early preterm birth among women in
preterm labor with bacterial vaginosis or intermediate flora." Am J Obstet Gynecol
187(4): 877-881.
Cerca, N. and K. K. Jefferson (2008). "Effect of growth conditions on poly-Nacetylglucosamine expression and biofilm formation in Escherichia coli." FEMS
Microbiol Lett 283(1): 36-41.
Cerca, N., K. K. Jefferson, et al. (2006). "Comparative antibody-mediated phagocytosis of
Staphylococcus epidermidis cells grown in a biofilm or in the planktonic state."
Infect Immun 74(8): 4849-4855.

190

Cerca, N., S. Martins, et al. (2005). "Comparative assessment of antibiotic susceptibility of
coagulase-negative staphylococci in biofilm versus planktonic culture as assessed
by bacterial enumeration or rapid XTT colorimetry." J Antimicrob Chemother
56(2): 331-336.
Chai, Y., F. Chu, et al. (2008). "Bistability and biofilm formation in Bacillus subtilis." Mol
Microbiol 67(2): 254-263.
Chaignon, P., I. Sadovskaya, et al. (2007). "Susceptibility of staphylococcal biofilms to
enzymatic treatments depends on their chemical composition." Appl Microbiol
Biotechnol 75(1): 125-132.
Choi, A. H., L. Slamti, et al. (2009). "The pgaABCD locus of Acinetobacter baumannii
encodes the production of poly-beta-1-6-N-acetylglucosamine, which is critical for
biofilm formation." J Bacteriol 191(19): 5953-5963.
Christensen, G. D., W. A. Simpson, et al. (1985). "Adherence of Coagulase-Negative
Staphylococci to Plastic Tissue-Culture Plates - a Quantitative Model for the
Adherence of Staphylococci to Medical Devices." Journal of Clinical Microbiology
22(6): 996-1006.
Cohen, C. R., A. Duerr, et al. (1995). "Bacterial vaginosis and HIV seroprevalence among
female commercial sex workers in Chiang Mai, Thailand." AIDS 9(9): 1093-1097.
Coleman, J. S., J. Hitti, et al. (2007). "Infectious correlates of HIV-1 shedding in the
female upper and lower genital tracts." AIDS 21(6): 755-759.
Costerton, J. W., P. S. Stewart, et al. (1999). "Bacterial biofilms: a common cause of
persistent infections." Science 284(5418): 1318-1322.
Cristiano, L., N. Coffetti, et al. (1989). "Bacterial vaginosis: prevalence in outpatients,
association with some micro-organisms and laboratory indices." Genitourin Med
65(6): 382-387.
Criswell, B. S., C. L. Ladwig, et al. (1969). "Haemophilus vaginalis: vaginitis by
inoculation from culture." Obstet Gynecol 33(2): 195-199.
Criswell, B. S., W. A. Stenback, et al. (1972). "Fine structure of Haemophilus vaginalis." J
Bacteriol 109(2): 930-932.
Cucarella, C., C. Solano, et al. (2001). "Bap, a Staphylococcus aureus surface protein
involved in biofilm formation." J Bacteriol 183(9): 2888-2896.
de Amorin, A., H. R. Borba, et al. (1999). "Anthelmintic activity of the latex of Ficus
species." J Ethnopharmacol 64(3): 255-258.
del Pozo, J. L. and R. Patel (2007). "The challenge of treating biofilm-associated bacterial
infections." Clin Pharmacol Ther 82(2): 204-209.
Denney, J. M. and J. F. Culhane (2009). "Bacterial vaginosis: a problematic infection from
both a perinatal and neonatal perspective." Semin Fetal Neonatal Med 14(4): 200203.
Dowd, S. E., R. D. Wolcott, et al. (2008). "Polymicrobial nature of chronic diabetic foot
ulcer biofilm infections determined using bacterial tag encoded FLX amplicon
pyrosequencing (bTEFAP)." PLoS One 3(10): e3326.
Dubois, M., K. Gilles, et al. (1951). "A colorimetric method for the determination of
sugars." Nature 168(4265): 167.
191

Easmon, C. S., L. Clark, et al. (1985). "Phagocytosis and killing of Gardnerella vaginalis
by human neutrophils." J Clin Pathol 38(7): 747-749.
Easmon, C. S., C. A. Ison, et al. (1982). "Pharmacokinetics of metronidazole and its
principal metabolites and their activity against Gardnerella vaginalis." Br J Vener
Dis 58(4): 246-249.
Edmunds, P. N. (1960). "Haemophilus vaginalis: morphology, cultural characters and
viability." J Pathol Bacteriol 79: 273-284.
Equils, O., E. Faure, et al. (2001). "Bacterial lipopolysaccharide activates HIV long
terminal repeat through Toll-like receptor 4." J Immunol 166(4): 2342-2347.
Eschenbach, D. A. (1993). "History and review of bacterial vaginosis." Am J Obstet
Gynecol 169(2 Pt 2): 441-445.
Eschenbach, D. A., S. Hillier, et al. (1988). "Diagnosis and clinical manifestations of
bacterial vaginosis." Am J Obstet Gynecol 158(4): 819-828.
Ferris, D. G., M. S. Litaker, et al. (1995). "Treatment of bacterial vaginosis: a comparison
of oral metronidazole, metronidazole vaginal gel, and clindamycin vaginal cream."
J Fam Pract 41(5): 443-449.
Fredheim, E. G., C. Klingenberg, et al. (2009). "Biofilm formation by Staphylococcus
haemolyticus." J Clin Microbiol 47(4): 1172-1180.
Fredricks, D. N., T. L. Fiedler, et al. (2005). "Molecular identification of bacteria
associated with bacterial vaginosis." N Engl J Med 353(18): 1899-1911.
Fredricks, D. N., T. L. Fiedler, et al. (2007). "Targeted PCR for detection of vaginal
bacteria associated with bacterial vaginosis." J Clin Microbiol 45(10): 3270-3276.
Fruton, J. S. (2002). "A history of pepsin and related enzymes." Q Rev Biol 77(2): 127147.
Fuqua, W. C., S. C. Winans, et al. (1994). "Quorum sensing in bacteria: the LuxR-LuxI
family of cell density-responsive transcriptional regulators." J Bacteriol 176(2):
269-275.
Gardner, H. L. and C. D. Dukes (1954). "New etiologic agent in nonspecific bacterial
vaginitis." Science 120(3125): 853.
Gardner, H. L. and C. D. Dukes (1955). "Haemophilus vaginalis vaginitis: a newly defined
specific infection previously classified non-specific vaginitis." Am J Obstet
Gynecol 69(5): 962-976.
Gelber, S. E., J. L. Aguilar, et al. (2008). "Functional and phylogenetic characterization of
Vaginolysin, the human-specific cytolysin from Gardnerella vaginalis." J Bacteriol
190(11): 3896-3903.
Geshnizgani, A. M. and A. B. Onderdonk (1992). "Defined medium simulating genital
tract secretions for growth of vaginal microflora." J Clin Microbiol 30(5): 13231326.
Giao, M. S., N. F. Azevedo, et al. (2008). "Persistence of Helicobacter pylori in
heterotrophic drinking-water biofilms." Appl Environ Microbiol 74(19): 58985904.

192

Goldberg, R. L. and J. A. Washington II. (1976). "Comparison of isolation of Haemophilus
vaginalis (Corynebacterium vaginale) from peptone-starch-dextrose agar and
Columbia colistin-nalidixic acid agar." J. Clin. Microbiol. 4: 245-247.
Graham, S., C. Howes, et al. (2009). "Vertebral osteomyelitis and discitis due to
Gardnerella vaginalis." J Med Microbiol 58(Pt 10): 1382-1384.
Gravett, M. G., D. Hummel, et al. (1986). "Preterm labor associated with subclinical
amniotic fluid infection and with bacterial vaginosis." Obstet Gynecol 67(2): 229237.
Greenwood, J. R. (1983). "Current taxonomic status of Gardnerella vaginalis." Scand J
Infect Dis Suppl 40: 11-14.
Hall-Stoodley, L. and P. Stoodley (2002). "Developmental regulation of microbial
biofilms." Curr Opin Biotechnol 13(3): 228-233.
Hamilton, M. A. (2002). "Testing antimicrobials against biofilm bacteria." J AOAC Int
85(2): 479-485.
Hanna, N. F., D. Taylor-Robinson, et al. (1985). "The relation between vaginal pH and the
microbiological status in vaginitis." Br J Obstet Gynaecol 92(12): 1267-1271.
Harmsen, M., M. Lappann, et al. (2010). "The role of extra-cellular DNA during biofilm
formation of Listeria monocytogenes." Appl Environ Microbiol.
Hauth, J. C., R. L. Goldenberg, et al. (1995). "Reduced incidence of preterm delivery with
metronidazole and erythromycin in women with bacterial vaginosis." N Engl J Med
333(26): 1732-1736.
Hay, P. E. (1998). "Recurrent bacterial vaginosis." Dermatol Clin 16(4): 769-773, xii-xiii.
Heilmann, C., M. Hussain, et al. (1997). "Evidence for autolysin-mediated primary
attachment of Staphylococcus epidermidis to a polystyrene surface." Mol Microbiol
24(5): 1013-1024.
Heilmann, C., O. Schweitzer, et al. (1996). "Molecular basis of intercellular adhesion in
the biofilm-forming Staphylococcus epidermidis." Mol Microbiol 20(5): 10831091.
Hendrickx, A. P., M. van Luit-Asbroek, et al. (2009). "SgrA, a nidogen-binding LPXTG
surface adhesin implicated in biofilm formation, and EcbA, a collagen binding
MSCRAMM, are two novel adhesins of hospital-acquired Enterococcus faecium."
Infect Immun 77(11): 5097-5106.
Hennig, S., S. Nyunt Wai, et al. (2007). "Spontaneous switch to PIA-independent biofilm
formation in an ica-positive Staphylococcus epidermidis isolate." Int J Med
Microbiol 297(2): 117-122.
Hillier, S. and K. K. Holmes (1990). Sexually Transmitted Diseases. New York, McGraw
Hill.
Hillier, S. L., R. P. Nugent, et al. (1995). "Association between bacterial vaginosis and
preterm delivery of a low-birth-weight infant. The Vaginal Infections and
Prematurity Study Group." N Engl J Med 333(26): 1737-1742.
Holmes, K. K., C. Spiegel, et al. (1981). "Nonspecific vaginosis." Scand J Infect Dis Suppl
26: 110-114.

193

Holst, E., L. Svensson, et al. (1984). "Vaginal colonization with Gardnerella vaginalis and
anaerobic curved rods." Scand J Urol Nephrol Suppl 86: 147-152.
Huang, R., D. M. Gascoyne-Binzi, et al. (1997). "Molecular evolution of the tet(M) gene in
Gardnerella vaginalis." J Antimicrob Chemother 40(4): 561-565.
Jackson, P., W. J. Ridley, et al. (1979). "Single dose metronidazole prophylaxis in
gynaecological surgery." N Z Med J 89(633): 243-245.
Jefferson, K. K. and N. Cerca (2006). "Bacterial-bacterial cell interactions in biofilms:
detection of polysaccharide intercellular adhesins by blotting and confocal
microscopy." Methods Mol Biol 341: 119-126.
Johnson, A. P. and H. A. Davies (1984). "Demonstration by electron microscopy of pili on
Gardnerella vaginalis." Br J Vener Dis 60(6): 396-397.
Johnson, A. P., C. A. Ison, et al. (1984). "Vaginal colonization of pig-tailed macaques by
Gardnerella vaginalis." Scand J Urol Nephrol Suppl 86: 207-210.
Jonas, K., H. Tomenius, et al. (2007). "Roles of curli, cellulose and BapA in Salmonella
biofilm morphology studied by atomic force microscopy." BMC Microbiol 7: 70.
Kapiga, S. H., N. E. Sam, et al. (2007). "The role of herpes simplex virus type 2 and other
genital infections in the acquisition of HIV-1 among high-risk women in northern
Tanzania." J Infect Dis 195(9): 1260-1269.
Kaplan, J. B., C. Ragunath, et al. (2003). "Detachment of Actinobacillus
actinomycetemcomitans biofilm cells by an endogenous beta-hexosaminidase
activity." J Bacteriol 185(16): 4693-4698.
Kaplan, J. B., C. Ragunath, et al. (2004). "Enzymatic detachment of Staphylococcus
epidermidis biofilms." Antimicrob Agents Chemother 48(7): 2633-2636.
Kaplan, J. B., K. Velliyagounder, et al. (2004). "Genes involved in the synthesis and
degradation of matrix polysaccharide in Actinobacillus actinomycetemcomitans
and Actinobacillus pleuropneumoniae biofilms." J Bacteriol 186(24): 8213-8220.
Kim, H., J. H. Ryu, et al. (2007). "Effectiveness of disinfectants in killing Enterobacter
sakazakii in suspension, dried on the surface of stainless steel, and in a biofilm."
Appl Environ Microbiol 73(4): 1256-1265.
Klebanoff, S. J. and R. W. Coombs (1991). "Viricidal effect of Lactobacillus acidophilus
on human immunodeficiency virus type 1: possible role in heterosexual
transmission." J Exp Med 174(1): 289-292.
Kolenbrander, P. E., R. N. Andersen, et al. (2002). "Communication among oral bacteria."
Microbiol Mol Biol Rev 66(3): 486-505, table of contents.
Kravitz, S. R., J. McGuire, et al. (2008). "Management of skin ulcers: understanding the
mechanism and selection of enzymatic debriding agents." Adv Skin Wound Care
21(2): 72-74.
Kubota, H., S. Senda, et al. (2009). "Stress resistance of biofilm and planktonic
Lactobacillus plantarum subsp. plantarum JCM 1149." Food Microbiol 26(6): 592597.
Lagace-Wiens, P. R., B. Ng, et al. (2008). "Gardnerella vaginalis bacteremia in a
previously healthy man: case report and characterization of the isolate." J Clin
Microbiol 46(2): 804-806.
194

Lam, M. H. and D. F. Birch (1991). "Survival of Gardnerella vaginalis in human urine."
Am J Clin Pathol 95(2): 234-239.
Larsson, P. G., M. Bergstrom, et al. (2005). "Bacterial vaginosis. Transmission, role in
genital tract infection and pregnancy outcome: an enigma." APMIS 113(4): 233245.
Larsson, P. G., J. J. Platz-Christensen, et al. (1991). "Clue cells in predicting infections
after abdominal hysterectomy." Obstet Gynecol 77(3): 450-452.
Lasa, I. and J. R. Penades (2006). "Bap: a family of surface proteins involved in biofilm
formation." Res Microbiol 157(2): 99-107.
Latasa, C., A. Roux, et al. (2005). "BapA, a large secreted protein required for biofilm
formation and host colonization of Salmonella enterica serovar Enteritidis." Mol
Microbiol 58(5): 1322-1339.
Latasa, C., C. Solano, et al. (2006). "Biofilm-associated proteins." C R Biol 329(11): 849857.
Libby, E. K., K. E. Pascal, et al. (2008). "Atopobium vaginae triggers an innate immune
response in an in vitro model of bacterial vaginosis." Microbes Infect 10(4): 439446.
Lindsay, D. and A. von Holy (2006). "Bacterial biofilms within the clinical setting: what
healthcare professionals should know." J Hosp Infect 64(4): 313-325.
Loehfelm, T. W., N. R. Luke, et al. (2008). "Identification and characterization of an
Acinetobacter baumannii biofilm-associated protein." J Bacteriol 190(3): 10361044.
Mack, D., J. Riedewald, et al. (1999). "Essential functional role of the polysaccharide
intercellular adhesin of Staphylococcus epidermidis in hemagglutination." Infect
Immun 67(2): 1004-1008.
Madden, J. C., N. Ruiz, et al. (2001). "Cytolysin-mediated translocation (CMT): a
functional equivalent of type III secretion in gram-positive bacteria." Cell 104(1):
143-152.
Mardh, P. A., E. Holst, et al. (1984). "The grivet monkey as a model for study of vaginitis.
Challenge with anaerobic curved rods and Gardnerella vaginalis." Scand J Urol
Nephrol Suppl 86: 201-205.
Marrazzo, J. M., K. K. Thomas, et al. (2008). "Relationship of specific vaginal bacteria and
bacterial vaginosis treatment failure in women who have sex with women." Ann
Intern Med 149(1): 20-28.
Maurer, H. R. (2001). "Bromelain: biochemistry, pharmacology and medical use." Cell
Mol Life Sci 58(9): 1234-1245.
McGregor, J. A., J. I. French, et al. (1995). "Prevention of premature birth by screening
and treatment for common genital tract infections: results of a prospective
controlled evaluation." Am J Obstet Gynecol 173(1): 157-167.
McKenney, D., J. Hubner, et al. (1998). "The ica locus of Staphylococcus epidermidis
encodes production of the capsular polysaccharide/adhesin." Infect Immun 66(10):
4711-4720.

195

McLean, N. W. and J. A. McGroarty (1996). "Growth inhibition of metronidazolesusceptible and metronidazole-resistant strains of Gardnerella vaginalis by
Lactobacilli in vitro." Appl Environ Microbiol 62(3): 1089-1092.
Mickelsen, P. A., L. R. McCarthy, et al. (1977). "New differential medium for the isolation
of Corynebacterium vaginale." J Clin Microbiol 5(4): 488-489.
Morales, W. J., S. Schorr, et al. (1994). "Effect of metronidazole in patients with preterm
birth in preceding pregnancy and bacterial vaginosis: a placebo-controlled, doubleblind study." Am J Obstet Gynecol 171(2): 345-347; discussion 348-349.
Muli, F. and J. K. Struthers (1998). "Use of a continuous-culture biofilm system to study
the antimicrobial susceptibilities of Gardnerella vaginalis and Lactobacillus
acidophilus." Antimicrob Agents Chemother 42(6): 1428-1432.
Navarre, W. W. and O. Schneewind (1994). "Proteolytic cleavage and cell wall anchoring
at the LPXTG motif of surface proteins in gram-positive bacteria." Mol Microbiol
14(1): 115-121.
Nelson, D. B., A. Hanlon, et al. (2009). "Preterm labor and bacterial vaginosis-associated
bacteria among urban women." J Perinat Med 37(2): 130-134.
Nemoto, K., K. Hirota, et al. (2000). "Effect of Varidase (streptokinase) on biofilm formed
by Staphylococcus aureus." Chemotherapy 46(2): 111-115.
Neri, P., S. Salvolini, et al. (2009). "Retinal vasculitis associated with asymptomatic
Gardnerella vaginalis infection: a new clinical entity." Ocul Immunol Inflamm
17(1): 36-40.
Nikolaitchouk, N., B. Andersch, et al. (2008). "The lower genital tract microbiota in
relation to cytokine-, SLPI- and endotoxin levels: application of checkerboard
DNA-DNA hybridization (CDH)." APMIS 116(4): 263-277.
O'Gara, J. P. (2007). "ica and beyond: biofilm mechanisms and regulation in
Staphylococcus epidermidis and Staphylococcus aureus." FEMS Microbiol Lett
270(2): 179-188.
O'Neill, E., H. Humphreys, et al. (2009). "Carriage of both the fnbA and fnbB genes and
growth at 37 degrees C promote FnBP-mediated biofilm development in meticillinresistant Staphylococcus aureus clinical isolates." J Med Microbiol 58(Pt 4): 399402.
O'Toole, G., H. B. Kaplan, et al. (2000). "Biofilm formation as microbial development."
Annu Rev Microbiol 54: 49-79.
Oakley, B. B., T. L. Fiedler, et al. (2008). "Diversity of human vaginal bacterial
communities and associations with clinically defined bacterial vaginosis." Appl
Environ Microbiol 74(15): 4898-4909.
Oleen-Burkey, M. A. and S. L. Hillier (1995). "Pregnancy complications associated with
bacterial vaginosis and their estimated costs." Infect Dis Obstet Gynecol 3(4): 149157.
Onderdonk, A. B., M. L. Lee, et al. (2003). "Quantitative microbiologic models for
preterm delivery." J Clin Microbiol 41(3): 1073-1079.

196

Overhage, J., M. Schemionek, et al. (2005). "Expression of the psl operon in Pseudomonas
aeruginosa PAO1 biofilms: PslA performs an essential function in biofilm
formation." Appl Environ Microbiol 71(8): 4407-4413.
Passerini de Rossi, B., C. Garcia, et al. (2009). "Activity of levofloxacin and ciprofloxacin
on biofilms and planktonic cells of Stenotrophomonas maltophilia isolates from
patients with device-associated infections." Int J Antimicrob Agents 34(3): 260264.
Patterson, J. L., P. H. Girerd, et al. (2007). "Effect of biofilm phenotype on resistance of
Gardnerella vaginalis to hydrogen peroxide and lactic acid." Am J Obstet Gynecol
197(2): 170 e171-177.
Patterson, J. L., A. Stull-Lane, et al. (2010). "Analysis of adherence, biofilm formation and
cytotoxicity suggests a greater virulence potential of Gardnerella vaginalis relative
to other bacterial-vaginosis-associated anaerobes." Microbiology 156(Pt 2): 392399.
Peeters, M. and P. Piot (1985). "Adhesion of Gardnerella vaginalis to vaginal epithelial
cells: variables affecting adhesion and inhibition by metronidazole." Genitourin
Med 61(6): 391-395.
Periasamy, S. and P. E. Kolenbrander (2009). "Aggregatibacter actinomycetemcomitans
builds mutualistic biofilm communities with Fusobacterium nucleatum and
Veillonella species in saliva." Infect Immun 77(9): 3542-3551.
Perry, R. D., A. G. Bobrov, et al. (2004). "Temperature regulation of the hemin storage
(Hms+) phenotype of Yersinia pestis is posttranscriptional." J Bacteriol 186(6):
1638-1647.
Pilatte, Y., J. Bignon, et al. (1993). "Sialic acids as important molecules in the regulation
of the immune system: pathophysiological implications of sialidases in immunity."
Glycobiology 3(3): 201-218.
Piot, P. and E. Van Dyck (1983). "Isolation and identification of Gardnerella vaginalis."
Scand J Infect Dis Suppl 40: 15-18.
Piot, P., E. Van Dyck, et al. (1984). "Biotypes of Gardnerella vaginalis." J Clin Microbiol
20(4): 677-679.
Platz-Christensen, J. J., I. Mattsby-Baltzer, et al. (1993). "Endotoxin and interleukin-1
alpha in the cervical mucus and vaginal fluid of pregnant women with bacterial
vaginosis." Am J Obstet Gynecol 169(5): 1161-1166.
Ramundo, J. and M. Gray (2008). "Enzymatic wound debridement." J Wound Ostomy
Continence Nurs 35(3): 273-280.
Reid, G. (2001). "Probiotic agents to protect the urogenital tract against infection." Am J
Clin Nutr 73(2 Suppl): 437S-443S.
Reimer, L. G. (1991). "Gardnerella vaginalis bacteremia." Compr Ther 17(2): 3-5.
Reimer, L. G. and L. B. Reller (1984). "Gardnerella vaginalis bacteremia: a review of
thirty cases." Obstet Gynecol 64(2): 170-172.
Reyn, A., A. Birch-Andersen, et al. (1966). "An electron microscope study of thin sections
of Haemophilus vaginalis (Gardner and Dukes) and some possibly related species."
Can J Microbiol 12(6): 1125-1136.
197

Roos, S. and H. Jonsson (2002). "A high-molecular-mass cell-surface protein from
Lactobacillus reuteri 1063 adheres to mucus components." Microbiology 148(Pt 2):
433-442.
Rottini, G., A. Dobrina, et al. (1990). "Identification and partial characterization of a
cytolytic toxin produced by Gardnerella vaginalis." Infect Immun 58(11): 37513758.
Ryder, C., M. Byrd, et al. (2007). "Role of polysaccharides in Pseudomonas aeruginosa
biofilm development." Curr Opin Microbiol 10(6): 644-648.
Salmon, S. A., R. D. Walker, et al. (1991). "Characterization of Gardnerella vaginalis and
G. vaginalis-like organisms from the reproductive tract of the mare." J Clin
Microbiol 29(6): 1157-1161.
Schmid, G., L. Markowitz, et al. (2000). "Bacterial vaginosis and HIV infection." Sex
Transm Infect 76(1): 3-4.
Schroeder, K., M. Jularic, et al. (2009). "Molecular characterization of a novel
Staphylococcus aureus surface protein (SasC) involved in cell aggregation and
biofilm accumulation." PLoS One 4(10): e7567.
Scott, T. G., B. Curran, et al. (1989). "Electron microscopy of adhesive interactions
between Gardnerella vaginalis and vaginal epithelial cells, McCoy cells and human
red blood cells." J Gen Microbiol 135(3): 475-480.
Scott, T. G. and C. J. Smyth (1987). "Haemagglutination and tissue culture adhesion of
Gardnerella vaginalis." J Gen Microbiol 133(8): 1999-2005.
Sewankambo, N., R. H. Gray, et al. (1997). "HIV-1 infection associated with abnormal
vaginal flora morphology and bacterial vaginosis." Lancet 350(9077): 546-550.
Shaw, C. E., M. E. Forsyth, et al. (1981). "Rapid presumptive identification of Gardnerella
vaginalis (Haemophilus vaginalis) from human blood agar media." J Clin Microbiol
14(1): 108-110.
Shikuma, N. J. and F. H. Yildiz (2009). "Identification and characterization of OscR, a
transcriptional regulator involved in osmolarity adaptation in Vibrio cholerae." J
Bacteriol 191(13): 4082-4096.
Sivadon-Tardy, V., A. L. Roux, et al. (2009). "Gardnerella vaginalis acute hip arthritis in a
renal transplant recipient." J Clin Microbiol 47(1): 264-265.
Sobel, J. D. (2000). "Bacterial vaginosis." Annu Rev Med 51: 349-356.
Sobel, J. D., J. Schneider, et al. (1981). "Adherence of bacteria to vaginal epithelial cells at
various times in the menstrual cycle." Infect Immun 32(1): 194-197.
Soper, D. E., R. C. Bump, et al. (1990). "Bacterial vaginosis and trichomoniasis vaginitis
are risk factors for cuff cellulitis after abdominal hysterectomy." Am J Obstet
Gynecol 163(3): 1016-1021; discussion 1021-1013.
Stalhammar-Carlemalm, M., L. Stenberg, et al. (1993). "Protein rib: a novel group B
streptococcal cell surface protein that confers protective immunity and is expressed
by most strains causing invasive infections." J Exp Med 177(6): 1593-1603.
Stamey, T. A. and M. M. Timothy (1975). "Studies of introital colonization in women with
recurrent urinary infections. III. Vaginal glycogen concentrations." J Urol 114(2):
268-270.
198

Stepek, G., D. J. Buttle, et al. (2005). "Assessment of the anthelmintic effect of natural
plant cysteine proteinases against the gastrointestinal nematode, Heligmosomoides
polygyrus, in vitro." Parasitology 130(Pt 2): 203-211.
Sung, J. M., P. D. Chantler, et al. (2006). "Accessory gene regulator locus of
Staphylococcus intermedius." Infect Immun 74(5): 2947-2956.
Swidsinski, A., W. Mendling, et al. (2005). "Adherent biofilms in bacterial vaginosis."
Obstet Gynecol 106(5 Pt 1): 1013-1023.
Swidsinski, A., W. Mendling, et al. (2008). "An adherent Gardnerella vaginalis biofilm
persists on the vaginal epithelium after standard therapy with oral metronidazole."
Am J Obstet Gynecol 198(1): 97 e91-96.
Taussig, S. J. and S. Batkin (1988). "Bromelain, the enzyme complex of pineapple (Ananas
comosus) and its clinical application. An update." J Ethnopharmacol 22(2): 191203.
Tendolkar, P. M., A. S. Baghdayan, et al. (2005). "The N-terminal domain of enterococcal
surface protein, Esp, is sufficient for Esp-mediated biofilm enhancement in
Enterococcus faecalis." J Bacteriol 187(17): 6213-6222.
Thomas, V. C., L. R. Thurlow, et al. (2008). "Regulation of autolysis-dependent
extracellular DNA release by Enterococcus faecalis extracellular proteases
influences biofilm development." J Bacteriol 190(16): 5690-5698.
Thompson, K. M., N. Abraham, et al. (2010). "Staphylococcus aureus extracellular
adherence protein contributes to biofilm formation in the presence of serum."
FEMS Microbiol Lett.
Toledo-Arana, A., J. Valle, et al. (2001). "The enterococcal surface protein, Esp, is
involved in Enterococcus faecalis biofilm formation." Appl Environ Microbiol
67(10): 4538-4545.
Turner, M. S., L. M. Hafner, et al. (2003). "Peptide surface display and secretion using two
LPXTG-containing surface proteins from Lactobacillus fermentum BR11." Appl
Environ Microbiol 69(10): 5855-5863.
Tysnes, B. B., H. R. Maurer, et al. (2001). "Bromelain reversibly inhibits invasive
properties of glioma cells." Neoplasia 3(6): 469-479.
Vandecasteele, S. J., W. E. Peetermans, et al. (2003). "Expression of biofilm-associated
genes in Staphylococcus epidermidis during in vitro and in vivo foreign body
infections." J Infect Dis 188(5): 730-737.
Vanderlinde, E. M., J. J. Harrison, et al. (2009). "Identification of a novel ABC transporter
required for desiccation tolerance, and biofilm formation in Rhizobium
leguminosarum bv. viciae 3841." FEMS Microbiol Ecol.
Veenstra, G. J., F. F. Cremers, et al. (1996). "Ultrastructural organization and regulation of
a biomaterial adhesin of Staphylococcus epidermidis." J Bacteriol 178(2): 537-541.
Verstraelen, H., R. Verhelst, et al. (2004). "Culture-independent analysis of vaginal
microflora: the unrecognized association of Atopobium vaginae with bacterial
vaginosis." Am J Obstet Gynecol 191(4): 1130-1132.
Vilain, S., J. M. Pretorius, et al. (2009). "DNA as an adhesin: Bacillus cereus requires
extracellular DNA to form biofilms." Appl Environ Microbiol 75(9): 2861-2868.
199

Vuong, C., J. M. Voyich, et al. (2004). "Polysaccharide intercellular adhesin (PIA) protects
Staphylococcus epidermidis against major components of the human innate
immune system." Cell Microbiol 6(3): 269-275.
Wang, X., J. F. Preston, 3rd, et al. (2004). "The pgaABCD locus of Escherichia coli
promotes the synthesis of a polysaccharide adhesin required for biofilm formation."
J Bacteriol 186(9): 2724-2734.
Watts, D. H., M. A. Krohn, et al. (1990). "Bacterial vaginosis as a risk factor for postcesarean endometritis." Obstet Gynecol 75(1): 52-58.
Wennerholm, U. B., B. Holm, et al. (1998). "Interleukin-1alpha, interleukin-6 and
interleukin-8 in cervico/vaginal secretion for screening of preterm birth in twin
gestation." Acta Obstet Gynecol Scand 77(5): 508-514.
Whitchurch, C. B., T. Tolker-Nielsen, et al. (2002). "Extracellular DNA required for
bacterial biofilm formation." Science 295(5559): 1487.
White-Ziegler, C. A., S. Um, et al. (2008). "Low temperature (23 degrees C) increases
expression of biofilm-, cold-shock- and RpoS-dependent genes in Escherichia coli
K-12." Microbiology 154(Pt 1): 148-166.
Witkin, S. S., I. M. Linhares, et al. (2007). "An altered immunity hypothesis for the
development of symptomatic bacterial vaginosis." Clin Infect Dis 44(4): 554-557.
Zariffard, M. R., R. M. Novak, et al. (2005). "Induction of tumor necrosis factor- alpha
secretion and toll-like receptor 2 and 4 mRNA expression by genital mucosal fluids
from women with bacterial vaginosis." J Infect Dis 191(11): 1913-1921.
Zhang, A., S. M. Gonzalez, et al. (2001). "Construction of a mini-intein fusion system to
allow both direct monitoring of soluble protein expression and rapid purification of
target proteins." Gene 275(2): 241-252.
Zinnemann, K. and G. C. Turner (1963). "The taxonomic position of "Haemophilus
vaginalis" [Corynebacterium vaginale]." J. Pathol. Bacteriol. 85: 213-219.

200

APPENDIX A
Percent reduction in biofilm mass of each enzyme concentration tested.

201

Appendix A. Percent reduction in biofilm mass of each enzyme
concentration tested.
Bromelain
Units

10

2

0.4

0.08 1.6E-2 3.2E-3 6.4E-4 1.3E-4 2.6E-5 5.1E-6

pH 7.4 67.1 52

75.6

69.4

55.9

38

13.5

12.9

14

24.4

59

47.8

40.3

34.6

28.9

20.6

24.3

pH 4.5 75.9 72.6 69.6

Papain
Units

10

2

0.4

0.08 1.6E-2 3.2E-3 6.4E-4 1.3E-4 2.6E-5 5.1E-6

pH 7.4 84.5 88.9 83.3

62.6

32.4

8

0

0

0

0.1

pH 4.5 88.5 88.6 85.9

61.7

32.3

26.4

19

13.5

12.3

15.1

Ficin
Units

5.78 1.12 2.3E-1 4.6E-2 9.3E-3 1.9E-3 3.7E-4 7.4E-5 1.4E-5 3.0E-6

pH 7.4 91.8 88.9 66.1

59.2

46.1

16.9

0

5.3

9.2

21

pH 4.5 92.7 75.2 77.8

74.5

41.1

24.5

22.2

26.9

21.1

20.6

Pepsin
Units

345 69

13.8

2.76 5.5E-1 1.1E-1 2.3E-2 4.4E-3 8.8E-4 1.8E-4

pH 7.4 34.7 19.3 26.8

22.4

19.6

13.3

10.6

7

11.5

21.4

pH 4.5 60.3 36.5 29.8

22

22.3

21

20.5

15.4

15.6

10

Values shown are percent biofilm reduction for each enzyme unit tested.
202

VITA
Jennifer Louise Patterson was born April 14, 1983 in Virginia Beach, Virginia.
She is a citizen of the United States. She graduated from Princess Anne High School,
Virginia Beach, Virginia in 2001. She received her Bachelor of Science degree in
Recombinant Gene Technology from Concord University in 2005. Her interest in bacterial
pathogenesis led her to Virginia Commonwealth University where she received a doctorate
degree in 2010. While at VCU, she received the Mary Coleman Award, Phi Kappa Phi
scholarship, C.C. Clayton Award and the Elizabeth Fries Young Investigator award.
Jennifer was selected as a member of the US Delegration to the 57th Nobel Laureate
Meeting in Lindau, Germany, as well as a member of the Phi Kappa Phi Honor Society.
Jennifer published two first author papers in the journals American Journal of Obstetrics
and Gynecology and Microbiology. She published a second author paper in the Journal of
Virology. She is a member of the American Society of Microbiology and Women in
Science (VCU Chapter).

203

